data_2rm4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rm4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.025 0.441 . . . . 1.6 110.075 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.33 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 1.03 110.391 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.16 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.94 110.493 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 1.04 110.178 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 1.04 110.748 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.6 109.435 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 1.01 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 1.02 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.94 109.658 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 1.15 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 1.16 111.531 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.16 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 1.0 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.28 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 1.03 109.988 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 1.02 110.475 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.6 109.887 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.56 109.548 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 1.05 109.944 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.88 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 1.07 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 1.02 109.469 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 1.01 110.532 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 1.15 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 1.03 110.597 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 3.21 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 1.22 111.623 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.54 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.97 110.248 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.3 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.33 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 1.08 109.835 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.39 110.286 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 1.34 110.276 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 4.18 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 3.33 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 2.19 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.39 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 1.18 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.06 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 1.06 109.2 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 1.07 109.582 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.447 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 1.04 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 2.39 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.95 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 1.05 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 1.05 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.93 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.52 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 1.1 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 1.16 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 1.11 109.965 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 120.815 0.341 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.425 ' CE3' HD23 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 HD11 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' CE3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.734 0.302 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.401 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.401 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.41 HD12 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.755 0.312 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.426 ' CE3' HD23 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.457 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 HD23 ' CE3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 120.842 0.353 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CE3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD22 ' CE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.438 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.405 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.438 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 120.802 0.334 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.457 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.721 0.296 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.416 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.467 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.934 0.397 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.425 ' CE3' HD21 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.404 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD21 ' CE3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.418 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.46 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 24' ' ' PHE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 120.932 0.396 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.435 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.412 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.821 0.344 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.451 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.437 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.43 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.418 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.459 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.459 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 120.788 0.327 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 120.772 0.32 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 120.774 0.321 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.441 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.401 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 120.819 0.342 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 7.17 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.91 75.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.766 -0.843 . . . . 5.59 110.132 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp -149.92 151.88 34.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 6.54 109.856 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.78 72.53 0.62 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.736 -1.346 . . . . 3.54 109.736 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.5 127.74 24.8 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.161 1.085 . . . . 2.96 110.633 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.5 p -153.88 94.51 1.77 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.686 -0.634 . . . . 1.81 110.208 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -165.33 168.82 16.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.71 -0.619 . . . . 1.65 110.234 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.25 -6.95 46.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.745 -0.597 . . . . 1.48 111.95 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.272 -0.893 . . . . 1.6 110.075 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.33 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 1.03 110.391 -170.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.16 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.94 110.493 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 1.04 110.178 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 1.04 110.748 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.6 109.435 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 1.01 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 1.02 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.94 109.658 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 1.15 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 1.16 111.531 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.16 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 1.0 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.28 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 1.03 109.988 172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 1.02 110.475 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.6 109.887 172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.56 109.548 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 1.05 109.944 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.88 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 1.07 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 1.02 109.469 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 1.01 110.532 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 1.15 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 1.03 110.597 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 3.21 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 1.22 111.623 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.54 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.97 110.248 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.3 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.33 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 1.08 109.835 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.39 110.286 -175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 1.34 110.276 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 4.18 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 3.33 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 2.19 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.39 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 1.18 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.06 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 1.06 109.2 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 1.07 109.582 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.447 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 1.04 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 2.39 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.95 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 1.05 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 1.05 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.93 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.52 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 1.1 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 1.16 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 1.11 109.965 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -137.11 99.9 9.79 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.65 158.19 47.51 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.325 1.171 . . . . 1.54 110.183 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.97 147.53 34.01 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.66 -0.65 . . . . 3.26 110.308 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -74.82 123.02 24.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.676 -0.64 . . . . 8.09 110.376 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -101.34 -45.23 5.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.821 -0.549 . . . . 8.91 110.25 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.8 125.17 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.785 -0.572 . . . . 8.68 110.42 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -33.24 72.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 11.96 110.177 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 44.8 t0 53.31 74.04 0.33 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.394 -0.816 . . . . 12.96 110.992 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 72.46 0.51 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 14.69 109.726 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 53.8 29.25 9.38 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.39 -1.065 . . . . 16.73 111.032 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -60.23 -38.12 82.43 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.722 -0.611 . . . . 18.17 110.152 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -124.17 170.97 7.77 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.723 -0.611 . . . . 18.89 110.236 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.73 159.33 24.94 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.194 1.102 . . . . 19.39 110.426 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 22.7 Cg_exo -57.62 -47.72 20.22 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.127 1.067 . . . . 19.65 111.262 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 27.2 Cg_exo -58.64 146.64 90.95 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 122.865 0.929 . . . . 19.71 110.573 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.2 143.74 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.775 -0.578 . . . . 20.71 110.351 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.53 -34.8 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.735 -0.603 . . . . 21.17 110.029 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.11 -35.57 64.78 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.582 -0.699 . . . . 22.73 110.881 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -62.85 145.56 95.96 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.673 -0.642 . . . . 22.59 110.088 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.57 142.43 98.85 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.247 1.13 . . . . 23.25 110.586 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.2 p -122.55 100.46 41.3 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.767 -0.583 . . . . 24.16 110.13 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.82 -53.64 0.69 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.176 1.093 . . . . 24.88 110.336 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.66 142.28 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.716 -0.615 . . . . 26.08 110.31 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -87.08 136.0 33.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.704 -0.623 . . . . 26.98 110.129 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.78 110.16 27.96 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.729 -0.607 . . . . 26.33 110.153 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.5 145.29 87.32 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.071 1.037 . . . . 27.21 110.393 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 52.38 -175.38 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.409 -0.807 . . . . 26.98 111.075 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.23 137.47 46.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 28.19 110.191 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.3 m -63.63 157.59 23.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.666 -0.646 . . . . 28.44 110.118 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -57.79 -34.98 70.18 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.585 -0.697 . . . . 29.08 110.52 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.69 133.75 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.759 -0.588 . . . . 30.34 110.049 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.31 130.27 46.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.667 -0.646 . . . . 31.27 110.177 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 117.978 -1.457 . . . . 29.95 109.557 -179.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.83 146.51 52.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.702 -0.881 . . . . 0.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -87.02 136.9 32.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.743 -0.598 . . . . 0.0 110.218 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.89 145.81 45.61 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 99.56 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.144 1.076 . . . . 0.0 110.457 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 67.9 p -96.94 8.94 43.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.624 . . . . 0.0 111.49 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -79.03 140.1 38.01 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.213 -0.93 . . . . 0.0 110.604 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.22 -3.87 29.46 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.643 -0.66 . . . . 0.0 111.849 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -68.32 -26.0 65.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.342 -0.849 . . . . 0.0 110.189 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.425 ' CE3' HD23 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 HD11 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' CE3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -137.33 146.57 54.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.75 -31.36 94.88 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.124 1.065 . . . . 0.0 110.627 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.92 141.67 12.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.685 -0.634 . . . . 0.0 110.138 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -61.14 -42.34 98.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.694 -0.629 . . . . 0.0 110.013 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 52.11 24.32 2.67 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.526 -0.734 . . . . 0.0 111.216 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -105.91 0.86 26.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.514 -0.741 . . . . 0.0 111.595 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.44 -35.06 79.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.55 -37.28 78.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 110.497 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.57 -77.99 1.36 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.25 170.66 15.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.737 -0.86 . . . . 0.0 110.342 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.0 m -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.723 -0.611 . . . . 0.0 110.121 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.3 59.36 13.2 Favored Pre-proline 0 N--CA 1.503 2.225 0 O-C-N 121.435 -0.79 . . . . 0.0 110.783 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.93 165.59 32.37 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.135 1.071 . . . . 0.0 110.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.6 146.76 96.49 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.21 1.111 . . . . 0.0 110.252 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.73 134.11 52.11 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.153 1.081 . . . . 0.0 110.572 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.94 -23.65 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.69 -0.631 . . . . 0.0 110.778 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.32 -37.88 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.495 -0.753 . . . . 0.0 110.016 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -77.57 140.03 39.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.129 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -67.65 142.22 95.83 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.17 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -62.19 143.67 94.68 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.219 1.115 . . . . 0.0 110.321 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 p -71.03 149.67 94.8 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 110.046 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.52 -28.59 86.94 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.121 1.064 . . . . 0.0 110.434 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.79 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.774 -0.579 . . . . 0.0 109.717 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -83.64 133.19 34.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.703 -0.623 . . . . 0.0 110.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mt -99.95 145.66 30.57 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.75 -0.594 . . . . 0.0 110.342 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.69 154.11 62.62 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.142 1.075 . . . . 0.0 110.314 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -104.8 130.06 52.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.33 -37.39 80.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.759 -0.588 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -56.91 -38.26 72.61 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.53 -0.731 . . . . 0.0 110.797 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 t30 53.02 48.9 21.34 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.368 -0.833 . . . . 0.0 110.932 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.4 mt -110.47 134.75 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.641 . . . . 0.0 109.995 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.67 -35.43 77.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.529 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.571 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.89 72.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.759 -0.848 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -149.59 158.16 43.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.721 -0.612 . . . . 0.0 109.891 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.88 89.69 1.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.03 140.53 90.42 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.186 1.098 . . . . 0.0 110.464 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.8 p -147.29 20.32 1.21 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.678 -0.639 . . . . 0.0 110.734 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -79.43 150.72 31.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.483 -0.761 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.14 -4.0 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.692 -0.63 . . . . 0.0 111.825 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -68.55 -25.2 64.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.401 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.401 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.41 HD12 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -137.08 102.53 9.08 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -62.4 143.37 93.38 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.189 1.1 . . . . 0.0 110.184 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.94 143.5 33.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.678 -0.639 . . . . 0.0 110.345 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -97.18 144.69 26.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.598 . . . . 0.0 110.13 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -114.06 148.27 37.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.635 . . . . 0.0 110.239 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -76.86 177.07 7.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.777 -0.577 . . . . 0.0 110.275 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 78' ' ' HIS . 27.4 tp -95.81 132.06 41.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.722 -0.611 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -58.47 -38.55 77.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.12 -172.7 38.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' CE1' ' CD2' ' A' ' 75' ' ' LEU . 98.7 m-70 -119.67 145.1 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.818 -0.813 . . . . 0.0 110.089 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 m -58.35 -40.18 81.48 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.584 -0.697 . . . . 0.0 110.389 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.55 142.82 28.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.762 -0.587 . . . . 0.0 110.14 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.95 138.18 43.46 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 O-C-N 123.118 1.062 . . . . 0.0 110.128 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.2 Cg_exo -59.01 -48.72 13.29 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 123.143 1.076 . . . . 0.0 111.064 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 20.9 Cg_exo -61.67 141.15 89.94 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.961 0.979 . . . . 0.0 110.376 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.02 127.92 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.647 -0.658 . . . . 0.0 109.917 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.73 -44.58 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.752 -0.592 . . . . 0.0 110.055 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -143.0 108.58 5.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.724 -0.61 . . . . 0.0 110.505 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -91.97 140.32 24.73 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.0 110.12 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -61.79 145.81 96.99 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.112 1.059 . . . . 0.0 110.417 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.7 p -122.45 100.4 41.68 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.702 -0.624 . . . . 0.0 110.274 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.92 -28.62 87.56 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.149 1.078 . . . . 0.0 110.441 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.35 155.94 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.288 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -59.63 -39.11 83.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.731 -0.605 . . . . 0.0 110.313 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.21 110.21 51.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.749 -0.595 . . . . 0.0 110.061 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.05 140.07 93.6 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 122.916 0.956 . . . . 0.0 110.638 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -104.42 17.91 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.781 -0.574 . . . . 0.0 111.138 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.35 -37.89 78.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.351 -0.843 . . . . 0.0 110.33 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -125.58 141.69 51.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -59.02 -34.87 72.39 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.623 -0.673 . . . . 0.0 110.343 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.03 134.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.701 -0.624 . . . . 0.0 110.092 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.9 tt -99.38 130.63 45.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.175 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -64.17 145.25 56.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.764 -0.845 . . . . 0.0 110.164 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm -149.97 154.27 37.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.646 -0.659 . . . . 0.0 109.935 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.87 153.84 20.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.42 65.72 5.5 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.194 1.102 . . . . 0.0 110.359 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -93.51 11.06 29.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 111.325 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -78.42 147.12 34.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.89 -3.9 31.67 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.712 -0.617 . . . . 0.0 111.885 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -67.34 -27.88 67.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.426 ' CE3' HD23 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.457 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 HD23 ' CE3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -137.2 139.59 28.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.87 153.16 52.52 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.251 1.132 . . . . 0.0 110.683 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.95 -171.93 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.762 -0.586 . . . . 0.0 110.116 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -58.13 -35.08 70.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.699 -0.626 . . . . 0.0 110.562 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.96 137.55 36.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.712 -0.618 . . . . 0.0 110.206 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 135.96 39.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.709 -0.62 . . . . 0.0 110.152 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.9 tt -107.25 128.55 54.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.709 -0.62 . . . . 0.0 110.271 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.73 119.14 25.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.733 -0.604 . . . . 0.0 110.032 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.58 -171.79 34.77 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -58.56 -37.21 75.24 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.875 . . . . 0.0 110.467 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.6 m -70.48 137.03 49.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 110.164 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.18 62.34 9.86 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.419 -0.801 . . . . 0.0 110.818 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 21.2 Cg_exo -58.81 -48.53 14.33 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.077 1.04 . . . . 0.0 111.04 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 22.8 Cg_exo -60.91 147.01 96.8 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 122.997 0.998 . . . . 0.0 110.363 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 146.56 97.56 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.212 1.111 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.03 134.96 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.71 -0.619 . . . . 0.0 109.887 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.61 135.24 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.923 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -104.32 137.43 42.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.759 -0.588 . . . . 0.0 110.149 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -66.61 147.63 98.93 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.711 -0.618 . . . . 0.0 110.147 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.94 146.34 97.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.162 1.085 . . . . 0.0 110.397 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.6 t -123.54 100.22 38.47 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.29 -25.39 57.09 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 122.894 0.944 . . . . 0.0 111.135 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.81 -28.17 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.515 -0.741 . . . . 0.0 110.513 -175.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -96.6 138.16 34.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 110.135 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.18 162.01 24.11 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 0.0 110.363 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.42 153.5 65.62 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.192 1.101 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -108.58 137.43 46.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.792 -0.568 . . . . 0.0 110.216 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.66 -37.59 76.32 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 0.0 110.521 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.4 m -57.12 -34.19 68.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.64 -0.662 . . . . 0.0 110.757 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.67 44.44 28.58 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.6 pt -123.14 160.84 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 110.448 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.8 130.21 45.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.845 -0.534 . . . . 0.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.543 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.36 72.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.729 -0.865 . . . . 0.0 110.093 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -87.48 136.78 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.693 -0.629 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.36 151.76 50.12 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.62 148.62 53.18 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.188 1.099 . . . . 0.0 111.016 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.9 p -96.08 24.65 5.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.711 -0.618 . . . . 0.0 110.604 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.9 151.83 37.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.622 -0.673 . . . . 0.0 110.484 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -71.99 -4.05 26.29 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.694 -0.629 . . . . 0.0 111.877 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.03 -22.03 65.9 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.347 -0.845 . . . . 0.0 110.253 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.449 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.423 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -137.15 94.04 12.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -61.46 -33.34 88.27 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 O-C-N 123.264 1.139 . . . . 0.0 110.432 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.81 -41.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.688 -0.633 . . . . 0.0 110.278 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -75.96 127.31 32.7 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.702 -0.624 . . . . 0.0 110.17 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.37 -34.62 75.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.739 -0.601 . . . . 0.0 110.592 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 54.04 46.8 24.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.372 -0.83 . . . . 0.0 110.717 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.42 -36.51 73.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.677 -0.64 . . . . 0.0 110.529 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.59 -36.42 73.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.6 26.41 50.75 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -58.89 -41.78 87.95 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -1.01 . . . . 0.0 110.207 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 m -61.08 -36.23 79.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.731 -0.606 . . . . 0.0 110.185 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.8 111.73 52.54 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.739 -0.601 . . . . 0.0 110.33 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.404 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 24.9 Cg_exo -57.88 -52.24 6.38 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.022 1.012 . . . . 0.0 111.367 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 27.9 Cg_endo -70.16 153.1 67.39 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 O-C-N 122.915 0.955 . . . . 0.0 110.696 -172.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.77 155.86 35.63 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.283 1.149 . . . . 0.0 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.09 138.76 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.698 -0.626 . . . . 0.0 109.879 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.15 -34.24 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.627 -0.671 . . . . 0.0 110.753 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.4 t30 54.63 48.83 19.44 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.332 -0.855 . . . . 0.0 110.705 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -54.62 -59.37 10.62 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.608 -0.683 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -62.02 146.77 96.1 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 O-C-N 123.035 1.019 . . . . 0.0 110.329 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.8 t -106.85 150.14 39.37 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.752 -0.592 . . . . 0.0 110.289 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.22 -36.51 68.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 123.226 1.119 . . . . 0.0 110.502 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.15 150.12 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.601 -0.687 . . . . 0.0 110.464 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -65.13 -34.89 79.46 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.735 -0.603 . . . . 0.0 110.505 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 25.6 mt -69.23 144.81 95.47 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.9 140.55 85.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.224 1.118 . . . . 0.0 110.383 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -59.34 -29.47 67.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.687 -0.633 . . . . 0.0 110.361 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.72 153.69 23.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.0 110.314 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -115.07 151.24 34.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.753 -0.592 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -93.72 148.79 21.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.774 -0.579 . . . . 0.0 110.22 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.31 -32.43 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.731 -0.606 . . . . 0.0 109.777 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.68 130.51 39.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.706 -0.621 . . . . 0.0 110.181 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.05 74.99 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.785 -0.832 . . . . 0.0 110.109 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm -146.7 149.4 33.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.732 -0.605 . . . . 0.0 109.655 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.31 74.32 0.44 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.12 59.57 7.04 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.118 1.062 . . . . 0.0 110.595 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.5 p -96.69 12.73 30.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.442 -0.786 . . . . 0.0 111.09 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.73 148.69 34.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.334 -0.854 . . . . 0.0 110.291 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.74 -4.16 32.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.699 -0.626 . . . . 0.0 111.918 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -67.58 -29.69 69.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.251 -0.906 . . . . 0.0 110.196 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CE3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.428 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD22 ' CE3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -137.24 138.21 24.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.2 148.93 91.52 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.09 1.048 . . . . 0.0 110.372 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.96 139.38 58.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.654 -0.653 . . . . 0.0 110.142 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -60.36 -35.98 76.94 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.771 -0.581 . . . . 0.0 110.312 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 54.12 40.74 31.95 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.557 -0.714 . . . . 0.0 110.774 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -108.6 154.98 21.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.709 -0.619 . . . . 0.0 110.185 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -98.32 122.46 41.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.604 . . . . 0.0 110.036 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -110.68 15.07 22.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.762 -0.586 . . . . 0.0 111.226 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.29 136.61 30.4 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -58.42 -35.29 71.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.897 . . . . 0.0 110.347 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -75.86 140.56 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.813 -0.555 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.87 68.47 2.8 Favored Pre-proline 0 N--CA 1.504 2.24 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.06 155.45 44.87 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.159 1.084 . . . . 0.0 110.468 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.33 148.12 91.39 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.209 1.11 . . . . 0.0 110.425 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.32 149.3 81.93 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.22 1.116 . . . . 0.0 110.609 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.26 -36.66 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 109.745 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.85 -38.05 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.727 -0.608 . . . . 0.0 109.917 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -96.87 126.78 42.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -125.79 101.77 29.4 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.729 -0.607 . . . . 0.0 110.339 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.15 150.64 64.39 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.126 1.066 . . . . 0.0 110.57 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.7 t -68.21 112.54 11.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.759 -0.588 . . . . 0.0 110.418 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.81 160.01 50.22 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 122.929 0.962 . . . . 0.0 110.326 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.1 133.32 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.69 -0.631 . . . . 0.0 109.696 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -65.74 126.79 29.55 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.802 -0.561 . . . . 0.0 110.681 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.17 163.2 18.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.772 -0.58 . . . . 0.0 110.067 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.65 141.66 97.44 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.047 1.025 . . . . 0.0 110.502 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.22 140.68 52.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.319 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.41 155.8 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.752 -0.592 . . . . 0.0 110.262 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -114.99 142.21 46.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -112.15 24.3 12.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.606 -0.684 . . . . 0.0 110.797 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.17 -34.48 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.624 -0.673 . . . . 0.0 109.826 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.0 mt -93.18 141.68 28.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.714 -0.616 . . . . 0.0 110.156 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.549 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.96 146.02 53.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.845 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.12 -33.65 38.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.736 -0.602 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.94 81.46 0.36 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 10.1 Cg_endo -57.36 156.64 24.98 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 O-C-N 123.119 1.062 . . . . 0.0 110.837 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 p -96.98 24.09 6.58 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.751 -0.593 . . . . 0.0 110.715 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -76.18 159.85 30.27 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.26 -3.71 25.28 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.0 112.108 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -65.99 -21.71 66.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.167 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.438 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.405 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.438 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -136.05 99.92 10.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.86 -24.61 74.35 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.32 1.168 . . . . 0.0 110.85 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.21 142.45 51.72 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.533 -0.729 . . . . 0.0 110.468 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -91.0 138.59 31.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.737 -0.602 . . . . 0.0 110.325 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -109.01 151.59 26.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.719 -0.613 . . . . 0.0 110.17 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -82.32 117.01 22.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.769 -0.582 . . . . 0.0 110.293 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' HB2' ' CE1' ' A' ' 78' ' ' HIS . 89.5 mt -100.02 138.43 37.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.732 -0.605 . . . . 0.0 110.273 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 148.05 36.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.601 . . . . 0.0 110.378 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.27 -38.89 3.0 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 75' ' ' LEU . 79.8 m80 -59.27 -33.76 71.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.671 -0.899 . . . . 0.0 110.269 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 p -119.47 164.57 15.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.637 . . . . 0.0 110.181 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 159.46 22.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.714 -0.616 . . . . 0.0 110.152 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.26 160.23 31.8 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.178 1.094 . . . . 0.0 110.343 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.76 -58.34 1.78 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 O-C-N 123.144 1.076 . . . . 0.0 111.884 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.8 Cg_endo -60.97 143.85 99.44 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 122.984 0.992 . . . . 0.0 110.385 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.55 143.32 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 110.261 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.35 -39.79 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.741 -0.599 . . . . 0.0 109.76 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -100.43 117.21 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -126.03 82.02 65.51 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.698 -0.626 . . . . 0.0 110.157 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.11 143.89 99.52 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.071 1.037 . . . . 0.0 110.512 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 p -115.26 106.58 50.85 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.0 110.192 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.65 145.28 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.03 1.016 . . . . 0.0 110.714 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.4 t -116.44 135.78 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.647 -0.658 . . . . 0.0 110.006 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt 54.47 42.51 31.32 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 110.928 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 tp -113.09 109.94 51.69 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.69 -0.631 . . . . 0.0 109.989 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -65.62 126.59 16.36 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.029 1.015 . . . . 0.0 110.597 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -69.5 -41.91 75.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.793 -0.567 . . . . 0.0 110.169 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -58.02 -36.29 72.49 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.724 -0.61 . . . . 0.0 110.692 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -56.21 -32.55 64.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.62 -0.675 . . . . 0.0 111.039 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -131.6 165.6 23.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.631 . . . . 0.0 110.567 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tp -126.11 137.35 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.766 -0.584 . . . . 0.0 110.191 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.32 -36.95 81.55 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.26 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.535 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.91 72.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.796 -0.826 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.5 140.54 29.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.758 -0.589 . . . . 0.0 110.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 69.13 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.59 125.03 16.73 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.187 1.098 . . . . 0.0 110.615 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.4 p -151.13 26.88 0.7 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.694 -0.629 . . . . 0.0 110.233 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -77.15 157.21 31.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.413 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.05 -6.34 32.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.613 -0.679 . . . . 0.0 111.749 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.26 -25.9 65.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 0.0 110.136 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.457 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -137.12 100.09 9.72 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.58 124.64 12.66 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 O-C-N 123.294 1.155 . . . . 0.0 110.165 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.33 155.37 7.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 110.307 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -130.46 126.51 37.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.681 -0.637 . . . . 0.0 109.965 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.66 -39.99 86.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.668 -0.645 . . . . 0.0 110.49 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.29 -166.25 0.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.717 . . . . 0.0 110.341 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 tp -58.09 -36.08 72.34 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.636 -0.665 . . . . 0.0 110.456 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 54.46 45.94 26.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.427 -0.796 . . . . 0.0 110.885 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.01 146.49 46.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -118.52 134.59 54.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.86 . . . . 0.0 110.374 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.9 p -83.53 -17.63 41.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.756 -0.59 . . . . 0.0 111.086 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' N ' ' CD ' ' A' ' 81' ' ' PRO . . . -51.55 -48.79 85.76 Favored Pre-proline 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 111.496 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 24.9 Cg_exo -59.03 140.49 95.55 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 122.95 0.974 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.0 Cg_exo -58.7 -49.24 12.2 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.17 1.09 . . . . 0.0 111.077 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 24.2 Cg_exo -59.49 140.64 95.05 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 122.915 0.955 . . . . 0.0 110.643 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.14 134.85 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 0.0 109.912 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.31 141.62 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.723 -0.611 . . . . 0.0 110.458 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -109.43 139.74 44.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.818 -0.551 . . . . 0.0 110.222 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -65.53 154.35 88.34 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.713 -0.617 . . . . 0.0 110.192 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.24 148.52 89.61 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.21 1.111 . . . . 0.0 110.531 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 95' ' ' HIS . 7.5 p -113.93 100.47 52.44 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.701 -0.624 . . . . 0.0 110.103 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.09 142.74 98.01 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.158 1.083 . . . . 0.0 110.45 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.04 -23.28 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.662 -0.649 . . . . 0.0 110.794 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.0 -35.2 70.9 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.793 . . . . 0.0 110.519 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.55 110.09 59.8 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.721 -0.612 . . . . 0.0 110.076 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.27 134.43 48.69 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.059 1.031 . . . . 0.0 110.396 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 89' ' ' THR . 78.5 m80 -97.48 -23.0 16.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.817 -0.552 . . . . 0.0 110.697 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -135.59 164.47 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.739 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 92.5 p -117.72 154.7 31.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 110.243 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.12 -33.63 69.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.42 -33.87 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.733 -0.604 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.86 130.49 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.673 -0.642 . . . . 0.0 110.198 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.84 144.83 56.75 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.703 -0.88 . . . . 0.0 110.135 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp -150.04 145.4 26.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.765 -0.584 . . . . 0.0 110.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.5 159.11 27.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -82.96 55.48 5.23 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 123.166 1.088 . . . . 0.0 111.008 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -99.64 10.71 40.87 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 111.18 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -79.44 171.26 15.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.277 -0.889 . . . . 0.0 110.9 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -75.52 -3.94 36.98 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.718 -0.614 . . . . 0.0 111.974 177.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.99 -31.92 73.11 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 HD12 ' CD1' ' A' ' 24' ' ' PHE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -137.06 94.69 12.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.29 -29.31 85.91 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.279 1.147 . . . . 0.0 110.672 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 51.81 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -92.7 147.07 23.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.766 -0.584 . . . . 0.0 110.446 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 54.82 44.19 28.82 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -60.32 -37.22 79.9 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.713 -0.617 . . . . 0.0 110.289 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -101.52 130.69 47.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.734 -0.604 . . . . 0.0 110.349 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.67 44.85 29.13 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.393 -0.817 . . . . 0.0 110.963 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.19 -73.86 1.21 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.96 -41.22 91.41 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.744 -0.857 . . . . 0.0 110.368 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.1 m -59.91 -40.4 88.69 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.741 -0.599 . . . . 0.0 110.414 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.84 79.43 74.52 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.741 -0.599 . . . . 0.0 110.443 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 140.25 45.47 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.131 1.069 . . . . 0.0 110.132 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.5 Cg_exo -59.05 -48.7 13.27 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 O-C-N 123.038 1.02 . . . . 0.0 111.015 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 21.5 Cg_exo -61.26 140.23 87.52 Favored 'Trans proline' 0 N--CA 1.488 1.184 0 O-C-N 123.01 1.005 . . . . 0.0 110.361 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.86 -43.3 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.637 -0.664 . . . . 0.0 109.621 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.88 155.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.761 -0.587 . . . . 0.0 110.287 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -91.8 12.97 19.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.697 -0.627 . . . . 0.0 111.301 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -56.8 -59.75 11.48 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 110.859 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.98 146.95 96.06 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.049 1.026 . . . . 0.0 110.409 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 m -95.46 118.54 66.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.627 . . . . 0.0 110.078 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.82 -25.21 78.64 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 122.973 0.986 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.45 135.36 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.652 -0.655 . . . . 0.0 109.994 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -59.29 -37.41 77.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.71 -0.619 . . . . 0.0 110.383 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.63 110.15 62.64 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.669 -0.644 . . . . 0.0 110.125 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.93 140.67 91.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.02 1.01 . . . . 0.0 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -88.22 -18.44 28.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.759 -0.588 . . . . 0.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -102.51 137.52 40.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -117.93 151.3 37.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.753 -0.592 . . . . 0.0 110.148 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -66.63 152.49 45.24 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.693 -0.63 . . . . 0.0 110.164 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.86 137.1 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.751 -0.593 . . . . 0.0 109.909 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.2 141.93 28.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.53 0 CA-C-O 117.912 -1.493 . . . . 0.0 109.466 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -143.4 153.78 43.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.731 -0.864 . . . . 0.0 110.161 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -81.01 -33.68 33.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.779 -0.576 . . . . 0.0 110.159 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.88 81.15 0.83 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -61.27 135.4 57.82 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.311 1.164 . . . . 0.0 110.272 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.5 p -149.83 28.24 0.77 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.743 -0.598 . . . . 0.0 110.372 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.1 151.48 35.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -67.95 -9.18 43.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.736 -0.602 . . . . 0.0 111.613 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.48 -25.39 65.85 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.402 -0.812 . . . . 0.0 110.095 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.416 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.467 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.467 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -137.09 95.65 11.8 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.45 -55.76 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 O-C-N 123.324 1.171 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.87 145.68 54.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.681 -0.637 . . . . 0.0 110.297 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -94.28 145.7 24.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.753 -0.592 . . . . 0.0 110.21 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.38 122.87 43.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 0.0 110.201 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -104.87 149.79 25.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.744 -0.597 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.05 -34.73 79.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.779 -0.576 . . . . 0.0 110.129 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -150.76 162.17 41.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.757 -0.59 . . . . 0.0 110.256 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.6 0.37 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -127.92 167.73 16.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.92 . . . . 0.0 110.163 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.2 m -58.5 -39.19 79.36 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.663 -0.648 . . . . 0.0 110.361 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -133.17 153.54 80.81 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.58 144.39 84.48 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 O-C-N 123.239 1.126 . . . . 0.0 110.347 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.3 155.14 71.36 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.182 1.096 . . . . 0.0 110.188 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.28 138.46 81.29 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.181 1.095 . . . . 0.0 110.439 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.05 138.06 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.748 -0.595 . . . . 0.0 110.002 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.42 134.68 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.638 . . . . 0.0 109.833 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -103.01 127.52 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.684 -0.635 . . . . 0.0 110.407 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -122.86 79.14 49.77 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.768 -0.583 . . . . 0.0 110.053 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.61 148.75 80.29 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.11 1.058 . . . . 0.0 110.758 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.0 p -114.34 100.52 53.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.717 -0.614 . . . . 0.0 110.192 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.47 -24.38 77.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.167 1.088 . . . . 0.0 110.809 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.525 -0.734 . . . . 0.0 109.986 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.94 -68.63 0.75 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.705 -0.622 . . . . 0.0 110.425 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.22 110.15 51.16 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.557 -0.715 . . . . 0.0 110.056 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 144.85 99.39 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.012 1.006 . . . . 0.0 110.409 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -118.03 136.31 53.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.613 . . . . 0.0 110.435 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -108.11 143.2 37.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.755 -0.59 . . . . 0.0 109.667 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -57.01 -39.72 75.28 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.512 -0.742 . . . . 0.0 111.13 -172.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -59.51 -39.99 85.62 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.653 -0.654 . . . . 0.0 110.62 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -126.8 134.52 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.621 -0.674 . . . . 0.0 110.4 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.701 -0.624 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.573 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.47 144.36 31.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.719 -0.871 . . . . 0.0 110.151 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.86 137.98 31.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.359 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.58 75.06 0.41 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.81 65.61 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.177 1.093 . . . . 0.0 110.427 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.7 p -148.48 130.49 15.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.586 -0.696 . . . . 0.0 110.127 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -166.48 169.03 14.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 110.409 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -67.3 -16.58 64.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.69 -0.631 . . . . 0.0 111.354 177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.16 -30.07 69.1 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.531 -0.731 . . . . 0.0 109.987 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.425 ' CE3' HD21 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.404 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD21 ' CE3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -137.17 131.92 17.86 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.0 151.59 64.75 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 122.996 0.998 . . . . 0.0 110.657 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.02 150.43 29.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.73 -0.607 . . . . 0.0 110.266 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -78.79 151.9 31.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.283 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.71 -35.26 70.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.696 -0.627 . . . . 0.0 110.597 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.71 139.88 58.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.713 -0.617 . . . . 0.0 110.165 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -99.32 141.76 31.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.754 -0.591 . . . . 0.0 110.254 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.84 46.68 25.23 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.428 -0.795 . . . . 0.0 110.961 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.45 64.94 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.98 -37.76 69.49 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.595 -0.944 . . . . 0.0 110.888 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -133.16 156.54 47.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 110.468 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.9 73.28 76.09 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.663 -0.648 . . . . 0.0 110.221 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.68 151.5 84.81 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.079 1.042 . . . . 0.0 110.193 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.49 111.28 1.44 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.177 1.093 . . . . 0.0 110.096 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.51 143.47 99.68 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 122.902 0.948 . . . . 0.0 110.682 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.68 -24.26 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.753 -0.592 . . . . 0.0 110.613 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.14 145.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -59.4 137.75 57.89 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.738 -0.601 . . . . 0.0 110.317 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 82.72 64.45 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.728 -0.608 . . . . 0.0 110.212 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.28 145.36 98.75 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 123.059 1.031 . . . . 0.0 110.411 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -68.34 142.27 94.45 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.773 -0.58 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.08 -26.92 83.61 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.633 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.97 135.14 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 110.009 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -97.52 153.92 17.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.769 -0.582 . . . . 0.0 110.19 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 161.82 24.32 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.737 -0.602 . . . . 0.0 110.17 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.5 138.26 82.81 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.125 1.066 . . . . 0.0 110.61 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.0 t60 54.85 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.594 -0.692 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.686 -0.634 . . . . 0.0 110.136 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -123.19 145.15 48.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.707 -0.62 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -126.7 120.55 29.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.749 -0.595 . . . . 0.0 110.509 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.5 pt -125.44 159.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.716 -0.615 . . . . 0.0 110.38 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 tp -102.24 130.49 48.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.73 -0.607 . . . . 0.0 110.191 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.535 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.4 144.75 56.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.749 -0.853 . . . . 0.0 110.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm -80.67 -34.94 34.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.716 -0.615 . . . . 0.0 110.038 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.37 78.63 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.1 85.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.139 1.073 . . . . 0.0 110.336 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.2 p -94.81 9.72 38.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.67 -0.644 . . . . 0.0 111.346 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -78.07 145.11 36.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -73.39 -3.99 30.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.713 -0.617 . . . . 0.0 111.883 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.23 -27.61 67.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.323 -0.86 . . . . 0.0 110.163 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.418 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.46 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -137.09 107.66 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -58.45 151.32 62.27 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.166 1.088 . . . . 0.0 110.723 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.84 68.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.805 -0.559 . . . . 0.0 110.242 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -130.38 155.44 46.39 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.679 -0.638 . . . . 0.0 110.385 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -98.15 121.89 40.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.744 -0.598 . . . . 0.0 110.223 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -83.81 -166.79 1.5 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.626 . . . . 0.0 110.465 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.3 149.53 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 110.108 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.38 119.2 21.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.09 -170.33 46.54 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -57.91 -39.55 78.22 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.624 -0.927 . . . . 0.0 110.495 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -80.26 159.78 25.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.805 -0.559 . . . . 0.0 110.154 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.1 162.59 53.04 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.705 -0.622 . . . . 0.0 110.368 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.99 154.77 73.57 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.224 1.118 . . . . 0.0 110.365 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 149.54 87.03 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 O-C-N 123.188 1.099 . . . . 0.0 110.357 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.73 141.96 96.42 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.183 1.096 . . . . 0.0 110.451 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.04 24.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.721 -0.612 . . . . 0.0 110.661 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.83 142.27 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.0 110.295 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -117.46 161.67 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.755 -0.591 . . . . 0.0 110.248 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt 53.86 67.66 3.4 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.451 -0.78 . . . . 0.0 110.797 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.58 145.05 99.16 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.05 1.026 . . . . 0.0 110.601 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.5 m -73.24 143.88 83.79 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.6 . . . . 0.0 110.205 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.85 147.54 95.02 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.077 1.041 . . . . 0.0 110.442 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.08 144.65 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.685 -0.635 . . . . 0.0 110.403 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 90.8 mttt 54.75 44.29 28.74 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.464 -0.773 . . . . 0.0 110.738 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tt -74.24 142.42 78.66 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.727 -0.608 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -62.11 151.92 78.87 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.065 1.034 . . . . 0.0 110.259 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -109.19 130.57 55.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -74.67 -22.88 58.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.748 -0.595 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -60.29 153.07 23.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 t30 53.86 43.59 30.72 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.399 -0.813 . . . . 0.0 110.926 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.79 -28.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.649 . . . . 0.0 110.447 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.2 tt -60.1 -37.01 78.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.749 -0.595 . . . . 0.0 110.313 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.573 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.17 72.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.758 -0.848 . . . . 0.0 110.159 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.76 158.44 44.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.684 -0.635 . . . . 0.0 109.825 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.5 103.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.1 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.056 1.029 . . . . 0.0 110.48 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.3 p -95.45 12.8 28.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.73 -0.606 . . . . 0.0 111.051 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -78.64 145.15 34.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.286 -0.884 . . . . 0.0 110.621 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -73.19 -3.96 29.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.667 -0.646 . . . . 0.0 111.938 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -67.51 -27.38 66.94 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.432 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.419 HD13 ' CD1' ' A' ' 24' ' ' PHE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.452 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -137.01 92.12 14.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -60.91 146.02 98.22 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.245 1.129 . . . . 0.0 110.591 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.17 -28.99 70.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.795 -0.566 . . . . 0.0 110.012 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttp 55.44 46.67 22.76 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.461 -0.775 . . . . 0.0 110.827 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 54.18 60.23 3.72 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.422 -0.799 . . . . 0.0 111.037 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -55.91 -36.6 67.89 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.492 -0.755 . . . . 0.0 110.652 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.23 124.08 42.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 110.084 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.85 117.69 29.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.29 169.01 38.54 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -137.18 162.83 32.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.873 . . . . 0.0 110.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.0 m -120.28 135.25 55.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.664 -0.647 . . . . 0.0 110.066 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.403 ' CB ' ' CD ' ' A' ' 81' ' ' PRO . . . -77.03 -57.86 1.09 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.723 -0.611 . . . . 0.0 110.384 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 80' ' ' ALA . 37.6 Cg_endo -72.04 141.12 35.84 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.09 1.047 . . . . 0.0 110.4 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -64.0 145.82 90.35 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.105 1.055 . . . . 0.0 110.092 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.79 85.04 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.079 1.041 . . . . 0.0 110.546 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.76 -39.71 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.679 -0.638 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.13 -40.2 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 0.0 110.017 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -105.48 137.51 43.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.656 -0.652 . . . . 0.0 110.409 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.07 161.48 36.39 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.707 -0.62 . . . . 0.0 110.13 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.04 80.45 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.165 1.087 . . . . 0.0 110.551 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -77.07 143.97 71.06 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.788 -0.57 . . . . 0.0 110.224 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.51 -33.25 88.04 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.163 1.086 . . . . 0.0 110.391 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 p -135.16 141.61 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.612 . . . . 0.0 110.187 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -83.35 129.77 35.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.769 -0.582 . . . . 0.0 110.154 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.71 153.74 70.53 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.743 -0.598 . . . . 0.0 110.279 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 148.91 91.32 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.199 1.105 . . . . 0.0 110.387 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -113.72 139.52 49.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.701 -0.625 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -134.73 162.94 30.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.76 -0.587 . . . . 0.0 110.317 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 m 51.98 92.52 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.369 -0.832 . . . . 0.0 111.076 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.51 -37.1 74.89 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.662 -0.649 . . . . 0.0 110.45 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.9 tt -123.33 138.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.74 -0.6 . . . . 0.0 110.198 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.5 tp -98.74 130.63 45.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.617 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.602 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.49 74.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.723 -0.869 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -150.07 152.26 34.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.683 -0.635 . . . . 0.0 109.944 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.06 63.67 4.85 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 14.9 Cg_endo -61.58 153.28 67.88 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.239 1.126 . . . . 0.0 110.433 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 p -90.75 107.3 19.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -166.51 174.13 9.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.736 -0.602 . . . . 0.0 110.561 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.92 -3.95 32.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.656 -0.653 . . . . 0.0 111.968 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -68.01 -28.64 67.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.435 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.453 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.412 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.417 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -135.83 91.93 17.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -63.95 -29.59 66.91 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 O-C-N 123.295 1.155 . . . . 0.0 110.488 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 139.21 53.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.74 -0.6 . . . . 0.0 110.283 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.05 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.85 164.8 29.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.805 -0.559 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.18 144.13 57.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.743 -0.598 . . . . 0.0 110.16 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.96 141.39 28.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.79 -0.569 . . . . 0.0 110.147 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.96 -37.09 75.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.709 -0.619 . . . . 0.0 110.407 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.26 179.09 50.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -129.71 148.72 51.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.781 -0.835 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.5 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.724 -0.61 . . . . 0.0 110.159 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -127.54 76.92 76.55 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.75 -0.594 . . . . 0.0 110.314 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.52 144.12 97.65 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.095 1.05 . . . . 0.0 110.201 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.12 111.03 2.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.214 1.113 . . . . 0.0 110.321 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 139.86 76.85 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.04 1.021 . . . . 0.0 110.353 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.31 133.37 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.728 -0.608 . . . . 0.0 109.96 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.35 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.733 -0.604 . . . . 0.0 109.903 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -152.31 171.92 17.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.666 -0.646 . . . . 0.0 110.472 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttt 53.85 177.15 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.492 -0.755 . . . . 0.0 110.933 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.48 152.84 58.63 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.015 1.008 . . . . 0.0 110.553 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.2 p -68.31 143.06 95.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.702 -0.624 . . . . 0.0 110.151 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.19 -25.07 80.26 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.099 1.052 . . . . 0.0 110.772 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.64 134.27 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.561 -0.712 . . . . 0.0 110.043 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -101.54 153.69 19.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.699 -0.626 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.61 155.65 88.4 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.771 -0.581 . . . . 0.0 110.197 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.22 134.44 55.77 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.17 1.089 . . . . 0.0 110.521 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -59.46 -38.79 81.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.609 -0.682 . . . . 0.0 110.448 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -101.22 131.25 47.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.69 -0.632 . . . . 0.0 110.5 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -121.73 148.73 44.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.79 -0.569 . . . . 0.0 110.003 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -97.93 108.65 21.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.675 -0.64 . . . . 0.0 110.215 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.5 -22.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.718 -0.614 . . . . 0.0 110.756 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.37 143.34 29.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.51 -0.744 . . . . 0.0 110.152 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.526 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.526 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.13 -33.45 74.5 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.743 -0.857 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -80.74 -34.33 34.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.769 -0.582 . . . . 0.0 110.021 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.62 112.16 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.16 135.09 66.12 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.906 0.95 . . . . 0.0 110.815 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -98.1 109.15 21.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.652 -0.655 . . . . 0.0 110.312 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -167.01 166.02 15.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.681 -0.637 . . . . 0.0 110.703 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -72.47 -6.26 42.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.665 -0.647 . . . . 0.0 111.7 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -68.1 -28.2 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.451 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -137.18 99.44 9.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -65.61 132.16 30.05 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 O-C-N 123.309 1.163 . . . . 0.0 110.266 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.78 72.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.729 -0.607 . . . . 0.0 110.145 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -142.51 124.89 15.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.782 -0.574 . . . . 0.0 110.186 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.26 93.29 3.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 110.229 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.31 -39.73 93.96 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.707 -0.62 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 tp -108.23 129.38 55.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.721 -0.612 . . . . 0.0 110.276 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -61.37 -35.93 78.85 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.75 -0.594 . . . . 0.0 110.541 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.48 179.76 46.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -60.17 -41.29 92.56 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.74 -0.859 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.7 p -122.8 162.35 22.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.772 -0.58 . . . . 0.0 110.293 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 159.09 84.9 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.733 -0.604 . . . . 0.0 110.22 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.29 156.43 59.84 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.199 1.105 . . . . 0.0 110.452 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.94 -58.52 1.66 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.129 1.068 . . . . 0.0 111.908 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.2 Cg_endo -60.41 148.82 89.21 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 122.975 0.987 . . . . 0.0 110.495 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.39 145.16 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.706 -0.621 . . . . 0.0 110.318 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.97 137.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.679 -0.638 . . . . 0.0 109.898 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -81.12 131.7 35.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.687 -0.633 . . . . 0.0 110.318 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 tttm 53.26 57.71 14.06 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.429 -0.794 . . . . 0.0 110.84 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.3 146.03 85.02 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.039 1.021 . . . . 0.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.9 t -68.3 150.36 97.74 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.706 -0.621 . . . . 0.0 110.073 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.04 -35.14 93.93 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.065 1.034 . . . . 0.0 110.492 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -128.04 131.09 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.639 . . . . 0.0 109.834 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -96.78 -64.84 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.729 -0.607 . . . . 0.0 110.262 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.12 163.15 18.87 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.183 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -58.86 148.49 83.76 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.126 1.066 . . . . 0.0 110.631 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -113.67 171.14 7.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.74 149.07 37.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.722 -0.611 . . . . 0.0 110.235 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.9 m -59.05 -35.13 72.82 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.75 -0.594 . . . . 0.0 110.418 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 54.66 44.98 27.77 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.441 -0.787 . . . . 0.0 110.711 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.5 tt -59.44 -28.1 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.751 -0.593 . . . . 0.0 110.542 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.2 -34.68 76.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.775 -0.578 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.535 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.91 -32.3 72.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.71 -0.876 . . . . 0.0 110.12 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -149.83 154.08 37.81 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.703 -0.623 . . . . 0.0 109.825 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.39 77.52 0.39 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.85 133.33 44.16 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.118 1.062 . . . . 0.0 110.145 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.8 p -146.84 16.96 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.673 -0.642 . . . . 0.0 111.077 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.46 141.67 35.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -66.73 -13.85 61.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.71 -26.59 67.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.437 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.43 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.406 HD11 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -137.09 98.38 10.41 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.15 138.45 61.7 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 O-C-N 123.286 1.15 . . . . 0.0 110.464 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 -14.0 60.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.637 -0.664 . . . . 0.0 111.319 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.82 -34.71 69.95 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.178 -0.951 . . . . 0.0 110.879 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.34 -51.27 70.64 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.58 -35.07 70.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 110.656 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.13 -36.98 83.43 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.642 -0.661 . . . . 0.0 110.466 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.94 -174.01 3.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.48 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.42 30.14 19.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -111.58 128.94 56.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.902 . . . . 0.0 110.181 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.6 p -128.64 159.08 36.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.737 -0.602 . . . . 0.0 110.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' N ' ' CD ' ' A' ' 81' ' ' PRO . . . -79.28 -48.85 1.5 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.706 -0.621 . . . . 0.0 110.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 80' ' ' ALA . 23.8 Cg_exo -59.7 167.86 6.23 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 122.981 0.99 . . . . 0.0 110.459 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -62.08 160.25 30.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.25 1.132 . . . . 0.0 110.3 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.78 154.64 48.23 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.111 1.058 . . . . 0.0 110.585 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.67 -39.64 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.669 -0.645 . . . . 0.0 109.916 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.0 144.81 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -155.38 -176.33 5.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.767 -0.583 . . . . 0.0 110.445 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -66.12 163.84 34.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.739 -0.601 . . . . 0.0 110.001 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.92 145.1 92.62 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.047 1.025 . . . . 0.0 110.759 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 p -122.97 100.53 39.97 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.749 -0.595 . . . . 0.0 110.158 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.5 -25.95 76.19 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.17 1.089 . . . . 0.0 110.807 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.44 141.68 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.371 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -101.54 141.97 33.61 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.736 -0.602 . . . . 0.0 110.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.57 142.1 70.13 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.735 -0.603 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 146.86 95.22 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.149 1.079 . . . . 0.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -122.07 131.16 53.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.684 -0.635 . . . . 0.0 110.177 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.14 -42.96 99.5 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.777 -0.577 . . . . 0.0 110.238 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.1 p -131.23 157.79 42.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 110.242 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -58.21 -34.26 70.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.73 -0.606 . . . . 0.0 110.53 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -115.56 131.22 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.667 -0.646 . . . . 0.0 109.825 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.5 mm? -61.4 -38.84 88.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.677 -0.639 . . . . 0.0 110.241 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.182 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.17 -33.46 74.55 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.861 -0.788 . . . . 0.0 110.219 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mtp -81.25 -39.64 24.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.772 -0.58 . . . . 0.0 110.126 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.15 150.82 20.91 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -67.5 85.4 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.168 1.088 . . . . 0.0 110.331 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -94.77 8.01 43.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.617 -0.677 . . . . 0.0 111.428 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -78.3 141.14 38.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.247 -0.908 . . . . 0.0 110.414 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.43 -4.49 30.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.707 -0.621 . . . . 0.0 111.881 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.26 -25.43 65.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.848 . . . . 0.0 110.122 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.43 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.418 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.459 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.459 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.17 102.37 9.04 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.32 -34.41 87.57 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.292 1.153 . . . . 0.0 110.352 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 58.12 -84.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.579 -0.701 . . . . 0.0 111.111 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.92 -34.61 68.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.309 -0.869 . . . . 0.0 110.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.12 119.65 27.57 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.607 -0.683 . . . . 0.0 110.384 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -162.61 170.3 18.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -101.05 120.23 39.9 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.715 -0.616 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -66.61 -45.62 78.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.734 -0.604 . . . . 0.0 110.489 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.19 -175.56 28.94 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -120.95 118.69 30.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.769 -0.842 . . . . 0.0 110.132 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -145.75 155.0 42.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.652 -0.655 . . . . 0.0 110.091 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 51.95 -174.5 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.338 -0.852 . . . . 0.0 110.756 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.72 137.8 79.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.035 1.018 . . . . 0.0 110.314 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 152.41 76.53 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.096 1.051 . . . . 0.0 110.379 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.9 143.95 99.46 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.151 1.08 . . . . 0.0 110.351 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.32 159.48 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.598 . . . . 0.0 110.329 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.31 162.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.772 -0.58 . . . . 0.0 110.161 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -79.15 117.26 20.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.741 -0.599 . . . . 0.0 110.188 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -126.49 170.11 10.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.292 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.51 147.9 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.082 1.043 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -68.31 141.55 93.75 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.775 -0.578 . . . . 0.0 110.213 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.32 -28.51 86.96 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.101 1.053 . . . . 0.0 110.509 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.09 145.82 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.768 -0.582 . . . . 0.0 110.161 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -81.61 138.15 35.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.729 -0.607 . . . . 0.0 110.059 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.88 160.86 26.74 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.736 -0.603 . . . . 0.0 110.271 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.42 154.04 61.79 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.138 1.073 . . . . 0.0 110.455 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -116.66 177.28 4.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.76 -0.587 . . . . 0.0 110.041 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -59.13 -30.54 68.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.694 -0.628 . . . . 0.0 110.361 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -62.71 -27.3 69.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.825 -0.547 . . . . 0.0 110.288 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.65 137.3 36.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.671 -0.643 . . . . 0.0 110.202 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.14 -36.48 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.769 -0.582 . . . . 0.0 109.794 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -94.83 141.52 28.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.718 -0.614 . . . . 0.0 110.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.498 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.08 73.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.669 -0.9 . . . . 0.0 110.165 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp -87.84 134.34 33.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.698 -0.626 . . . . 0.0 110.226 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.62 161.53 24.27 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.95 68.01 1.82 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.2 1.105 . . . . 0.0 110.345 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -94.3 14.0 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.642 -0.661 . . . . 0.0 111.202 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -78.76 145.68 34.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.344 -0.848 . . . . 0.0 110.611 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.15 -3.91 29.51 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.689 -0.632 . . . . 0.0 111.983 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -67.49 -25.35 65.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 0.0 110.355 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.431 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.45 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD12 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.45 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -137.21 144.21 44.89 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.46 150.11 82.81 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.278 1.146 . . . . 0.0 110.543 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.39 142.05 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.615 . . . . 0.0 110.443 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -93.18 143.05 26.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.731 -0.606 . . . . 0.0 109.942 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -56.21 139.46 47.69 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.57 -0.706 . . . . 0.0 110.756 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.683 -0.636 . . . . 0.0 110.409 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.7 tp -102.4 131.26 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 109.897 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.17 13.75 10.71 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.618 -0.676 . . . . 0.0 111.686 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 30.16 56.51 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -59.19 -40.72 86.59 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.654 -0.91 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -86.13 165.36 16.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.72 -0.613 . . . . 0.0 110.225 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.05 160.35 16.73 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.752 -0.592 . . . . 0.0 110.16 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -58.7 110.06 0.61 Allowed 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.17 1.09 . . . . 0.0 110.596 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.66 167.15 26.44 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 O-C-N 123.099 1.052 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.51 152.96 51.34 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.129 1.068 . . . . 0.0 110.548 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.32 157.41 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.758 -0.589 . . . . 0.0 110.441 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.54 147.12 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.814 -0.553 . . . . 0.0 110.197 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -61.3 170.13 1.87 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.68 -0.637 . . . . 0.0 110.059 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -59.23 142.71 85.92 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.641 -0.662 . . . . 0.0 110.201 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.42 136.67 73.28 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.161 1.085 . . . . 0.0 110.61 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -76.73 140.38 67.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.744 -0.597 . . . . 0.0 110.206 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.41 -35.59 71.49 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.111 1.058 . . . . 0.0 110.177 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.49 153.52 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.808 -0.558 . . . . 0.0 110.145 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -118.11 135.28 54.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.692 -0.63 . . . . 0.0 110.382 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 mt -110.63 163.08 18.11 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.5 134.77 60.37 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.121 1.064 . . . . 0.0 110.601 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -135.53 -44.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.759 -0.588 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -133.96 152.35 51.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.678 -0.639 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -75.96 -25.37 55.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.684 -0.635 . . . . 0.0 110.966 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.96 142.74 57.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.14 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 82.0 mt -118.23 136.16 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.771 -0.581 . . . . 0.0 109.901 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.86 -34.74 75.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.755 -0.591 . . . . 0.0 110.169 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.61 71.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.727 -0.867 . . . . 0.0 110.125 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -145.95 153.07 40.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.19 62.01 6.51 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -68.13 78.27 0.6 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.109 1.058 . . . . 0.0 110.315 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.2 p -94.89 15.34 18.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.725 -0.61 . . . . 0.0 111.246 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -78.21 147.21 34.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 110.507 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -73.12 -3.97 29.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.757 -0.589 . . . . 0.0 112.096 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.58 -24.4 64.6 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.376 -0.827 . . . . 0.0 110.41 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.433 ' CZ3' HD23 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CG2' ' CG1' ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' CG1' ' CG2' ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 24' ' ' PHE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 55' ' ' VAL . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.418 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 HD23 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -137.13 95.13 12.03 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.04 150.47 84.04 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.307 1.162 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.95 144.33 25.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.087 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -87.2 133.1 33.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.635 -0.665 . . . . 0.0 110.276 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.77 -36.73 81.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.728 -0.607 . . . . 0.0 110.168 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -59.93 -38.01 81.13 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.51 133.57 48.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.707 -0.621 . . . . 0.0 109.901 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -81.25 118.0 22.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.747 -0.596 . . . . 0.0 110.068 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.21 -31.34 69.14 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -97.49 77.99 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.667 -0.902 . . . . 0.0 110.437 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 69.7 p -127.25 156.12 42.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.67 -0.643 . . . . 0.0 110.01 176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -98.08 -53.5 0.2 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.697 -0.627 . . . . 0.0 111.191 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 18.6 Cg_exo -58.09 -49.64 12.13 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 122.877 0.935 . . . . 0.0 111.253 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 19.7 Cg_exo -62.54 146.0 95.43 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 122.964 0.981 . . . . 0.0 110.428 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.68 153.46 67.14 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.139 1.073 . . . . 0.0 110.21 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.92 130.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.629 -0.669 . . . . 0.0 110.42 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.01 -36.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.761 -0.587 . . . . 0.0 110.055 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -71.28 122.87 21.02 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.736 -0.603 . . . . 0.0 110.387 -176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -134.04 166.33 30.04 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.793 -0.567 . . . . 0.0 110.122 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.96 144.15 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.156 1.082 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 p -119.38 100.34 49.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 110.47 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.34 151.2 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.317 1.167 . . . . 0.0 110.162 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.43 -40.76 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.662 -0.649 . . . . 0.0 109.832 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -82.84 136.78 34.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.676 -0.64 . . . . 0.0 110.12 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.7 140.62 96.45 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.722 -0.611 . . . . 0.0 110.027 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.83 145.45 98.22 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.093 1.049 . . . . 0.0 110.589 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -122.03 146.01 47.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 110.092 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -61.5 -27.38 68.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.712 -0.617 . . . . 0.0 110.288 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 t -117.95 141.12 48.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.677 -0.639 . . . . 0.0 110.148 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -105.55 119.97 40.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.654 -0.654 . . . . 0.0 110.265 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.36 -35.37 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.703 -0.623 . . . . 0.0 109.743 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.1 141.6 28.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.609 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -104.09 146.65 28.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.746 -0.856 . . . . 0.0 110.276 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp -87.32 147.7 25.38 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.664 . . . . 0.0 110.264 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.4 164.29 12.45 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 14.1 Cg_endo -61.27 98.12 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.249 1.131 . . . . 0.0 110.403 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -97.43 15.7 22.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.643 . . . . 0.0 111.141 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -78.15 142.25 38.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.389 -0.819 . . . . 0.0 110.49 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.1 -4.0 29.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.659 -0.651 . . . . 0.0 111.892 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.281 -0.887 . . . . 0.0 110.18 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.441 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.427 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.06 91.9 14.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.96 -12.55 21.6 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.478 1.251 . . . . 0.0 111.507 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -162.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.402 -0.811 . . . . 0.0 110.621 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 55.15 50.29 15.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.532 -0.73 . . . . 0.0 110.706 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -105.18 149.33 26.02 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.755 -0.591 . . . . 0.0 110.022 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -103.32 165.41 11.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -101.3 127.47 47.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.71 -0.619 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB3' ' CE1' ' A' ' 78' ' ' HIS . 36.0 t0 -143.39 143.01 31.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 110.188 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.58 132.54 14.46 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 76' ' ' ASP . 75.0 m80 -125.93 142.1 51.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.623 -0.928 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.9 m -59.83 -38.25 81.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.647 -0.658 . . . . 0.0 110.203 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.82 173.76 7.21 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.74 -0.6 . . . . 0.0 110.219 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.63 162.41 15.41 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.268 1.141 . . . . 0.0 110.485 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.69 151.59 69.1 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.1 1.052 . . . . 0.0 110.491 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 146.41 93.9 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.206 1.108 . . . . 0.0 110.655 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t 53.34 97.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.414 -0.804 . . . . 0.0 110.643 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 21.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.666 -0.646 . . . . 0.0 110.886 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.75 -36.3 74.14 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.0 110.354 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.1 145.77 46.91 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.705 -0.622 . . . . 0.0 110.168 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.89 143.75 99.55 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.155 1.082 . . . . 0.0 110.504 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.5 p -105.67 114.53 62.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.753 -0.592 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -57.53 -22.09 49.44 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.978 0.988 . . . . 0.0 111.242 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.51 -45.54 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.492 -0.755 . . . . 0.0 110.105 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -61.65 -34.7 76.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.162 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.34 120.08 76.21 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.796 -0.565 . . . . 0.0 110.229 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.52 152.71 71.54 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 122.91 0.952 . . . . 0.0 110.283 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -107.56 130.09 54.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.788 -0.57 . . . . 0.0 110.126 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -60.4 -34.66 74.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.768 -0.583 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t 51.67 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.393 -0.817 . . . . 0.0 111.107 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -57.7 -37.62 73.78 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.2 mt -116.78 133.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.0 109.774 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.63 130.37 46.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.736 -0.602 . . . . 0.0 110.243 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.557 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.529 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.62 145.61 29.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.849 . . . . 0.0 110.254 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm -155.16 148.66 25.17 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.742 -0.599 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.58 162.52 15.3 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.92 63.58 3.24 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.176 1.093 . . . . 0.0 110.426 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -92.89 -14.12 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.617 -0.677 . . . . 0.0 111.384 -178.568 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -78.33 163.38 25.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.323 -0.861 . . . . 0.0 110.999 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -75.49 -3.76 35.87 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.702 -0.624 . . . . 0.0 112.031 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.97 -30.26 70.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.259 -0.9 . . . . 0.0 110.12 -175.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.417 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -137.12 99.26 10.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -62.56 -25.78 75.72 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.267 1.141 . . . . 0.0 110.426 175.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.88 165.27 23.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.594 -0.691 . . . . 0.0 110.143 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -57.56 -37.14 72.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.691 -0.631 . . . . 0.0 110.638 -178.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -102.47 130.18 49.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.683 -0.636 . . . . 0.0 110.165 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.84 -40.29 92.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.722 -0.611 . . . . 0.0 110.291 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.9 tp -112.16 135.66 52.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.04 -33.88 67.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.529 -0.732 . . . . 0.0 110.728 -178.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.3 177.74 5.54 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -178.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -58.75 -41.39 86.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.895 . . . . 0.0 110.648 -177.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -132.62 158.11 43.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.702 -0.624 . . . . 0.0 110.659 -177.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -125.15 83.9 60.07 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.97 147.06 94.32 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.162 1.085 . . . . 0.0 110.426 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.9 Cg_exo -58.4 -48.68 14.54 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.186 1.098 . . . . 0.0 111.146 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 28.2 Cg_exo -58.06 147.29 83.67 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 122.908 0.952 . . . . 0.0 110.754 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.03 137.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.735 -0.603 . . . . 0.0 110.297 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -68.31 -27.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.735 -0.603 . . . . 0.0 110.468 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.03 117.76 30.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.648 -0.657 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -128.56 167.02 20.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.751 -0.593 . . . . 0.0 110.209 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.61 146.79 96.46 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.148 1.078 . . . . 0.0 110.401 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 t -68.23 142.47 94.85 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 0.0 110.255 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 144.86 95.23 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.164 1.086 . . . . 0.0 110.41 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t 52.99 97.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -132.14 128.16 37.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 0.0 110.233 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 8.7 mt -76.9 146.51 75.94 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.782 -0.574 . . . . 0.0 110.169 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.38 139.94 85.26 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 O-C-N 123.113 1.06 . . . . 0.0 110.335 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.2 m80 53.13 29.73 8.66 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.369 -0.832 . . . . 0.0 110.938 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.407 ' CG ' ' HB2' ' A' ' 93' ' ' LEU . 67.3 t80 -103.15 132.7 49.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.729 -0.607 . . . . 0.0 110.252 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.6 m -119.61 145.31 46.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.764 -0.585 . . . . 0.0 110.231 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.5 -32.73 70.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.767 -0.583 . . . . 0.0 110.349 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -58.77 -28.78 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.715 -0.616 . . . . 0.0 110.645 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -61.89 -34.61 76.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.686 -0.634 . . . . 0.0 110.126 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 CA-C-O 117.969 -1.462 . . . . 0.0 109.501 179.987 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -100.58 26.05 7.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.715 -0.874 . . . . 0.0 110.434 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -149.7 154.9 39.29 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.644 -0.66 . . . . 0.0 109.973 -179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.89 68.62 1.59 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 9.5 Cg_endo -58.56 155.4 36.79 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.14 1.073 . . . . 0.0 110.799 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p -97.41 25.37 5.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.629 . . . . 0.0 110.415 178.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 159.45 30.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.627 -0.671 . . . . 0.0 110.709 -175.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -71.82 -3.85 24.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.718 -0.614 . . . . 0.0 111.965 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.94 -22.26 66.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 175.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.428 ' CZ3' HD21 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG13 ' CZ ' ' A' ' 24' ' ' PHE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.456 ' CE2' ' CD1' ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD13 ' CD1' ' A' ' 24' ' ' PHE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HG3' ' CE2' ' A' ' 42' ' ' PHE . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.456 ' CD1' ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD21 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -137.16 99.9 9.75 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.6 141.43 86.0 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 O-C-N 123.224 1.118 . . . . 0.0 110.083 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.97 85.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.715 -0.616 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.5 -45.16 95.38 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.65 -0.656 . . . . 0.0 110.534 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.582 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -93.37 120.2 33.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.838 -0.539 . . . . 0.0 110.053 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.95 -37.32 79.21 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.673 . . . . 0.0 110.325 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -160.7 165.99 29.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.731 -0.605 . . . . 0.0 110.386 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.85 124.55 7.89 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -128.49 136.89 51.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.692 -0.887 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.6 m -80.97 134.62 35.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.623 -0.673 . . . . 0.0 110.14 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.46 -52.63 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 121.624 -0.673 . . . . 0.0 110.884 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -62.47 162.9 22.51 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.791 0.89 . . . . 0.0 110.292 -177.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.14 163.53 19.64 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.221 1.116 . . . . 0.0 110.27 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.45 147.69 90.26 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.135 1.071 . . . . 0.0 110.653 -178.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 160.32 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.771 -0.58 . . . . 0.0 110.388 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.65 -38.63 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.734 -0.604 . . . . 0.0 109.98 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t30 54.46 48.19 21.1 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.326 -0.859 . . . . 0.0 110.767 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.2 mttt 57.06 161.99 0.08 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.788 -0.57 . . . . 0.0 110.898 -177.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.12 149.35 89.58 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 122.938 0.967 . . . . 0.0 110.418 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -123.6 155.36 66.17 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.757 -0.589 . . . . 0.0 110.276 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.5 146.78 96.24 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.246 1.129 . . . . 0.0 110.555 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.23 -38.87 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.757 -0.589 . . . . 0.0 109.797 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -85.3 148.19 26.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.752 -0.593 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' O ' ' CE1' ' A' ' 95' ' ' HIS . 4.5 mm? -66.67 148.26 98.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.727 -0.608 . . . . 0.0 110.092 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.71 144.21 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.187 1.098 . . . . 0.0 110.495 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.402 ' CE1' ' O ' ' A' ' 93' ' ' LEU . 75.5 m80 -121.49 144.0 48.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.76 -0.588 . . . . 0.0 110.214 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -98.6 132.92 43.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.033 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -113.05 145.48 40.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.739 -0.601 . . . . 0.0 110.35 -177.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 m120 55.0 171.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.62 -0.675 . . . . 0.0 110.866 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tp -125.05 137.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.722 -0.612 . . . . 0.0 110.123 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.92 -40.09 83.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.625 -0.672 . . . . 0.0 110.532 -177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.467 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.523 178.9 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.025 0.441 . . . . 1.6 110.075 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.661 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.3 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 0.2 110.391 -170.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.15 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 28' ' ' ILE . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.16 110.493 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.13 110.178 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 0.12 110.748 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB2' HD11 ' A' ' 68' ' ' ILE . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.18 109.435 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 0.15 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 0.11 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.21 109.658 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 0.44 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 0.42 111.531 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.13 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 0.14 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.24 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 0.13 109.988 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.953 HG21 HD11 ' A' ' 31' ' ' ILE . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 0.14 110.475 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.13 109.887 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.08 109.548 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 28' ' ' ILE . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 0.19 109.944 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.19 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 0.24 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.565 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 0.17 109.469 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.809 HG23 HG22 ' A' ' 56' ' ' VAL . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.15 110.532 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 0.33 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 0.17 110.597 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 2.59 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 0.57 111.623 -173.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.4 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.819 ' HB3' HD21 ' A' ' 48' ' ' LEU . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.64 110.248 -175.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.28 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.32 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 0.31 109.835 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.35 110.286 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 0.89 110.276 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 3.51 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 2.85 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 1.93 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.06 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 0.51 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.06 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 0.21 109.2 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.809 HG22 HG23 ' A' ' 37' ' ' THR . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.17 109.582 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 0.15 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 1.87 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.28 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 0.28 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 0.19 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.36 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.22 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.851 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 0.42 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.661 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 0.43 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 0.36 109.965 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 25.4 mt-10 . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 120.815 0.341 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HD13 ' A' ' 15' ' ' ILE . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' ALA . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 11' ' ' CYS . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.741 HD11 HG21 ' A' ' 28' ' ' ILE . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.754 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.827 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.822 ' HB3' HD21 ' A' ' 48' ' ' LEU . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.827 HD12 ' CB ' ' A' ' 41' ' ' ALA . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.734 0.302 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.649 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.748 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.677 ' HB2' HD11 ' A' ' 68' ' ' ILE . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.894 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 12' ' ' ALA . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 39' ' ' VAL . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.985 HD11 HG21 ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.642 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.785 HG23 HG22 ' A' ' 56' ' ' VAL . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.833 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.875 HD12 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 37' ' ' THR . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.894 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 14' ' ' SER . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.755 0.312 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.689 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.73 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 39' ' ' VAL . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 28' ' ' ILE . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.799 HG23 HG22 ' A' ' 56' ' ' VAL . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.802 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.827 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.801 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 57' ' ' LEU . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.799 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.73 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.689 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.767 ' SG ' HD12 ' A' ' 28' ' ' ILE . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.84 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 12' ' ' ALA . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 39' ' ' VAL . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HA ' HD12 ' A' ' 9' ' ' ILE . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.786 HG23 HG22 ' A' ' 56' ' ' VAL . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 48' ' ' LEU . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 41' ' ' ALA . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 57' ' ' LEU . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.451 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 59' ' ' CYS . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.675 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 120.842 0.353 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.616 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.843 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.732 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 31' ' ' ILE . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.603 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HA ' HD12 ' A' ' 9' ' ' ILE . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 28' ' ' ILE . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.774 HG23 HG22 ' A' ' 56' ' ' VAL . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 48' ' ' LEU . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 37' ' ' THR . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.843 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 3.6 mm-40 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.652 HG12 ' HG ' ' A' ' 67' ' ' LEU . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.829 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.824 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' HG11 ' A' ' 39' ' ' VAL . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.957 HD11 HG21 ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.837 HG23 HG22 ' A' ' 56' ' ' VAL . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HA3' ' A' ' 26' ' ' GLY . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.673 ' HB3' HD21 ' A' ' 48' ' ' LEU . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' HB3' ' A' ' 41' ' ' ALA . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.738 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.533 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 15' ' ' ILE . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.688 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.443 HG22 ' HG2' ' A' ' 69' ' ' GLU . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 70.4 mm-40 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 120.802 0.334 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.708 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.582 ' HB2' HD11 ' A' ' 68' ' ' ILE . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.896 HG21 HD11 ' A' ' 31' ' ' ILE . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 39' ' ' VAL . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 28' ' ' ILE . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.673 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.796 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.561 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 50' ' ' LYS . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 41' ' ' ALA . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.839 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.681 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 mm-40 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.721 0.296 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.739 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.71 ' CE2' HD13 ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' HB2' HG13 ' A' ' 39' ' ' VAL . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 56' ' ' VAL . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.748 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG3' HD11 ' A' ' 48' ' ' LEU . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 41' ' ' ALA . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG12 HD12 ' A' ' 57' ' ' LEU . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 37' ' ' THR . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 59.0 mm-40 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.647 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.774 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.718 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 68' ' ' ILE . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.706 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 31' ' ' ILE . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' VAL . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 9' ' ' ILE . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.976 HD11 HG21 ' A' ' 28' ' ' ILE . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.788 HG22 ' HA ' ' A' ' 28' ' ' ILE . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 40' ' ' ARG . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 39' ' ' VAL . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HE ' HD11 ' A' ' 48' ' ' LEU . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 46' ' ' VAL . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' ALA . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.654 HG23 ' HB2' ' A' ' 41' ' ' ALA . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.706 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 21' ' ' LEU . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.897 HG23 ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 14' ' ' SER . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 mt-10 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.934 0.397 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.744 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.889 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.727 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 31' ' ' ILE . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.596 ' HB2' HG13 ' A' ' 39' ' ' VAL . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 28' ' ' ILE . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.62 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.727 HG23 HG22 ' A' ' 56' ' ' VAL . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.678 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.632 HG21 ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 37' ' ' THR . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.889 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.631 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.76 ' HB2' HD11 ' A' ' 68' ' ' ILE . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 65' ' ' ILE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.769 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.901 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.879 HG23 HG22 ' A' ' 56' ' ' VAL . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.901 HD12 ' HA3' ' A' ' 26' ' ' GLY . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.743 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.868 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 43' ' ' ARG . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG12 HD12 ' A' ' 57' ' ' LEU . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 15' ' ' ILE . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.631 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 33.8 mt-10 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.775 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.921 HG21 HD11 ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' HB2' HG13 ' A' ' 39' ' ' VAL . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.921 HD11 HG21 ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.671 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.783 HG23 HG22 ' A' ' 56' ' ' VAL . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 45' ' ' GLY . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 41' ' ' ALA . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 37' ' ' THR . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.854 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 10.4 mt-10 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 120.932 0.396 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.695 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 15' ' ' ILE . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.859 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' ALA . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HD2' HG11 ' A' ' 39' ' ' VAL . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HG21 ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.765 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.87 HG23 HG22 ' A' ' 56' ' ' VAL . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.736 ' CB ' HD21 ' A' ' 48' ' ' LEU . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 47' ' ' PRO . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 41' ' ' ALA . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 HG23 ' A' ' 37' ' ' THR . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.718 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HB2' HD11 ' A' ' 21' ' ' LEU . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.859 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.695 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 69.5 mt-10 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.821 0.344 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 68' ' ' ILE . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.696 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.878 HG21 HD11 ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HB2' HG13 ' A' ' 39' ' ' VAL . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.878 HD11 HG21 ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG21 ' CB ' ' A' ' 41' ' ' ALA . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.696 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 14' ' ' SER . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 20.4 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB2' HD11 ' A' ' 68' ' ' ILE . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.746 HG23 HG22 ' A' ' 56' ' ' VAL . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG12 HD12 ' A' ' 57' ' ' LEU . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 37' ' ' THR . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.427 HG21 HG23 ' A' ' 15' ' ' ILE . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 36.3 mt-10 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.753 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.851 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.825 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.787 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.863 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 39' ' ' VAL . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 28' ' ' ILE . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.867 HG23 HG22 ' A' ' 56' ' ' VAL . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.863 HD12 ' HA3' ' A' ' 26' ' ' GLY . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.807 ' HB3' HD21 ' A' ' 48' ' ' LEU . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 43' ' ' ARG . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 57' ' ' LEU . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 37' ' ' THR . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.787 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.851 HD11 ' HB2' ' A' ' 14' ' ' SER . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 37.7 mt-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 120.788 0.327 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.715 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' HD13 ' A' ' 15' ' ' ILE . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.805 HG23 HG22 ' A' ' 56' ' ' VAL . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.787 ' HB3' HD21 ' A' ' 48' ' ' LEU . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 47' ' ' PRO . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 43' ' ' ARG . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 57' ' ' LEU . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.805 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 69' ' ' GLU . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.774 ' HG3' HG22 ' A' ' 68' ' ' ILE . 23.9 mt-10 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 120.772 0.32 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.657 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.778 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.856 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.619 ' HB2' HG13 ' A' ' 39' ' ' VAL . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.761 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.701 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.734 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' A' ' 47' ' ' PRO . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 49.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 120.774 0.321 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.573 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 15' ' ' ILE . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.904 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.943 HG21 HD11 ' A' ' 31' ' ' ILE . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HB2' HG13 ' A' ' 39' ' ' VAL . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 9' ' ' ILE . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.943 HD11 HG21 ' A' ' 28' ' ' ILE . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.791 HG23 HG22 ' A' ' 56' ' ' VAL . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.77 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.732 ' CD ' HD11 ' A' ' 48' ' ' LEU . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 41' ' ' ALA . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.791 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.713 ' HG ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.9 mt-10 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 120.819 0.342 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.634 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.781 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.918 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 31' ' ' ILE . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 28' ' ' ILE . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.612 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.989 HG23 HG22 ' A' ' 56' ' ' VAL . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.918 HD12 ' HA3' ' A' ' 26' ' ' GLY . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.802 ' HG3' HD11 ' A' ' 48' ' ' LEU . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG13 ' HD2' ' A' ' 47' ' ' PRO . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 43' ' ' ARG . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 57' ' ' LEU . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.989 HG22 HG23 ' A' ' 37' ' ' THR . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.781 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.83 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.634 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 14' ' ' SER . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 12.8 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.685 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.742 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.589 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.868 HG21 HD11 ' A' ' 31' ' ' ILE . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' HG13 ' A' ' 39' ' ' VAL . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.78 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.778 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.684 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 47' ' ' PRO . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 46' ' ' VAL . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.866 HD12 ' HB1' ' A' ' 41' ' ' ALA . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 57' ' ' LEU . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.78 HG22 HG23 ' A' ' 37' ' ' THR . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.711 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.834 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 30.7 mt-10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 6.87 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.91 75.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.766 -0.843 . . . . 5.17 110.132 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp -149.92 151.88 34.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 6.16 109.856 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.78 72.53 0.62 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.736 -1.346 . . . . 3.09 109.736 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 4' ' ' THR . 11.6 Cg_endo -59.5 127.74 24.8 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.161 1.085 . . . . 2.47 110.633 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 3' ' ' PRO . 11.5 p -153.88 94.51 1.77 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.686 -0.634 . . . . 1.37 110.208 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -165.33 168.82 16.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.71 -0.619 . . . . 1.65 110.234 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' HG12 ' A' ' 9' ' ' ILE . 96.0 mt-30 -72.25 -6.95 46.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.745 -0.597 . . . . 1.22 111.95 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.272 -0.893 . . . . 1.6 110.075 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.661 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.3 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 0.2 110.391 -170.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.15 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 28' ' ' ILE . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.16 110.493 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.13 110.178 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 0.12 110.748 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB2' HD11 ' A' ' 68' ' ' ILE . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.18 109.435 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 0.15 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 0.11 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.21 109.658 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 0.44 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 0.42 111.531 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.13 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 0.14 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.24 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.3 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 0.13 109.988 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.953 HG21 HD11 ' A' ' 31' ' ' ILE . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 0.14 110.475 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.13 109.887 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.08 109.548 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 28' ' ' ILE . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 0.19 109.944 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.19 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 0.24 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.565 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 0.17 109.469 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.809 HG23 HG22 ' A' ' 56' ' ' VAL . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.15 110.532 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 0.33 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 0.17 110.597 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 2.59 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 0.57 111.623 -173.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.4 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.819 ' HB3' HD21 ' A' ' 48' ' ' LEU . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.64 110.248 -175.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.28 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.32 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 0.31 109.835 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.35 110.286 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 0.89 110.276 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 3.51 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 2.85 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 1.93 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.06 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 0.51 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.06 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 0.21 109.2 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.809 HG22 HG23 ' A' ' 37' ' ' THR . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.17 109.582 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 0.15 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 1.87 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.28 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 0.28 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 0.19 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.36 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.22 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.851 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 0.42 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.661 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 0.43 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 0.36 109.965 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 25.4 mt-10 -137.11 99.9 9.79 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.65 158.19 47.51 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.325 1.171 . . . . 1.38 110.183 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.97 147.53 34.01 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.66 -0.65 . . . . 2.69 110.308 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -74.82 123.02 24.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.676 -0.64 . . . . 7.8 110.376 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -101.34 -45.23 5.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.821 -0.549 . . . . 8.25 110.25 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.8 125.17 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.785 -0.572 . . . . 8.68 110.42 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -33.24 72.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 11.59 110.177 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 44.8 t0 53.31 74.04 0.33 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.394 -0.816 . . . . 12.96 110.992 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 72.46 0.51 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 14.69 109.726 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 53.8 29.25 9.38 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.39 -1.065 . . . . 16.73 111.032 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -60.23 -38.12 82.43 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.722 -0.611 . . . . 17.87 110.152 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -124.17 170.97 7.77 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.723 -0.611 . . . . 18.67 110.236 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.73 159.33 24.94 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.194 1.102 . . . . 19.17 110.426 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 22.7 Cg_exo -57.62 -47.72 20.22 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.127 1.067 . . . . 19.46 111.262 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 27.2 Cg_exo -58.64 146.64 90.95 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 122.865 0.929 . . . . 19.51 110.573 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 86' ' ' ASN . 8.8 p -130.2 143.74 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.775 -0.578 . . . . 20.71 110.351 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.53 -34.8 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.735 -0.603 . . . . 21.17 110.029 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.478 ' H ' HG22 ' A' ' 84' ' ' VAL . 18.7 t-20 -55.11 -35.57 64.78 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.582 -0.699 . . . . 22.4 110.881 -176.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -62.85 145.56 95.96 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.673 -0.642 . . . . 22.39 110.088 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.57 142.43 98.85 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.247 1.13 . . . . 22.9 110.586 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.2 p -122.55 100.46 41.3 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.767 -0.583 . . . . 24.07 110.13 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.82 -53.64 0.69 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.176 1.093 . . . . 24.88 110.336 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.66 142.28 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.716 -0.615 . . . . 25.86 110.31 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -87.08 136.0 33.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.704 -0.623 . . . . 26.84 110.129 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.78 110.16 27.96 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.729 -0.607 . . . . 26.13 110.153 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.5 145.29 87.32 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.071 1.037 . . . . 26.9 110.393 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 52.38 -175.38 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.409 -0.807 . . . . 26.98 111.075 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.23 137.47 46.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 27.99 110.191 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.3 m -63.63 157.59 23.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.666 -0.646 . . . . 28.44 110.118 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -57.79 -34.98 70.18 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.585 -0.697 . . . . 29.08 110.52 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.69 133.75 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.759 -0.588 . . . . 30.07 110.049 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.31 130.27 46.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.667 -0.646 . . . . 30.95 110.177 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 117.978 -1.457 . . . . 29.95 109.557 -179.923 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.83 146.51 52.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.702 -0.881 . . . . 0.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -87.02 136.9 32.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.743 -0.598 . . . . 0.0 110.218 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 4' ' ' THR . . . -67.89 145.81 45.61 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 99.56 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.144 1.076 . . . . 0.0 110.457 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 2' ' ' GLY . 67.9 p -96.94 8.94 43.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.624 . . . . 0.0 111.49 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -79.03 140.1 38.01 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.213 -0.93 . . . . 0.0 110.604 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.22 -3.87 29.46 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.643 -0.66 . . . . 0.0 111.849 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -68.32 -26.0 65.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.342 -0.849 . . . . 0.0 110.189 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HD13 ' A' ' 15' ' ' ILE . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 72' ' ' LYS . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 11' ' ' CYS . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.741 HD11 HG21 ' A' ' 28' ' ' ILE . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.754 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.827 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.822 ' HB3' HD21 ' A' ' 48' ' ' LEU . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD12 ' CB ' ' A' ' 41' ' ' ALA . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -137.33 146.57 54.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.75 -31.36 94.88 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.124 1.065 . . . . 0.0 110.627 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.92 141.67 12.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.685 -0.634 . . . . 0.0 110.138 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.559 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.3 tptt -61.14 -42.34 98.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.694 -0.629 . . . . 0.0 110.013 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 52.11 24.32 2.67 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.526 -0.734 . . . . 0.0 111.216 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -105.91 0.86 26.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.514 -0.741 . . . . 0.0 111.595 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.44 -35.06 79.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.55 -37.28 78.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 110.497 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.57 -77.99 1.36 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.25 170.66 15.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.737 -0.86 . . . . 0.0 110.342 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.0 m -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.723 -0.611 . . . . 0.0 110.121 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.3 59.36 13.2 Favored Pre-proline 0 N--CA 1.503 2.225 0 O-C-N 121.435 -0.79 . . . . 0.0 110.783 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.93 165.59 32.37 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.135 1.071 . . . . 0.0 110.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.6 146.76 96.49 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.21 1.111 . . . . 0.0 110.252 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.73 134.11 52.11 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.153 1.081 . . . . 0.0 110.572 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.94 -23.65 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.69 -0.631 . . . . 0.0 110.778 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.32 -37.88 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.495 -0.753 . . . . 0.0 110.016 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -77.57 140.03 39.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.129 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -67.65 142.22 95.83 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.17 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -62.19 143.67 94.68 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.219 1.115 . . . . 0.0 110.321 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 p -71.03 149.67 94.8 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 110.046 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.52 -28.59 86.94 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.121 1.064 . . . . 0.0 110.434 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.79 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.774 -0.579 . . . . 0.0 109.717 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -83.64 133.19 34.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.703 -0.623 . . . . 0.0 110.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mt -99.95 145.66 30.57 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.75 -0.594 . . . . 0.0 110.342 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.69 154.11 62.62 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.142 1.075 . . . . 0.0 110.314 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -104.8 130.06 52.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.33 -37.39 80.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.759 -0.588 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -56.91 -38.26 72.61 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.53 -0.731 . . . . 0.0 110.797 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 t30 53.02 48.9 21.34 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.368 -0.833 . . . . 0.0 110.932 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.4 mt -110.47 134.75 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.641 . . . . 0.0 109.995 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.67 -35.43 77.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.529 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.571 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.89 72.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.759 -0.848 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -149.59 158.16 43.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.721 -0.612 . . . . 0.0 109.891 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.88 89.69 1.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 4' ' ' THR . 13.7 Cg_endo -61.03 140.53 90.42 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.186 1.098 . . . . 0.0 110.464 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 3' ' ' PRO . 56.8 p -147.29 20.32 1.21 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.678 -0.639 . . . . 0.0 110.734 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -79.43 150.72 31.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.483 -0.761 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.14 -4.0 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.692 -0.63 . . . . 0.0 111.825 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -68.55 -25.2 64.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.649 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.748 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.677 ' HB2' HD11 ' A' ' 68' ' ' ILE . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.894 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 12' ' ' ALA . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 39' ' ' VAL . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.985 HD11 HG21 ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.642 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.785 HG23 HG22 ' A' ' 56' ' ' VAL . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.833 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.875 HD12 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 37' ' ' THR . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.894 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 14' ' ' SER . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 -137.08 102.53 9.08 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 69' ' ' GLU . 17.0 Cg_endo -62.4 143.37 93.38 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.189 1.1 . . . . 0.0 110.184 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.94 143.5 33.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.678 -0.639 . . . . 0.0 110.345 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -97.18 144.69 26.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.598 . . . . 0.0 110.13 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -114.06 148.27 37.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.635 . . . . 0.0 110.239 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -76.86 177.07 7.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.777 -0.577 . . . . 0.0 110.275 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.4 tp -95.81 132.06 41.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.722 -0.611 . . . . 0.0 110.143 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -58.47 -38.55 77.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.12 -172.7 38.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -119.67 145.1 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.818 -0.813 . . . . 0.0 110.089 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 m -58.35 -40.18 81.48 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.584 -0.697 . . . . 0.0 110.389 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.55 142.82 28.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.762 -0.587 . . . . 0.0 110.14 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.95 138.18 43.46 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 O-C-N 123.118 1.062 . . . . 0.0 110.128 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.2 Cg_exo -59.01 -48.72 13.29 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 123.143 1.076 . . . . 0.0 111.064 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 20.9 Cg_exo -61.67 141.15 89.94 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.961 0.979 . . . . 0.0 110.376 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.02 127.92 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.647 -0.658 . . . . 0.0 109.917 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.73 -44.58 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.752 -0.592 . . . . 0.0 110.055 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -143.0 108.58 5.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.724 -0.61 . . . . 0.0 110.505 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -91.97 140.32 24.73 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.0 110.12 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -61.79 145.81 96.99 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.112 1.059 . . . . 0.0 110.417 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.7 p -122.45 100.4 41.68 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.702 -0.624 . . . . 0.0 110.274 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.92 -28.62 87.56 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.149 1.078 . . . . 0.0 110.441 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.35 155.94 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.288 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -59.63 -39.11 83.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.731 -0.605 . . . . 0.0 110.313 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -113.21 110.21 51.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.749 -0.595 . . . . 0.0 110.061 179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.05 140.07 93.6 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 122.916 0.956 . . . . 0.0 110.638 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -104.42 17.91 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.781 -0.574 . . . . 0.0 111.138 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.35 -37.89 78.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.351 -0.843 . . . . 0.0 110.33 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -125.58 141.69 51.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -59.02 -34.87 72.39 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.623 -0.673 . . . . 0.0 110.343 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.03 134.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.701 -0.624 . . . . 0.0 110.092 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 100' ' ' LEU . 8.9 tt -99.38 130.63 45.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.175 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -64.17 145.25 56.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.764 -0.845 . . . . 0.0 110.164 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm -149.97 154.27 37.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.646 -0.659 . . . . 0.0 109.935 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.87 153.84 20.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.42 65.72 5.5 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.194 1.102 . . . . 0.0 110.359 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -93.51 11.06 29.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 111.325 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -78.42 147.12 34.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.89 -3.9 31.67 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.712 -0.617 . . . . 0.0 111.885 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -67.34 -27.88 67.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.689 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.73 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 39' ' ' VAL . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 28' ' ' ILE . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.799 HG23 HG22 ' A' ' 56' ' ' VAL . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.802 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.827 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.801 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 57' ' ' LEU . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.799 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.73 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.689 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -137.2 139.59 28.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.87 153.16 52.52 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.251 1.132 . . . . 0.0 110.683 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -62.95 -171.93 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.762 -0.586 . . . . 0.0 110.116 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -58.13 -35.08 70.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.699 -0.626 . . . . 0.0 110.562 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -97.96 137.55 36.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.712 -0.618 . . . . 0.0 110.206 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 135.96 39.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.709 -0.62 . . . . 0.0 110.152 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.9 tt -107.25 128.55 54.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.709 -0.62 . . . . 0.0 110.271 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.73 119.14 25.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.733 -0.604 . . . . 0.0 110.032 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.58 -171.79 34.77 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -58.56 -37.21 75.24 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.875 . . . . 0.0 110.467 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.6 m -70.48 137.03 49.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 110.164 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.18 62.34 9.86 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.419 -0.801 . . . . 0.0 110.818 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 21.2 Cg_exo -58.81 -48.53 14.33 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.077 1.04 . . . . 0.0 111.04 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 22.8 Cg_exo -60.91 147.01 96.8 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 122.997 0.998 . . . . 0.0 110.363 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 146.56 97.56 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.212 1.111 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.03 134.96 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.71 -0.619 . . . . 0.0 109.887 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.61 135.24 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.923 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -104.32 137.43 42.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.759 -0.588 . . . . 0.0 110.149 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -66.61 147.63 98.93 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.711 -0.618 . . . . 0.0 110.147 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.94 146.34 97.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.162 1.085 . . . . 0.0 110.397 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.6 t -123.54 100.22 38.47 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.444 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.29 -25.39 57.09 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 122.894 0.944 . . . . 0.0 111.135 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' A' ' 92' ' ' LYS . 34.0 m -64.81 -28.17 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.515 -0.741 . . . . 0.0 110.513 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.691 ' HG3' HG23 ' A' ' 91' ' ' VAL . 36.6 mtpt -96.6 138.16 34.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 110.135 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.419 ' H ' HD23 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -113.18 162.01 24.11 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 0.0 110.363 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.42 153.5 65.62 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.192 1.101 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -108.58 137.43 46.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.792 -0.568 . . . . 0.0 110.216 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.66 -37.59 76.32 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 0.0 110.521 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.4 m -57.12 -34.19 68.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.64 -0.662 . . . . 0.0 110.757 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.67 44.44 28.58 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 46.6 pt -123.14 160.84 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 110.448 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.8 130.21 45.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.845 -0.534 . . . . 0.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.543 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.36 72.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.729 -0.865 . . . . 0.0 110.093 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -87.48 136.78 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.693 -0.629 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.36 151.76 50.12 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.62 148.62 53.18 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.188 1.099 . . . . 0.0 111.016 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.9 p -96.08 24.65 5.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.711 -0.618 . . . . 0.0 110.604 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.9 151.83 37.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.622 -0.673 . . . . 0.0 110.484 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -71.99 -4.05 26.29 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.694 -0.629 . . . . 0.0 111.877 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.03 -22.03 65.9 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.347 -0.845 . . . . 0.0 110.253 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.767 ' SG ' HD12 ' A' ' 28' ' ' ILE . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.84 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 12' ' ' ALA . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 39' ' ' VAL . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HA ' HD12 ' A' ' 9' ' ' ILE . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.786 HG23 HG22 ' A' ' 56' ' ' VAL . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 48' ' ' LEU . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 41' ' ' ALA . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 57' ' ' LEU . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.451 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 59' ' ' CYS . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.675 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt-10 -137.15 94.04 12.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -61.46 -33.34 88.27 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 O-C-N 123.264 1.139 . . . . 0.0 110.432 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.81 -41.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.688 -0.633 . . . . 0.0 110.278 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -75.96 127.31 32.7 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.702 -0.624 . . . . 0.0 110.17 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.37 -34.62 75.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.739 -0.601 . . . . 0.0 110.592 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 54.04 46.8 24.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.372 -0.83 . . . . 0.0 110.717 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.42 -36.51 73.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.677 -0.64 . . . . 0.0 110.529 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.59 -36.42 73.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.6 26.41 50.75 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -58.89 -41.78 87.95 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -1.01 . . . . 0.0 110.207 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 m -61.08 -36.23 79.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.731 -0.606 . . . . 0.0 110.185 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.8 111.73 52.54 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.739 -0.601 . . . . 0.0 110.33 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 24.9 Cg_exo -57.88 -52.24 6.38 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.022 1.012 . . . . 0.0 111.367 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 27.9 Cg_endo -70.16 153.1 67.39 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 O-C-N 122.915 0.955 . . . . 0.0 110.696 -172.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.77 155.86 35.63 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.283 1.149 . . . . 0.0 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 86' ' ' ASN . 60.1 t -106.09 138.76 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.698 -0.626 . . . . 0.0 109.879 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.15 -34.24 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.627 -0.671 . . . . 0.0 110.753 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' H ' HG12 ' A' ' 84' ' ' VAL . 55.4 t30 54.63 48.83 19.44 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.332 -0.855 . . . . 0.0 110.705 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.9 tmtt? -54.62 -59.37 10.62 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.608 -0.683 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 87' ' ' LYS . 13.6 Cg_endo -62.02 146.77 96.1 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 O-C-N 123.035 1.019 . . . . 0.0 110.329 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.8 t -106.85 150.14 39.37 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.752 -0.592 . . . . 0.0 110.289 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.22 -36.51 68.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 123.226 1.119 . . . . 0.0 110.502 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.15 150.12 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.601 -0.687 . . . . 0.0 110.464 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -65.13 -34.89 79.46 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.735 -0.603 . . . . 0.0 110.505 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 93' ' ' LEU . 25.6 mt -69.23 144.81 95.47 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.9 140.55 85.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.224 1.118 . . . . 0.0 110.383 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -59.34 -29.47 67.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.687 -0.633 . . . . 0.0 110.361 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.72 153.69 23.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.0 110.314 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -115.07 151.24 34.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.753 -0.592 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -93.72 148.79 21.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.774 -0.579 . . . . 0.0 110.22 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.31 -32.43 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.731 -0.606 . . . . 0.0 109.777 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.68 130.51 39.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.706 -0.621 . . . . 0.0 110.181 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.05 74.99 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.785 -0.832 . . . . 0.0 110.109 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm -146.7 149.4 33.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.732 -0.605 . . . . 0.0 109.655 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.31 74.32 0.44 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.12 59.57 7.04 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.118 1.062 . . . . 0.0 110.595 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.5 p -96.69 12.73 30.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.442 -0.786 . . . . 0.0 111.09 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.73 148.69 34.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.334 -0.854 . . . . 0.0 110.291 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.74 -4.16 32.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.699 -0.626 . . . . 0.0 111.918 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -67.58 -29.69 69.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.251 -0.906 . . . . 0.0 110.196 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.616 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.843 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.732 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 31' ' ' ILE . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.603 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HA ' HD12 ' A' ' 9' ' ' ILE . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 28' ' ' ILE . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.774 HG23 HG22 ' A' ' 56' ' ' VAL . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 48' ' ' LEU . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 37' ' ' THR . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.843 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 3.6 mm-40 -137.24 138.21 24.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.2 148.93 91.52 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.09 1.048 . . . . 0.0 110.372 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -60.96 139.38 58.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.654 -0.653 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -60.36 -35.98 76.94 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.771 -0.581 . . . . 0.0 110.312 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 54.12 40.74 31.95 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.557 -0.714 . . . . 0.0 110.774 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -108.6 154.98 21.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.709 -0.619 . . . . 0.0 110.185 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -98.32 122.46 41.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.604 . . . . 0.0 110.036 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -110.68 15.07 22.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.762 -0.586 . . . . 0.0 111.226 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.29 136.61 30.4 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -58.42 -35.29 71.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.897 . . . . 0.0 110.347 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -75.86 140.56 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.813 -0.555 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.87 68.47 2.8 Favored Pre-proline 0 N--CA 1.504 2.24 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.06 155.45 44.87 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.159 1.084 . . . . 0.0 110.468 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.33 148.12 91.39 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.209 1.11 . . . . 0.0 110.425 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.32 149.3 81.93 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.22 1.116 . . . . 0.0 110.609 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.26 -36.66 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 109.745 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.85 -38.05 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.727 -0.608 . . . . 0.0 109.917 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -96.87 126.78 42.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -125.79 101.77 29.4 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.729 -0.607 . . . . 0.0 110.339 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.15 150.64 64.39 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.126 1.066 . . . . 0.0 110.57 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 89' ' ' THR . 6.7 t -68.21 112.54 11.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.759 -0.588 . . . . 0.0 110.418 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.81 160.01 50.22 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 122.929 0.962 . . . . 0.0 110.326 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.1 133.32 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.69 -0.631 . . . . 0.0 109.696 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -65.74 126.79 29.55 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.802 -0.561 . . . . 0.0 110.681 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.17 163.2 18.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.772 -0.58 . . . . 0.0 110.067 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.65 141.66 97.44 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.047 1.025 . . . . 0.0 110.502 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.22 140.68 52.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.319 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.41 155.8 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.752 -0.592 . . . . 0.0 110.262 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -114.99 142.21 46.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -112.15 24.3 12.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.606 -0.684 . . . . 0.0 110.797 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.17 -34.48 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.624 -0.673 . . . . 0.0 109.826 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.0 mt -93.18 141.68 28.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.714 -0.616 . . . . 0.0 110.156 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.549 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.96 146.02 53.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.845 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.12 -33.65 38.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.736 -0.602 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.94 81.46 0.36 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 10.1 Cg_endo -57.36 156.64 24.98 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 O-C-N 123.119 1.062 . . . . 0.0 110.837 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 p -96.98 24.09 6.58 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.751 -0.593 . . . . 0.0 110.715 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -76.18 159.85 30.27 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.26 -3.71 25.28 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.0 112.108 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -65.99 -21.71 66.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.167 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.652 HG12 ' HG ' ' A' ' 67' ' ' LEU . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.829 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.824 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' HG11 ' A' ' 39' ' ' VAL . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.957 HD11 HG21 ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.837 HG23 HG22 ' A' ' 56' ' ' VAL . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HA3' ' A' ' 26' ' ' GLY . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.673 ' HB3' HD21 ' A' ' 48' ' ' LEU . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' HB3' ' A' ' 41' ' ' ALA . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.738 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.533 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 15' ' ' ILE . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.688 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.443 HG22 ' HG2' ' A' ' 69' ' ' GLU . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 70.4 mm-40 -136.05 99.92 10.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.86 -24.61 74.35 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.32 1.168 . . . . 0.0 110.85 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.21 142.45 51.72 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.533 -0.729 . . . . 0.0 110.468 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -91.0 138.59 31.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.737 -0.602 . . . . 0.0 110.325 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -109.01 151.59 26.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.719 -0.613 . . . . 0.0 110.17 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -82.32 117.01 22.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.769 -0.582 . . . . 0.0 110.293 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 78' ' ' HIS . 89.5 mt -100.02 138.43 37.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.732 -0.605 . . . . 0.0 110.273 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 148.05 36.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.601 . . . . 0.0 110.378 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.27 -38.89 3.0 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 75' ' ' LEU . 79.8 m80 -59.27 -33.76 71.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.671 -0.899 . . . . 0.0 110.269 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 p -119.47 164.57 15.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.637 . . . . 0.0 110.181 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 159.46 22.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.714 -0.616 . . . . 0.0 110.152 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.26 160.23 31.8 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.178 1.094 . . . . 0.0 110.343 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.76 -58.34 1.78 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 O-C-N 123.144 1.076 . . . . 0.0 111.884 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.8 Cg_endo -60.97 143.85 99.44 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 122.984 0.992 . . . . 0.0 110.385 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.55 143.32 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 110.261 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.35 -39.79 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.741 -0.599 . . . . 0.0 109.76 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -100.43 117.21 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -126.03 82.02 65.51 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.698 -0.626 . . . . 0.0 110.157 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.11 143.89 99.52 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.071 1.037 . . . . 0.0 110.512 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 p -115.26 106.58 50.85 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.0 110.192 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.65 145.28 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.03 1.016 . . . . 0.0 110.714 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.4 t -116.44 135.78 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.647 -0.658 . . . . 0.0 110.006 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt 54.47 42.51 31.32 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 110.928 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 tp -113.09 109.94 51.69 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.69 -0.631 . . . . 0.0 109.989 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -65.62 126.59 16.36 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.029 1.015 . . . . 0.0 110.597 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -69.5 -41.91 75.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.793 -0.567 . . . . 0.0 110.169 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -58.02 -36.29 72.49 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.724 -0.61 . . . . 0.0 110.692 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -56.21 -32.55 64.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.62 -0.675 . . . . 0.0 111.039 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -131.6 165.6 23.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.631 . . . . 0.0 110.567 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tp -126.11 137.35 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.766 -0.584 . . . . 0.0 110.191 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.32 -36.95 81.55 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.26 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.535 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.91 72.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.796 -0.826 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.5 140.54 29.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.758 -0.589 . . . . 0.0 110.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 69.13 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' C ' HG23 ' A' ' 4' ' ' THR . 23.8 Cg_exo -59.59 125.03 16.73 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.187 1.098 . . . . 0.0 110.615 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.458 HG23 ' C ' ' A' ' 3' ' ' PRO . 44.4 p -151.13 26.88 0.7 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.694 -0.629 . . . . 0.0 110.233 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -77.15 157.21 31.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.413 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.05 -6.34 32.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.613 -0.679 . . . . 0.0 111.749 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.26 -25.9 65.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 0.0 110.136 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.708 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.582 ' HB2' HD11 ' A' ' 68' ' ' ILE . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.896 HG21 HD11 ' A' ' 31' ' ' ILE . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 39' ' ' VAL . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 28' ' ' ILE . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.673 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.796 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.561 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 50' ' ' LYS . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 41' ' ' ALA . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.839 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.681 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 mm-40 -137.12 100.09 9.72 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.58 124.64 12.66 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 O-C-N 123.294 1.155 . . . . 0.0 110.165 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.33 155.37 7.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 110.307 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -130.46 126.51 37.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.681 -0.637 . . . . 0.0 109.965 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -59.66 -39.99 86.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.668 -0.645 . . . . 0.0 110.49 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.29 -166.25 0.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.717 . . . . 0.0 110.341 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 tp -58.09 -36.08 72.34 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.636 -0.665 . . . . 0.0 110.456 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 54.46 45.94 26.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.427 -0.796 . . . . 0.0 110.885 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.01 146.49 46.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -118.52 134.59 54.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.86 . . . . 0.0 110.374 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.9 p -83.53 -17.63 41.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.756 -0.59 . . . . 0.0 111.086 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -51.55 -48.79 85.76 Favored Pre-proline 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 111.496 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 24.9 Cg_exo -59.03 140.49 95.55 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 122.95 0.974 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.0 Cg_exo -58.7 -49.24 12.2 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.17 1.09 . . . . 0.0 111.077 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 24.2 Cg_exo -59.49 140.64 95.05 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 122.915 0.955 . . . . 0.0 110.643 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.14 134.85 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 0.0 109.912 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.31 141.62 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.723 -0.611 . . . . 0.0 110.458 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -109.43 139.74 44.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.818 -0.551 . . . . 0.0 110.222 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -65.53 154.35 88.34 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.713 -0.617 . . . . 0.0 110.192 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.24 148.52 89.61 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.21 1.111 . . . . 0.0 110.531 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.5 p -113.93 100.47 52.44 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.701 -0.624 . . . . 0.0 110.103 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.09 142.74 98.01 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.158 1.083 . . . . 0.0 110.45 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.04 -23.28 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.662 -0.649 . . . . 0.0 110.794 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.0 -35.2 70.9 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.793 . . . . 0.0 110.519 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.55 110.09 59.8 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.721 -0.612 . . . . 0.0 110.076 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.27 134.43 48.69 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.059 1.031 . . . . 0.0 110.396 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -97.48 -23.0 16.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.817 -0.552 . . . . 0.0 110.697 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -135.59 164.47 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.739 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 92.5 p -117.72 154.7 31.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 110.243 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.12 -33.63 69.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.42 -33.87 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.733 -0.604 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.86 130.49 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.673 -0.642 . . . . 0.0 110.198 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.84 144.83 56.75 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.703 -0.88 . . . . 0.0 110.135 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp -150.04 145.4 26.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.765 -0.584 . . . . 0.0 110.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.5 159.11 27.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -82.96 55.48 5.23 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 123.166 1.088 . . . . 0.0 111.008 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -99.64 10.71 40.87 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 111.18 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -79.44 171.26 15.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.277 -0.889 . . . . 0.0 110.9 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.424 ' HA ' HG12 ' A' ' 9' ' ' ILE . 95.4 mt-30 -75.52 -3.94 36.98 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.718 -0.614 . . . . 0.0 111.974 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.99 -31.92 73.11 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.739 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.71 ' CE2' HD13 ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' HB2' HG13 ' A' ' 39' ' ' VAL . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 56' ' ' VAL . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.748 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG3' HD11 ' A' ' 48' ' ' LEU . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 41' ' ' ALA . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG12 HD12 ' A' ' 57' ' ' LEU . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 37' ' ' THR . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 59.0 mm-40 -137.06 94.69 12.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.29 -29.31 85.91 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.279 1.147 . . . . 0.0 110.672 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.582 ' HB1' ' OD1' ' A' ' 74' ' ' ASP . . . 51.81 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -92.7 147.07 23.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.766 -0.584 . . . . 0.0 110.446 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 54.82 44.19 28.82 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 71' ' ' ALA . 82.1 m-20 -60.32 -37.22 79.9 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.713 -0.617 . . . . 0.0 110.289 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -101.52 130.69 47.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.734 -0.604 . . . . 0.0 110.349 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.67 44.85 29.13 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.393 -0.817 . . . . 0.0 110.963 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.19 -73.86 1.21 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.96 -41.22 91.41 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.744 -0.857 . . . . 0.0 110.368 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.1 m -59.91 -40.4 88.69 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.741 -0.599 . . . . 0.0 110.414 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.84 79.43 74.52 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.741 -0.599 . . . . 0.0 110.443 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 140.25 45.47 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.131 1.069 . . . . 0.0 110.132 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.5 Cg_exo -59.05 -48.7 13.27 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 O-C-N 123.038 1.02 . . . . 0.0 111.015 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 21.5 Cg_exo -61.26 140.23 87.52 Favored 'Trans proline' 0 N--CA 1.488 1.184 0 O-C-N 123.01 1.005 . . . . 0.0 110.361 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 85' ' ' VAL . 75.4 t -63.86 -43.3 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.637 -0.664 . . . . 0.0 109.621 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 84' ' ' VAL . 34.4 m -132.88 155.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.761 -0.587 . . . . 0.0 110.287 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -91.8 12.97 19.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.697 -0.627 . . . . 0.0 111.301 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -56.8 -59.75 11.48 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 110.859 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.98 146.95 96.06 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.049 1.026 . . . . 0.0 110.409 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 m -95.46 118.54 66.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.627 . . . . 0.0 110.078 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.82 -25.21 78.64 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 122.973 0.986 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.45 135.36 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.652 -0.655 . . . . 0.0 109.994 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -59.29 -37.41 77.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.71 -0.619 . . . . 0.0 110.383 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.63 110.15 62.64 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.669 -0.644 . . . . 0.0 110.125 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.93 140.67 91.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.02 1.01 . . . . 0.0 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -88.22 -18.44 28.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.759 -0.588 . . . . 0.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -102.51 137.52 40.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -117.93 151.3 37.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.753 -0.592 . . . . 0.0 110.148 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -66.63 152.49 45.24 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.693 -0.63 . . . . 0.0 110.164 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.86 137.1 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.751 -0.593 . . . . 0.0 109.909 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.2 141.93 28.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.53 0 CA-C-O 117.912 -1.493 . . . . 0.0 109.466 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -143.4 153.78 43.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.731 -0.864 . . . . 0.0 110.161 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -81.01 -33.68 33.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.779 -0.576 . . . . 0.0 110.159 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.88 81.15 0.83 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' C ' HG23 ' A' ' 4' ' ' THR . 18.5 Cg_exo -61.27 135.4 57.82 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.311 1.164 . . . . 0.0 110.272 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.659 ' HA ' HG21 ' A' ' 31' ' ' ILE . 31.5 p -149.83 28.24 0.77 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.743 -0.598 . . . . 0.0 110.372 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.1 151.48 35.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -67.95 -9.18 43.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.736 -0.602 . . . . 0.0 111.613 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.48 -25.39 65.85 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.402 -0.812 . . . . 0.0 110.095 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.647 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.774 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.718 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 68' ' ' ILE . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.706 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 31' ' ' ILE . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' VAL . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 9' ' ' ILE . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.976 HD11 HG21 ' A' ' 28' ' ' ILE . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.788 HG22 ' HA ' ' A' ' 28' ' ' ILE . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 40' ' ' ARG . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 39' ' ' VAL . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HE ' HD11 ' A' ' 48' ' ' LEU . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 46' ' ' VAL . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' ALA . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.654 HG23 ' HB2' ' A' ' 41' ' ' ALA . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.706 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 21' ' ' LEU . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.897 HG23 ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 14' ' ' SER . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 mt-10 -137.09 95.65 11.8 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.45 -55.76 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 O-C-N 123.324 1.171 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.87 145.68 54.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.681 -0.637 . . . . 0.0 110.297 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -94.28 145.7 24.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.753 -0.592 . . . . 0.0 110.21 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.38 122.87 43.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 0.0 110.201 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -104.87 149.79 25.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.744 -0.597 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.05 -34.73 79.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.779 -0.576 . . . . 0.0 110.129 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -150.76 162.17 41.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.757 -0.59 . . . . 0.0 110.256 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.6 0.37 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -127.92 167.73 16.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.92 . . . . 0.0 110.163 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.2 m -58.5 -39.19 79.36 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.663 -0.648 . . . . 0.0 110.361 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -133.17 153.54 80.81 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.58 144.39 84.48 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 O-C-N 123.239 1.126 . . . . 0.0 110.347 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.3 155.14 71.36 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.182 1.096 . . . . 0.0 110.188 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.28 138.46 81.29 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.181 1.095 . . . . 0.0 110.439 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.05 138.06 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.748 -0.595 . . . . 0.0 110.002 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.42 134.68 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.638 . . . . 0.0 109.833 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -103.01 127.52 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.684 -0.635 . . . . 0.0 110.407 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -122.86 79.14 49.77 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.768 -0.583 . . . . 0.0 110.053 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.61 148.75 80.29 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.11 1.058 . . . . 0.0 110.758 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.0 p -114.34 100.52 53.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.717 -0.614 . . . . 0.0 110.192 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.47 -24.38 77.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.167 1.088 . . . . 0.0 110.809 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.525 -0.734 . . . . 0.0 109.986 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.94 -68.63 0.75 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.705 -0.622 . . . . 0.0 110.425 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.22 110.15 51.16 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.557 -0.715 . . . . 0.0 110.056 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 144.85 99.39 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.012 1.006 . . . . 0.0 110.409 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -118.03 136.31 53.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.613 . . . . 0.0 110.435 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -108.11 143.2 37.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.755 -0.59 . . . . 0.0 109.667 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -57.01 -39.72 75.28 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.512 -0.742 . . . . 0.0 111.13 -172.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -59.51 -39.99 85.62 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.653 -0.654 . . . . 0.0 110.62 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -126.8 134.52 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.621 -0.674 . . . . 0.0 110.4 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.701 -0.624 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.573 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.47 144.36 31.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.719 -0.871 . . . . 0.0 110.151 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.86 137.98 31.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.359 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.58 75.06 0.41 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 4' ' ' THR . 36.6 Cg_endo -70.81 65.61 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.177 1.093 . . . . 0.0 110.427 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 3' ' ' PRO . 76.7 p -148.48 130.49 15.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.586 -0.696 . . . . 0.0 110.127 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -166.48 169.03 14.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 110.409 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' HA ' HG12 ' A' ' 9' ' ' ILE . 96.5 mt-30 -67.3 -16.58 64.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.69 -0.631 . . . . 0.0 111.354 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.16 -30.07 69.1 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.531 -0.731 . . . . 0.0 109.987 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.744 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.889 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.727 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 31' ' ' ILE . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.596 ' HB2' HG13 ' A' ' 39' ' ' VAL . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 28' ' ' ILE . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.62 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.727 HG23 HG22 ' A' ' 56' ' ' VAL . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.678 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.632 HG21 ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 37' ' ' THR . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.889 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 -137.17 131.92 17.86 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.0 151.59 64.75 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 122.996 0.998 . . . . 0.0 110.657 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -60.02 150.43 29.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.73 -0.607 . . . . 0.0 110.266 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -78.79 151.9 31.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.283 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.71 -35.26 70.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.696 -0.627 . . . . 0.0 110.597 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.71 139.88 58.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.713 -0.617 . . . . 0.0 110.165 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -99.32 141.76 31.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.754 -0.591 . . . . 0.0 110.254 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.84 46.68 25.23 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.428 -0.795 . . . . 0.0 110.961 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.45 64.94 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.98 -37.76 69.49 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.595 -0.944 . . . . 0.0 110.888 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -133.16 156.54 47.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 110.468 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.9 73.28 76.09 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.663 -0.648 . . . . 0.0 110.221 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.68 151.5 84.81 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.079 1.042 . . . . 0.0 110.193 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.49 111.28 1.44 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.177 1.093 . . . . 0.0 110.096 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.51 143.47 99.68 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 122.902 0.948 . . . . 0.0 110.682 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.68 -24.26 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.753 -0.592 . . . . 0.0 110.613 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.14 145.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -59.4 137.75 57.89 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.738 -0.601 . . . . 0.0 110.317 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 82.72 64.45 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.728 -0.608 . . . . 0.0 110.212 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.28 145.36 98.75 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 123.059 1.031 . . . . 0.0 110.411 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -68.34 142.27 94.45 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.773 -0.58 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.08 -26.92 83.61 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.633 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.97 135.14 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 110.009 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -97.52 153.92 17.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.769 -0.582 . . . . 0.0 110.19 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 161.82 24.32 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.737 -0.602 . . . . 0.0 110.17 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.5 138.26 82.81 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.125 1.066 . . . . 0.0 110.61 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.0 t60 54.85 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.594 -0.692 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.686 -0.634 . . . . 0.0 110.136 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -123.19 145.15 48.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.707 -0.62 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -126.7 120.55 29.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.749 -0.595 . . . . 0.0 110.509 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.5 pt -125.44 159.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.716 -0.615 . . . . 0.0 110.38 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 tp -102.24 130.49 48.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.73 -0.607 . . . . 0.0 110.191 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.535 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.4 144.75 56.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.749 -0.853 . . . . 0.0 110.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm -80.67 -34.94 34.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.716 -0.615 . . . . 0.0 110.038 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 4' ' ' THR . . . -126.37 78.63 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.1 85.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.139 1.073 . . . . 0.0 110.336 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 2' ' ' GLY . 71.2 p -94.81 9.72 38.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.67 -0.644 . . . . 0.0 111.346 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -78.07 145.11 36.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -73.39 -3.99 30.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.713 -0.617 . . . . 0.0 111.883 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.23 -27.61 67.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.323 -0.86 . . . . 0.0 110.163 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.631 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.76 ' HB2' HD11 ' A' ' 68' ' ' ILE . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 65' ' ' ILE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.769 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.901 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.879 HG23 HG22 ' A' ' 56' ' ' VAL . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.901 HD12 ' HA3' ' A' ' 26' ' ' GLY . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.743 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.868 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 43' ' ' ARG . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG12 HD12 ' A' ' 57' ' ' LEU . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 15' ' ' ILE . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.631 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 33.8 mt-10 -137.09 107.66 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -58.45 151.32 62.27 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.166 1.088 . . . . 0.0 110.723 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.84 68.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.805 -0.559 . . . . 0.0 110.242 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -130.38 155.44 46.39 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.679 -0.638 . . . . 0.0 110.385 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -98.15 121.89 40.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.744 -0.598 . . . . 0.0 110.223 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -83.81 -166.79 1.5 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.626 . . . . 0.0 110.465 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.3 149.53 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 110.108 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.38 119.2 21.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.09 -170.33 46.54 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -57.91 -39.55 78.22 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.624 -0.927 . . . . 0.0 110.495 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -80.26 159.78 25.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.805 -0.559 . . . . 0.0 110.154 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.1 162.59 53.04 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.705 -0.622 . . . . 0.0 110.368 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.99 154.77 73.57 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.224 1.118 . . . . 0.0 110.365 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 149.54 87.03 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 O-C-N 123.188 1.099 . . . . 0.0 110.357 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.73 141.96 96.42 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.183 1.096 . . . . 0.0 110.451 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.04 24.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.721 -0.612 . . . . 0.0 110.661 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.83 142.27 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.0 110.295 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -117.46 161.67 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.755 -0.591 . . . . 0.0 110.248 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt 53.86 67.66 3.4 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.451 -0.78 . . . . 0.0 110.797 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.58 145.05 99.16 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.05 1.026 . . . . 0.0 110.601 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.5 m -73.24 143.88 83.79 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.6 . . . . 0.0 110.205 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.85 147.54 95.02 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.077 1.041 . . . . 0.0 110.442 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 92' ' ' LYS . 13.6 p -133.08 144.65 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.685 -0.635 . . . . 0.0 110.403 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 91' ' ' VAL . 90.8 mttt 54.75 44.29 28.74 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.464 -0.773 . . . . 0.0 110.738 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.408 HD23 ' CD ' ' A' ' 94' ' ' PRO . 1.4 tt -74.24 142.42 78.66 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.727 -0.608 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 93' ' ' LEU . 16.6 Cg_endo -62.11 151.92 78.87 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.065 1.034 . . . . 0.0 110.259 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -109.19 130.57 55.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -74.67 -22.88 58.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.748 -0.595 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -60.29 153.07 23.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 t30 53.86 43.59 30.72 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.399 -0.813 . . . . 0.0 110.926 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.79 -28.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.649 . . . . 0.0 110.447 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.493 HD23 ' C ' ' A' ' 100' ' ' LEU . 9.2 tt -60.1 -37.01 78.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.749 -0.595 . . . . 0.0 110.313 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.573 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.17 72.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.758 -0.848 . . . . 0.0 110.159 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.76 158.44 44.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.684 -0.635 . . . . 0.0 109.825 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 4' ' ' THR . . . 73.5 103.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.1 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.056 1.029 . . . . 0.0 110.48 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 2' ' ' GLY . 68.3 p -95.45 12.8 28.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.73 -0.606 . . . . 0.0 111.051 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -78.64 145.15 34.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.286 -0.884 . . . . 0.0 110.621 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -73.19 -3.96 29.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.667 -0.646 . . . . 0.0 111.938 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -67.51 -27.38 66.94 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.775 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.921 HG21 HD11 ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' HB2' HG13 ' A' ' 39' ' ' VAL . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.921 HD11 HG21 ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.671 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.783 HG23 HG22 ' A' ' 56' ' ' VAL . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 45' ' ' GLY . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 41' ' ' ALA . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 37' ' ' THR . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.854 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 10.4 mt-10 -137.01 92.12 14.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -60.91 146.02 98.22 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.245 1.129 . . . . 0.0 110.591 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.17 -28.99 70.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.795 -0.566 . . . . 0.0 110.012 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttp 55.44 46.67 22.76 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.461 -0.775 . . . . 0.0 110.827 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 54.18 60.23 3.72 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.422 -0.799 . . . . 0.0 111.037 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -55.91 -36.6 67.89 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.492 -0.755 . . . . 0.0 110.652 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.23 124.08 42.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 110.084 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.85 117.69 29.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.29 169.01 38.54 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -137.18 162.83 32.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.873 . . . . 0.0 110.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.0 m -120.28 135.25 55.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.664 -0.647 . . . . 0.0 110.066 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.828 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -77.03 -57.86 1.09 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.723 -0.611 . . . . 0.0 110.384 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.828 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 37.6 Cg_endo -72.04 141.12 35.84 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.09 1.047 . . . . 0.0 110.4 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 16.6 Cg_exo -64.0 145.82 90.35 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.105 1.055 . . . . 0.0 110.092 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.79 85.04 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.079 1.041 . . . . 0.0 110.546 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.76 -39.71 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.679 -0.638 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.13 -40.2 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 0.0 110.017 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -105.48 137.51 43.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.656 -0.652 . . . . 0.0 110.409 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.07 161.48 36.39 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.707 -0.62 . . . . 0.0 110.13 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.04 80.45 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.165 1.087 . . . . 0.0 110.551 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -77.07 143.97 71.06 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.788 -0.57 . . . . 0.0 110.224 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.51 -33.25 88.04 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.163 1.086 . . . . 0.0 110.391 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 p -135.16 141.61 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.612 . . . . 0.0 110.187 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -83.35 129.77 35.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.769 -0.582 . . . . 0.0 110.154 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.71 153.74 70.53 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.743 -0.598 . . . . 0.0 110.279 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 148.91 91.32 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.199 1.105 . . . . 0.0 110.387 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -113.72 139.52 49.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.701 -0.625 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -134.73 162.94 30.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.76 -0.587 . . . . 0.0 110.317 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 m 51.98 92.52 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.369 -0.832 . . . . 0.0 111.076 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.51 -37.1 74.89 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.662 -0.649 . . . . 0.0 110.45 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.9 tt -123.33 138.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.74 -0.6 . . . . 0.0 110.198 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.5 tp -98.74 130.63 45.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.617 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.602 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.49 74.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.723 -0.869 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -150.07 152.26 34.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.683 -0.635 . . . . 0.0 109.944 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.06 63.67 4.85 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 14.9 Cg_endo -61.58 153.28 67.88 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.239 1.126 . . . . 0.0 110.433 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 p -90.75 107.3 19.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -166.51 174.13 9.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.736 -0.602 . . . . 0.0 110.561 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.92 -3.95 32.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.656 -0.653 . . . . 0.0 111.968 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -68.01 -28.64 67.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.695 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 15' ' ' ILE . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.859 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' ALA . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HD2' HG11 ' A' ' 39' ' ' VAL . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HG21 ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.765 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.87 HG23 HG22 ' A' ' 56' ' ' VAL . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.736 ' CB ' HD21 ' A' ' 48' ' ' LEU . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 47' ' ' PRO . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 41' ' ' ALA . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 HG23 ' A' ' 37' ' ' THR . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.718 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HB2' HD11 ' A' ' 21' ' ' LEU . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.859 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.695 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 69.5 mt-10 -135.83 91.93 17.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -63.95 -29.59 66.91 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 O-C-N 123.295 1.155 . . . . 0.0 110.488 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 139.21 53.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.74 -0.6 . . . . 0.0 110.283 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.05 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.85 164.8 29.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.805 -0.559 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.18 144.13 57.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.743 -0.598 . . . . 0.0 110.16 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.96 141.39 28.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.79 -0.569 . . . . 0.0 110.147 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.96 -37.09 75.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.709 -0.619 . . . . 0.0 110.407 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.26 179.09 50.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -129.71 148.72 51.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.781 -0.835 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.5 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.724 -0.61 . . . . 0.0 110.159 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -127.54 76.92 76.55 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.75 -0.594 . . . . 0.0 110.314 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.52 144.12 97.65 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.095 1.05 . . . . 0.0 110.201 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.12 111.03 2.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.214 1.113 . . . . 0.0 110.321 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 139.86 76.85 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.04 1.021 . . . . 0.0 110.353 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.31 133.37 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.728 -0.608 . . . . 0.0 109.96 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.35 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.733 -0.604 . . . . 0.0 109.903 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -152.31 171.92 17.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.666 -0.646 . . . . 0.0 110.472 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttt 53.85 177.15 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.492 -0.755 . . . . 0.0 110.933 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.48 152.84 58.63 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.015 1.008 . . . . 0.0 110.553 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.2 p -68.31 143.06 95.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.702 -0.624 . . . . 0.0 110.151 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.19 -25.07 80.26 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.099 1.052 . . . . 0.0 110.772 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.64 134.27 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.561 -0.712 . . . . 0.0 110.043 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -101.54 153.69 19.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.699 -0.626 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.61 155.65 88.4 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.771 -0.581 . . . . 0.0 110.197 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.22 134.44 55.77 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.17 1.089 . . . . 0.0 110.521 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -59.46 -38.79 81.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.609 -0.682 . . . . 0.0 110.448 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -101.22 131.25 47.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.69 -0.632 . . . . 0.0 110.5 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -121.73 148.73 44.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.79 -0.569 . . . . 0.0 110.003 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -97.93 108.65 21.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.675 -0.64 . . . . 0.0 110.215 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.5 -22.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.718 -0.614 . . . . 0.0 110.756 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.37 143.34 29.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.51 -0.744 . . . . 0.0 110.152 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.526 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.526 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.13 -33.45 74.5 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.743 -0.857 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -80.74 -34.33 34.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.769 -0.582 . . . . 0.0 110.021 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.62 112.16 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.16 135.09 66.12 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.906 0.95 . . . . 0.0 110.815 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -98.1 109.15 21.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.652 -0.655 . . . . 0.0 110.312 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -167.01 166.02 15.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.681 -0.637 . . . . 0.0 110.703 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -72.47 -6.26 42.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.665 -0.647 . . . . 0.0 111.7 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -68.1 -28.2 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 68' ' ' ILE . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.696 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.878 HG21 HD11 ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HB2' HG13 ' A' ' 39' ' ' VAL . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.878 HD11 HG21 ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG21 ' CB ' ' A' ' 41' ' ' ALA . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.696 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 14' ' ' SER . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 20.4 mt-10 -137.18 99.44 9.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -65.61 132.16 30.05 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 O-C-N 123.309 1.163 . . . . 0.0 110.266 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.78 72.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.729 -0.607 . . . . 0.0 110.145 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -142.51 124.89 15.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.782 -0.574 . . . . 0.0 110.186 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.26 93.29 3.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 110.229 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.31 -39.73 93.96 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.707 -0.62 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 tp -108.23 129.38 55.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.721 -0.612 . . . . 0.0 110.276 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -61.37 -35.93 78.85 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.75 -0.594 . . . . 0.0 110.541 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.48 179.76 46.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -60.17 -41.29 92.56 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.74 -0.859 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.7 p -122.8 162.35 22.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.772 -0.58 . . . . 0.0 110.293 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 159.09 84.9 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.733 -0.604 . . . . 0.0 110.22 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.29 156.43 59.84 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.199 1.105 . . . . 0.0 110.452 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.94 -58.52 1.66 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.129 1.068 . . . . 0.0 111.908 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.2 Cg_endo -60.41 148.82 89.21 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 122.975 0.987 . . . . 0.0 110.495 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.39 145.16 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.706 -0.621 . . . . 0.0 110.318 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.97 137.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.679 -0.638 . . . . 0.0 109.898 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -81.12 131.7 35.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.687 -0.633 . . . . 0.0 110.318 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 tttm 53.26 57.71 14.06 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.429 -0.794 . . . . 0.0 110.84 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.3 146.03 85.02 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.039 1.021 . . . . 0.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.9 t -68.3 150.36 97.74 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.706 -0.621 . . . . 0.0 110.073 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.04 -35.14 93.93 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.065 1.034 . . . . 0.0 110.492 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -128.04 131.09 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.639 . . . . 0.0 109.834 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HG2' HD12 ' A' ' 93' ' ' LEU . 29.7 tttt -96.78 -64.84 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.729 -0.607 . . . . 0.0 110.262 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -100.12 163.15 18.87 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.183 -178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -58.86 148.49 83.76 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.126 1.066 . . . . 0.0 110.631 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -113.67 171.14 7.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.74 149.07 37.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.722 -0.611 . . . . 0.0 110.235 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.9 m -59.05 -35.13 72.82 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.75 -0.594 . . . . 0.0 110.418 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 54.66 44.98 27.77 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.441 -0.787 . . . . 0.0 110.711 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.5 tt -59.44 -28.1 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.751 -0.593 . . . . 0.0 110.542 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.2 -34.68 76.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.775 -0.578 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.535 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.91 -32.3 72.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.71 -0.876 . . . . 0.0 110.12 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -149.83 154.08 37.81 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.703 -0.623 . . . . 0.0 109.825 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.39 77.52 0.39 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.85 133.33 44.16 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.118 1.062 . . . . 0.0 110.145 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.434 ' HA ' HG22 ' A' ' 31' ' ' ILE . 55.8 p -146.84 16.96 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.673 -0.642 . . . . 0.0 111.077 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.46 141.67 35.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -66.73 -13.85 61.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.71 -26.59 67.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB2' HD11 ' A' ' 68' ' ' ILE . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.746 HG23 HG22 ' A' ' 56' ' ' VAL . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG12 HD12 ' A' ' 57' ' ' LEU . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 37' ' ' THR . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.427 HG21 HG23 ' A' ' 15' ' ' ILE . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 36.3 mt-10 -137.09 98.38 10.41 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.15 138.45 61.7 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 O-C-N 123.286 1.15 . . . . 0.0 110.464 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 -14.0 60.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.637 -0.664 . . . . 0.0 111.319 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.82 -34.71 69.95 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.178 -0.951 . . . . 0.0 110.879 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.34 -51.27 70.64 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.58 -35.07 70.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 110.656 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.13 -36.98 83.43 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.642 -0.661 . . . . 0.0 110.466 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.94 -174.01 3.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.48 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.42 30.14 19.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -111.58 128.94 56.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.902 . . . . 0.0 110.181 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.6 p -128.64 159.08 36.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.737 -0.602 . . . . 0.0 110.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -79.28 -48.85 1.5 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.706 -0.621 . . . . 0.0 110.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 23.8 Cg_exo -59.7 167.86 6.23 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 122.981 0.99 . . . . 0.0 110.459 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -62.08 160.25 30.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.25 1.132 . . . . 0.0 110.3 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.78 154.64 48.23 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.111 1.058 . . . . 0.0 110.585 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.67 -39.64 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.669 -0.645 . . . . 0.0 109.916 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.0 144.81 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -155.38 -176.33 5.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.767 -0.583 . . . . 0.0 110.445 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -66.12 163.84 34.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.739 -0.601 . . . . 0.0 110.001 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.92 145.1 92.62 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.047 1.025 . . . . 0.0 110.759 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 p -122.97 100.53 39.97 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.749 -0.595 . . . . 0.0 110.158 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.5 -25.95 76.19 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.17 1.089 . . . . 0.0 110.807 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.44 141.68 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.371 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -101.54 141.97 33.61 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.736 -0.602 . . . . 0.0 110.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.57 142.1 70.13 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.735 -0.603 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 146.86 95.22 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.149 1.079 . . . . 0.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -122.07 131.16 53.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.684 -0.635 . . . . 0.0 110.177 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.14 -42.96 99.5 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.777 -0.577 . . . . 0.0 110.238 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.1 p -131.23 157.79 42.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 110.242 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -58.21 -34.26 70.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.73 -0.606 . . . . 0.0 110.53 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -115.56 131.22 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.667 -0.646 . . . . 0.0 109.825 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.5 mm? -61.4 -38.84 88.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.677 -0.639 . . . . 0.0 110.241 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.182 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.17 -33.46 74.55 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.861 -0.788 . . . . 0.0 110.219 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mtp -81.25 -39.64 24.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.772 -0.58 . . . . 0.0 110.126 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.15 150.82 20.91 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 26.7 Cg_endo -67.5 85.4 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.168 1.088 . . . . 0.0 110.331 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -94.77 8.01 43.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.617 -0.677 . . . . 0.0 111.428 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -78.3 141.14 38.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.247 -0.908 . . . . 0.0 110.414 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.43 -4.49 30.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.707 -0.621 . . . . 0.0 111.881 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.26 -25.43 65.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.848 . . . . 0.0 110.122 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.753 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.851 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.825 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.787 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.863 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 39' ' ' VAL . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 28' ' ' ILE . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.867 HG23 HG22 ' A' ' 56' ' ' VAL . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.863 HD12 ' HA3' ' A' ' 26' ' ' GLY . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.807 ' HB3' HD21 ' A' ' 48' ' ' LEU . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 43' ' ' ARG . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 57' ' ' LEU . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 37' ' ' THR . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.787 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.851 HD11 ' HB2' ' A' ' 14' ' ' SER . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 37.7 mt-10 -137.17 102.37 9.04 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.32 -34.41 87.57 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.292 1.153 . . . . 0.0 110.352 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 58.12 -84.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.579 -0.701 . . . . 0.0 111.111 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.92 -34.61 68.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.309 -0.869 . . . . 0.0 110.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.12 119.65 27.57 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.607 -0.683 . . . . 0.0 110.384 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -162.61 170.3 18.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -101.05 120.23 39.9 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.715 -0.616 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -66.61 -45.62 78.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.734 -0.604 . . . . 0.0 110.489 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.19 -175.56 28.94 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -120.95 118.69 30.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.769 -0.842 . . . . 0.0 110.132 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -145.75 155.0 42.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.652 -0.655 . . . . 0.0 110.091 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 81' ' ' PRO . . . 51.95 -174.5 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.338 -0.852 . . . . 0.0 110.756 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 80' ' ' ALA . 24.3 Cg_exo -59.72 137.8 79.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.035 1.018 . . . . 0.0 110.314 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 152.41 76.53 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.096 1.051 . . . . 0.0 110.379 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.9 143.95 99.46 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.151 1.08 . . . . 0.0 110.351 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.32 159.48 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.598 . . . . 0.0 110.329 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.31 162.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.772 -0.58 . . . . 0.0 110.161 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -79.15 117.26 20.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.741 -0.599 . . . . 0.0 110.188 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -126.49 170.11 10.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.292 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.51 147.9 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.082 1.043 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -68.31 141.55 93.75 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.775 -0.578 . . . . 0.0 110.213 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.32 -28.51 86.96 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.101 1.053 . . . . 0.0 110.509 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.09 145.82 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.768 -0.582 . . . . 0.0 110.161 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -81.61 138.15 35.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.729 -0.607 . . . . 0.0 110.059 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.88 160.86 26.74 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.736 -0.603 . . . . 0.0 110.271 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.42 154.04 61.79 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.138 1.073 . . . . 0.0 110.455 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -116.66 177.28 4.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.76 -0.587 . . . . 0.0 110.041 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -59.13 -30.54 68.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.694 -0.628 . . . . 0.0 110.361 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -62.71 -27.3 69.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.825 -0.547 . . . . 0.0 110.288 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.65 137.3 36.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.671 -0.643 . . . . 0.0 110.202 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.14 -36.48 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.769 -0.582 . . . . 0.0 109.794 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -94.83 141.52 28.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.718 -0.614 . . . . 0.0 110.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.498 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.08 73.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.669 -0.9 . . . . 0.0 110.165 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp -87.84 134.34 33.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.698 -0.626 . . . . 0.0 110.226 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.62 161.53 24.27 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.95 68.01 1.82 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.2 1.105 . . . . 0.0 110.345 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -94.3 14.0 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.642 -0.661 . . . . 0.0 111.202 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -78.76 145.68 34.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.344 -0.848 . . . . 0.0 110.611 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.15 -3.91 29.51 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.689 -0.632 . . . . 0.0 111.983 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -67.49 -25.35 65.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 0.0 110.355 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.715 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' HD13 ' A' ' 15' ' ' ILE . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.805 HG23 HG22 ' A' ' 56' ' ' VAL . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.787 ' HB3' HD21 ' A' ' 48' ' ' LEU . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 47' ' ' PRO . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 43' ' ' ARG . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 57' ' ' LEU . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.805 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 69' ' ' GLU . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.774 ' HG3' HG22 ' A' ' 68' ' ' ILE . 23.9 mt-10 -137.21 144.21 44.89 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.46 150.11 82.81 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.278 1.146 . . . . 0.0 110.543 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -72.39 142.05 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.615 . . . . 0.0 110.443 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -93.18 143.05 26.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.731 -0.606 . . . . 0.0 109.942 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -56.21 139.46 47.69 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.57 -0.706 . . . . 0.0 110.756 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.683 -0.636 . . . . 0.0 110.409 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.7 tp -102.4 131.26 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 109.897 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.17 13.75 10.71 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.618 -0.676 . . . . 0.0 111.686 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 30.16 56.51 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -59.19 -40.72 86.59 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.654 -0.91 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -86.13 165.36 16.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.72 -0.613 . . . . 0.0 110.225 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.05 160.35 16.73 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.752 -0.592 . . . . 0.0 110.16 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -58.7 110.06 0.61 Allowed 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.17 1.09 . . . . 0.0 110.596 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.66 167.15 26.44 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 O-C-N 123.099 1.052 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.51 152.96 51.34 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.129 1.068 . . . . 0.0 110.548 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.32 157.41 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.758 -0.589 . . . . 0.0 110.441 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.54 147.12 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.814 -0.553 . . . . 0.0 110.197 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -61.3 170.13 1.87 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.68 -0.637 . . . . 0.0 110.059 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -59.23 142.71 85.92 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.641 -0.662 . . . . 0.0 110.201 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.42 136.67 73.28 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.161 1.085 . . . . 0.0 110.61 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -76.73 140.38 67.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.744 -0.597 . . . . 0.0 110.206 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.41 -35.59 71.49 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.111 1.058 . . . . 0.0 110.177 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.49 153.52 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.808 -0.558 . . . . 0.0 110.145 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -118.11 135.28 54.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.692 -0.63 . . . . 0.0 110.382 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 mt -110.63 163.08 18.11 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.5 134.77 60.37 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.121 1.064 . . . . 0.0 110.601 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -135.53 -44.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.759 -0.588 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -133.96 152.35 51.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.678 -0.639 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -75.96 -25.37 55.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.684 -0.635 . . . . 0.0 110.966 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.96 142.74 57.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.14 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 101' ' ' GLY . 82.0 mt -118.23 136.16 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.771 -0.581 . . . . 0.0 109.901 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.86 -34.74 75.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.755 -0.591 . . . . 0.0 110.169 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.61 71.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.727 -0.867 . . . . 0.0 110.125 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -145.95 153.07 40.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.19 62.01 6.51 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 28.6 Cg_endo -68.13 78.27 0.6 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.109 1.058 . . . . 0.0 110.315 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' ALA . 72.2 p -94.89 15.34 18.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.725 -0.61 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -78.21 147.21 34.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 110.507 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -73.12 -3.97 29.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.757 -0.589 . . . . 0.0 112.096 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.58 -24.4 64.6 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.376 -0.827 . . . . 0.0 110.41 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.657 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.778 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.856 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.619 ' HB2' HG13 ' A' ' 39' ' ' VAL . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' HG21 ' A' ' 4' ' ' THR . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.761 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.701 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.734 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' A' ' 47' ' ' PRO . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 49.1 mt-10 -137.13 95.13 12.03 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.04 150.47 84.04 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.307 1.162 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.95 144.33 25.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.087 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -87.2 133.1 33.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.635 -0.665 . . . . 0.0 110.276 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.77 -36.73 81.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.728 -0.607 . . . . 0.0 110.168 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -59.93 -38.01 81.13 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -103.51 133.57 48.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.707 -0.621 . . . . 0.0 109.901 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 75' ' ' LEU . 33.1 t0 -81.25 118.0 22.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.747 -0.596 . . . . 0.0 110.068 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.21 -31.34 69.14 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -97.49 77.99 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.667 -0.902 . . . . 0.0 110.437 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 76' ' ' ASP . 69.7 p -127.25 156.12 42.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.67 -0.643 . . . . 0.0 110.01 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -98.08 -53.5 0.2 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.697 -0.627 . . . . 0.0 111.191 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 18.6 Cg_exo -58.09 -49.64 12.13 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 122.877 0.935 . . . . 0.0 111.253 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HD3' ' CD ' ' A' ' 81' ' ' PRO . 19.7 Cg_exo -62.54 146.0 95.43 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 122.964 0.981 . . . . 0.0 110.428 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.68 153.46 67.14 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.139 1.073 . . . . 0.0 110.21 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.92 130.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.629 -0.669 . . . . 0.0 110.42 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.01 -36.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.761 -0.587 . . . . 0.0 110.055 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.587 HD22 HD11 ' A' ' 27' ' ' LEU . 55.0 t-20 -71.28 122.87 21.02 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.736 -0.603 . . . . 0.0 110.387 -176.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -134.04 166.33 30.04 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.793 -0.567 . . . . 0.0 110.122 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.96 144.15 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.156 1.082 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 p -119.38 100.34 49.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 110.47 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.34 151.2 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.317 1.167 . . . . 0.0 110.162 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.43 -40.76 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.662 -0.649 . . . . 0.0 109.832 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -82.84 136.78 34.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.676 -0.64 . . . . 0.0 110.12 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.7 140.62 96.45 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.722 -0.611 . . . . 0.0 110.027 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.83 145.45 98.22 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.093 1.049 . . . . 0.0 110.589 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -122.03 146.01 47.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 110.092 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -61.5 -27.38 68.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.712 -0.617 . . . . 0.0 110.288 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 t -117.95 141.12 48.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.677 -0.639 . . . . 0.0 110.148 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -105.55 119.97 40.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.654 -0.654 . . . . 0.0 110.265 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.36 -35.37 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.703 -0.623 . . . . 0.0 109.743 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.1 141.6 28.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.609 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -104.09 146.65 28.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.746 -0.856 . . . . 0.0 110.276 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp -87.32 147.7 25.38 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.664 . . . . 0.0 110.264 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 4' ' ' THR . . . -109.4 164.29 12.45 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 14.1 Cg_endo -61.27 98.12 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.249 1.131 . . . . 0.0 110.403 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 2' ' ' GLY . 73.4 p -97.43 15.7 22.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.643 . . . . 0.0 111.141 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -78.15 142.25 38.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.389 -0.819 . . . . 0.0 110.49 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.1 -4.0 29.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.659 -0.651 . . . . 0.0 111.892 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.281 -0.887 . . . . 0.0 110.18 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.573 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 15' ' ' ILE . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.904 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.943 HG21 HD11 ' A' ' 31' ' ' ILE . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HB2' HG13 ' A' ' 39' ' ' VAL . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 9' ' ' ILE . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.943 HD11 HG21 ' A' ' 28' ' ' ILE . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.791 HG23 HG22 ' A' ' 56' ' ' VAL . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.77 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.732 ' CD ' HD11 ' A' ' 48' ' ' LEU . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 41' ' ' ALA . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.791 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.713 ' HG ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.9 mt-10 -137.06 91.9 14.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.96 -12.55 21.6 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.478 1.251 . . . . 0.0 111.507 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -162.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.402 -0.811 . . . . 0.0 110.621 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 55.15 50.29 15.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.532 -0.73 . . . . 0.0 110.706 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -105.18 149.33 26.02 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.755 -0.591 . . . . 0.0 110.022 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -103.32 165.41 11.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -101.3 127.47 47.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.71 -0.619 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 78' ' ' HIS . 36.0 t0 -143.39 143.01 31.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 110.188 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.58 132.54 14.46 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.408 ' CE1' ' HB3' ' A' ' 76' ' ' ASP . 75.0 m80 -125.93 142.1 51.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.623 -0.928 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.9 m -59.83 -38.25 81.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.647 -0.658 . . . . 0.0 110.203 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 81' ' ' PRO . . . -80.82 173.76 7.21 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.74 -0.6 . . . . 0.0 110.219 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' A' ' 80' ' ' ALA . 24.2 Cg_exo -59.63 162.41 15.41 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.268 1.141 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.69 151.59 69.1 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.1 1.052 . . . . 0.0 110.491 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 146.41 93.9 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.206 1.108 . . . . 0.0 110.655 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t 53.34 97.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.414 -0.804 . . . . 0.0 110.643 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 21.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.666 -0.646 . . . . 0.0 110.886 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.75 -36.3 74.14 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.0 110.354 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.1 145.77 46.91 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.705 -0.622 . . . . 0.0 110.168 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.89 143.75 99.55 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.155 1.082 . . . . 0.0 110.504 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.5 p -105.67 114.53 62.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.753 -0.592 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -57.53 -22.09 49.44 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.978 0.988 . . . . 0.0 111.242 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.51 -45.54 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.492 -0.755 . . . . 0.0 110.105 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -61.65 -34.7 76.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.162 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 93' ' ' LEU . 2.4 mm? -82.34 120.08 76.21 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.796 -0.565 . . . . 0.0 110.229 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.52 152.71 71.54 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 122.91 0.952 . . . . 0.0 110.283 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -107.56 130.09 54.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.788 -0.57 . . . . 0.0 110.126 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -60.4 -34.66 74.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.768 -0.583 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t 51.67 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.393 -0.817 . . . . 0.0 111.107 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -57.7 -37.62 73.78 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.2 mt -116.78 133.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.0 109.774 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.63 130.37 46.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.736 -0.602 . . . . 0.0 110.243 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.557 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.529 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.62 145.61 29.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.849 . . . . 0.0 110.254 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm -155.16 148.66 25.17 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.742 -0.599 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.58 162.52 15.3 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 31' ' ' ILE . 38.3 Cg_endo -71.92 63.58 3.24 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.176 1.093 . . . . 0.0 110.426 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -92.89 -14.12 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.617 -0.677 . . . . 0.0 111.384 -178.568 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -78.33 163.38 25.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.323 -0.861 . . . . 0.0 110.999 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -75.49 -3.76 35.87 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.702 -0.624 . . . . 0.0 112.031 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.97 -30.26 70.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.259 -0.9 . . . . 0.0 110.12 -175.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.634 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.781 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.918 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 31' ' ' ILE . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 28' ' ' ILE . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.612 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.989 HG23 HG22 ' A' ' 56' ' ' VAL . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.918 HD12 ' HA3' ' A' ' 26' ' ' GLY . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.802 ' HG3' HD11 ' A' ' 48' ' ' LEU . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG13 ' HD2' ' A' ' 47' ' ' PRO . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 43' ' ' ARG . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 57' ' ' LEU . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.989 HG22 HG23 ' A' ' 37' ' ' THR . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.781 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.83 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.634 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 14' ' ' SER . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 12.8 mt-10 -137.12 99.26 10.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 69' ' ' GLU . 16.8 Cg_endo -62.56 -25.78 75.72 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.267 1.141 . . . . 0.0 110.426 175.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.88 165.27 23.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.594 -0.691 . . . . 0.0 110.143 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -57.56 -37.14 72.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.691 -0.631 . . . . 0.0 110.638 -178.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -102.47 130.18 49.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.683 -0.636 . . . . 0.0 110.165 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.84 -40.29 92.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.722 -0.611 . . . . 0.0 110.291 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 79' ' ' THR . 16.9 tp -112.16 135.66 52.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.04 -33.88 67.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.529 -0.732 . . . . 0.0 110.728 -178.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.3 177.74 5.54 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -178.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -58.75 -41.39 86.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.895 . . . . 0.0 110.648 -177.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 75' ' ' LEU . 10.1 t -132.62 158.11 43.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.702 -0.624 . . . . 0.0 110.659 -177.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -125.15 83.9 60.07 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.97 147.06 94.32 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.162 1.085 . . . . 0.0 110.426 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.9 Cg_exo -58.4 -48.68 14.54 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.186 1.098 . . . . 0.0 111.146 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 28.2 Cg_exo -58.06 147.29 83.67 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 122.908 0.952 . . . . 0.0 110.754 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.03 137.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.735 -0.603 . . . . 0.0 110.297 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -68.31 -27.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.735 -0.603 . . . . 0.0 110.468 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.03 117.76 30.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.648 -0.657 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -128.56 167.02 20.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.751 -0.593 . . . . 0.0 110.209 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.61 146.79 96.46 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.148 1.078 . . . . 0.0 110.401 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 t -68.23 142.47 94.85 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 0.0 110.255 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 144.86 95.23 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.164 1.086 . . . . 0.0 110.41 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t 52.99 97.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -132.14 128.16 37.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 0.0 110.233 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 8.7 mt -76.9 146.51 75.94 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.782 -0.574 . . . . 0.0 110.169 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.38 139.94 85.26 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 O-C-N 123.113 1.06 . . . . 0.0 110.335 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.2 m80 53.13 29.73 8.66 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.369 -0.832 . . . . 0.0 110.938 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CG ' ' HB2' ' A' ' 93' ' ' LEU . 67.3 t80 -103.15 132.7 49.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.729 -0.607 . . . . 0.0 110.252 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.51 ' H ' HD12 ' A' ' 100' ' ' LEU . 49.6 m -119.61 145.31 46.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.764 -0.585 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.5 -32.73 70.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.767 -0.583 . . . . 0.0 110.349 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -58.77 -28.78 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.715 -0.616 . . . . 0.0 110.645 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 97' ' ' SER . 98.1 mt -61.89 -34.61 76.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.686 -0.634 . . . . 0.0 110.126 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 CA-C-O 117.969 -1.462 . . . . 0.0 109.501 179.987 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -100.58 26.05 7.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.715 -0.874 . . . . 0.0 110.434 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -149.7 154.9 39.29 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.644 -0.66 . . . . 0.0 109.973 -179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.89 68.62 1.59 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 9.5 Cg_endo -58.56 155.4 36.79 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.14 1.073 . . . . 0.0 110.799 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p -97.41 25.37 5.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.629 . . . . 0.0 110.415 178.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 159.45 30.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.627 -0.671 . . . . 0.0 110.709 -175.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -71.82 -3.85 24.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.718 -0.614 . . . . 0.0 111.965 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.94 -22.26 66.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 175.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.685 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.742 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.589 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.868 HG21 HD11 ' A' ' 31' ' ' ILE . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' HG13 ' A' ' 39' ' ' VAL . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.78 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.778 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.684 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 47' ' ' PRO . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 46' ' ' VAL . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.866 HD12 ' HB1' ' A' ' 41' ' ' ALA . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 57' ' ' LEU . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.78 HG22 HG23 ' A' ' 37' ' ' THR . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.711 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.834 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 30.7 mt-10 -137.16 99.9 9.75 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.6 141.43 86.0 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 O-C-N 123.224 1.118 . . . . 0.0 110.083 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.97 85.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.715 -0.616 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.5 -45.16 95.38 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.65 -0.656 . . . . 0.0 110.534 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.582 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -93.37 120.2 33.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.838 -0.539 . . . . 0.0 110.053 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' ILE . 97.1 mt -59.95 -37.32 79.21 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.673 . . . . 0.0 110.325 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -160.7 165.99 29.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.731 -0.605 . . . . 0.0 110.386 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.85 124.55 7.89 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -128.49 136.89 51.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.692 -0.887 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.6 m -80.97 134.62 35.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.623 -0.673 . . . . 0.0 110.14 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -174.46 -52.63 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 121.624 -0.673 . . . . 0.0 110.884 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 21.7 Cg_exo -62.47 162.9 22.51 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.791 0.89 . . . . 0.0 110.292 -177.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.14 163.53 19.64 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.221 1.116 . . . . 0.0 110.27 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.45 147.69 90.26 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.135 1.071 . . . . 0.0 110.653 -178.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 160.32 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.771 -0.58 . . . . 0.0 110.388 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.65 -38.63 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.734 -0.604 . . . . 0.0 109.98 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t30 54.46 48.19 21.1 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.326 -0.859 . . . . 0.0 110.767 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.2 mttt 57.06 161.99 0.08 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.788 -0.57 . . . . 0.0 110.898 -177.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.12 149.35 89.58 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 122.938 0.967 . . . . 0.0 110.418 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -123.6 155.36 66.17 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.757 -0.589 . . . . 0.0 110.276 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.5 146.78 96.24 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.246 1.129 . . . . 0.0 110.555 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.23 -38.87 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.757 -0.589 . . . . 0.0 109.797 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -85.3 148.19 26.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.752 -0.593 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 93' ' ' LEU . 4.5 mm? -66.67 148.26 98.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.727 -0.608 . . . . 0.0 110.092 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.71 144.21 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.187 1.098 . . . . 0.0 110.495 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.402 ' CE1' ' O ' ' A' ' 93' ' ' LEU . 75.5 m80 -121.49 144.0 48.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.76 -0.588 . . . . 0.0 110.214 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -98.6 132.92 43.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.033 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -113.05 145.48 40.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.739 -0.601 . . . . 0.0 110.35 -177.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 m120 55.0 171.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.62 -0.675 . . . . 0.0 110.866 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tp -125.05 137.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.722 -0.612 . . . . 0.0 110.123 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.92 -40.09 83.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.625 -0.672 . . . . 0.0 110.532 -177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.467 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.523 178.9 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 121.025 0.441 . . . . 1.6000000000000001 110.075 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.661 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.29999999999999999 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 0.20000000000000001 110.391 -170.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.14999999999999999 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 28' ' ' ILE . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.16 110.493 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.13 110.178 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 0.12 110.748 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB2' HD11 ' A' ' 68' ' ' ILE . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.17999999999999999 109.435 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 0.14999999999999999 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 0.11 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.20999999999999999 109.658 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 0.44 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 0.41999999999999998 111.531 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.13 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 0.14000000000000001 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.23999999999999999 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.29999999999999999 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14000000000000001 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 0.13 109.988 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.953 HG21 HD11 ' A' ' 31' ' ' ILE . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 0.14000000000000001 110.475 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.1299999999999999 109.887 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.0800000000000001 109.548 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 28' ' ' ILE . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 0.19 109.944 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.19 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 0.23999999999999999 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.565 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 0.17000000000000001 109.469 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.809 HG23 HG22 ' A' ' 56' ' ' VAL . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.14999999999999999 110.532 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 0.33000000000000002 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 0.17000000000000001 110.597 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 2.5899999999999999 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 0.56999999999999995 111.623 -173.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.40000000000000002 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.819 ' HB3' HD21 ' A' ' 48' ' ' LEU . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.6400000000000001 110.248 -175.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.28000000000000003 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.32000000000000001 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 0.31 109.835 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.34999999999999998 110.286 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 0.89000000000000001 110.276 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 3.5099999999999998 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 2.8500000000000001 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 1.9299999999999999 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.0600000000000001 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 0.51000000000000001 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.0600000000000001 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 0.20999999999999999 109.2 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.809 HG22 HG23 ' A' ' 37' ' ' THR . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.17000000000000001 109.582 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 0.14999999999999999 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 1.8700000000000001 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.28000000000000003 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 0.28000000000000003 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68000000000000005 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 0.19 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.3599999999999999 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.22 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.851 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 0.41999999999999998 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.661 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 0.42999999999999999 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 0.35999999999999999 109.965 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 25.4 mt-10 . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.498 1.966 0 CA-C-O 120.815 0.341 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HD13 ' A' ' 15' ' ' ILE . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 12' ' ' ALA . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 11' ' ' CYS . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.741 HD11 HG21 ' A' ' 28' ' ' ILE . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.754 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.827 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.822 ' HB3' HD21 ' A' ' 48' ' ' LEU . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.827 HD12 ' CB ' ' A' ' 41' ' ' ALA . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 120.734 0.302 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.649 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.748 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.677 ' HB2' HD11 ' A' ' 68' ' ' ILE . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.894 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 12' ' ' ALA . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 39' ' ' VAL . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.985 HD11 HG21 ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.642 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.785 HG23 HG22 ' A' ' 56' ' ' VAL . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.833 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.875 HD12 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 37' ' ' THR . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.894 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.649 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 14' ' ' SER . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 120.755 0.312 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.689 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.73 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 39' ' ' VAL . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 28' ' ' ILE . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.799 HG23 HG22 ' A' ' 56' ' ' VAL . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.802 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.827 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.801 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 57' ' ' LEU . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.799 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.73 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.689 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 . . . . . 0 N--CA 1.497 1.923 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.767 ' SG ' HD12 ' A' ' 28' ' ' ILE . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.84 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 12' ' ' ALA . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 39' ' ' VAL . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HA ' HD12 ' A' ' 9' ' ' ILE . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.786 HG23 HG22 ' A' ' 56' ' ' VAL . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.669 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 48' ' ' LEU . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 41' ' ' ALA . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 57' ' ' LEU . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.451 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 59' ' ' CYS . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.675 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.498 1.968 0 CA-C-O 120.842 0.353 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.616 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.843 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.732 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 31' ' ' ILE . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.603 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HA ' HD12 ' A' ' 9' ' ' ILE . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 28' ' ' ILE . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.774 HG23 HG22 ' A' ' 56' ' ' VAL . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 48' ' ' LEU . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 37' ' ' THR . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.843 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 3.6 mm-40 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.652 HG12 ' HG ' ' A' ' 67' ' ' LEU . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.829 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.824 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' HG11 ' A' ' 39' ' ' VAL . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.957 HD11 HG21 ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.837 HG23 HG22 ' A' ' 56' ' ' VAL . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HA3' ' A' ' 26' ' ' GLY . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.673 ' HB3' HD21 ' A' ' 48' ' ' LEU . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' HB3' ' A' ' 41' ' ' ALA . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.738 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.533 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 15' ' ' ILE . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.688 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.443 HG22 ' HG2' ' A' ' 69' ' ' GLU . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 70.4 mm-40 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.498 1.938 0 CA-C-O 120.802 0.334 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.708 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.582 ' HB2' HD11 ' A' ' 68' ' ' ILE . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.896 HG21 HD11 ' A' ' 31' ' ' ILE . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 39' ' ' VAL . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 28' ' ' ILE . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.673 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.796 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.561 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.411 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 50' ' ' LYS . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 41' ' ' ALA . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.839 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.681 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 mm-40 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.498 1.974 0 CA-C-O 120.721 0.296 . . . . 0.0 110.281 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.739 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.71 ' CE2' HD13 ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.641 ' HB2' HG13 ' A' ' 39' ' ' VAL . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 56' ' ' VAL . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.748 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG3' HD11 ' A' ' 48' ' ' LEU . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 41' ' ' ALA . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG12 HD12 ' A' ' 57' ' ' LEU . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 37' ' ' THR . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 59.0 mm-40 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.647 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.774 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.718 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 68' ' ' ILE . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.706 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 31' ' ' ILE . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' VAL . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 9' ' ' ILE . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.976 HD11 HG21 ' A' ' 28' ' ' ILE . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.788 HG22 ' HA ' ' A' ' 28' ' ' ILE . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 40' ' ' ARG . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 39' ' ' VAL . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HE ' HD11 ' A' ' 48' ' ' LEU . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 46' ' ' VAL . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' ALA . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.654 HG23 ' HB2' ' A' ' 41' ' ' ALA . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.706 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 21' ' ' LEU . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.897 HG23 ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 14' ' ' SER . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 mt-10 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 120.934 0.397 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.744 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.889 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.727 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 31' ' ' ILE . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.596 ' HB2' HG13 ' A' ' 39' ' ' VAL . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 28' ' ' ILE . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.62 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.727 HG23 HG22 ' A' ' 56' ' ' VAL . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.678 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.632 HG21 ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 37' ' ' THR . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.727 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.889 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 120.789 0.328 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.631 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.76 ' HB2' HD11 ' A' ' 68' ' ' ILE . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 65' ' ' ILE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.769 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.901 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.879 HG23 HG22 ' A' ' 56' ' ' VAL . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.901 HD12 ' HA3' ' A' ' 26' ' ' GLY . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.743 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.868 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 43' ' ' ARG . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.682 HG12 HD12 ' A' ' 57' ' ' LEU . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 15' ' ' ILE . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.631 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 33.8 mt-10 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.799 0.333 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.775 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.921 HG21 HD11 ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.607 ' HB2' HG13 ' A' ' 39' ' ' VAL . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.921 HD11 HG21 ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.671 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.783 HG23 HG22 ' A' ' 56' ' ' VAL . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 45' ' ' GLY . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 41' ' ' ALA . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 37' ' ' THR . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.854 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 10.4 mt-10 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 . . . . . 0 N--CA 1.499 1.977 0 CA-C-O 120.932 0.396 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.695 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 15' ' ' ILE . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.859 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.718 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' ALA . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HD2' HG11 ' A' ' 39' ' ' VAL . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HG21 ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.765 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.87 HG23 HG22 ' A' ' 56' ' ' VAL . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.736 ' CB ' HD21 ' A' ' 48' ' ' LEU . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 47' ' ' PRO . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 41' ' ' ALA . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 HG23 ' A' ' 37' ' ' THR . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.718 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HB2' HD11 ' A' ' 21' ' ' LEU . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.859 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.695 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 69.5 mt-10 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 120.821 0.344 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 68' ' ' ILE . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.696 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.878 HG21 HD11 ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HB2' HG13 ' A' ' 39' ' ' VAL . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.878 HD11 HG21 ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG21 ' CB ' ' A' ' 41' ' ' ALA . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.696 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 14' ' ' SER . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 20.4 mt-10 . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB2' HD11 ' A' ' 68' ' ' ILE . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.746 HG23 HG22 ' A' ' 56' ' ' VAL . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.639 HG12 HD12 ' A' ' 57' ' ' LEU . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 37' ' ' THR . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.427 HG21 HG23 ' A' ' 15' ' ' ILE . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 36.3 mt-10 . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.753 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.851 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.825 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.787 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.863 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 39' ' ' VAL . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 28' ' ' ILE . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.867 HG23 HG22 ' A' ' 56' ' ' VAL . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.863 HD12 ' HA3' ' A' ' 26' ' ' GLY . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.807 ' HB3' HD21 ' A' ' 48' ' ' LEU . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 43' ' ' ARG . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 57' ' ' LEU . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 37' ' ' THR . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.787 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.851 HD11 ' HB2' ' A' ' 14' ' ' SER . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 37.7 mt-10 . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 120.788 0.327 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.715 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' HD13 ' A' ' 15' ' ' ILE . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.805 HG23 HG22 ' A' ' 56' ' ' VAL . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.787 ' HB3' HD21 ' A' ' 48' ' ' LEU . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 47' ' ' PRO . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 43' ' ' ARG . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 57' ' ' LEU . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.805 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 69' ' ' GLU . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.774 ' HG3' HG22 ' A' ' 68' ' ' ILE . 23.9 mt-10 . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 120.772 0.32 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.657 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.778 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.856 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.619 ' HB2' HG13 ' A' ' 39' ' ' VAL . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.761 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.701 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.734 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' A' ' 47' ' ' PRO . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 49.1 mt-10 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.497 1.922 0 CA-C-O 120.774 0.321 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.573 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 15' ' ' ILE . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.904 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.943 HG21 HD11 ' A' ' 31' ' ' ILE . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HB2' HG13 ' A' ' 39' ' ' VAL . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 9' ' ' ILE . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.943 HD11 HG21 ' A' ' 28' ' ' ILE . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.791 HG23 HG22 ' A' ' 56' ' ' VAL . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.77 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.732 ' CD ' HD11 ' A' ' 48' ' ' LEU . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 41' ' ' ALA . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.791 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.713 ' HG ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.9 mt-10 . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 120.819 0.342 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.634 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.781 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.918 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 31' ' ' ILE . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 28' ' ' ILE . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.612 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.989 HG23 HG22 ' A' ' 56' ' ' VAL . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.918 HD12 ' HA3' ' A' ' 26' ' ' GLY . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.802 ' HG3' HD11 ' A' ' 48' ' ' LEU . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG13 ' HD2' ' A' ' 47' ' ' PRO . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 43' ' ' ARG . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 57' ' ' LEU . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.989 HG22 HG23 ' A' ' 37' ' ' THR . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.781 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.83 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.634 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 14' ' ' SER . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 12.8 mt-10 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.685 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.742 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.589 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.868 HG21 HD11 ' A' ' 31' ' ' ILE . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' HG13 ' A' ' 39' ' ' VAL . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.78 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.778 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.684 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 47' ' ' PRO . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 46' ' ' VAL . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.866 HD12 ' HB1' ' A' ' 41' ' ' ALA . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 57' ' ' LEU . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.78 HG22 HG23 ' A' ' 37' ' ' THR . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.711 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.834 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 30.7 mt-10 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 6.8700000000000001 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.91 75.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.766 -0.843 . . . . 5.1699999999999999 110.132 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.0 mtp -149.92 151.88 34.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.662 -0.649 . . . . 6.1600000000000001 109.856 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.78 72.53 0.62 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.736 -1.346 . . . . 3.0899999999999999 109.736 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.511 ' O ' HG23 ' A' ' 4' ' ' THR . 11.6 Cg_endo -59.5 127.74 24.8 Favored 'Trans proline' 0 N--CA 1.488 1.172 0 O-C-N 123.161 1.085 . . . . 2.4700000000000002 110.633 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 3' ' ' PRO . 11.5 p -153.88 94.51 1.77 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.686 -0.634 . . . . 1.3700000000000001 110.208 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -165.33 168.82 16.48 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.71 -0.619 . . . . 1.6499999999999999 110.234 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' HG12 ' A' ' 9' ' ' ILE . 96.0 mt-30 -72.25 -6.95 46.59 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.745 -0.597 . . . . 1.22 111.95 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.1 -31.33 70.86 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.272 -0.893 . . . . 1.6000000000000001 110.075 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.661 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -78.4 -13.66 59.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.749 -0.594 . . . . 0.29999999999999999 111.604 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -55.79 134.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 120.869 -1.144 . . . . 0.20000000000000001 110.391 -170.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.72 89.2 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.808 -0.71 . . . . 0.14999999999999999 111.967 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 28' ' ' ILE . 10.4 p -84.28 155.23 22.52 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 119.145 1.473 . . . . 0.16 110.493 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.73 121.31 32.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.802 -0.561 . . . . 0.13 110.178 -176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.25 158.02 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.634 . . . . 0.12 110.748 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.818 ' HB2' HD11 ' A' ' 68' ' ' ILE . 43.2 t -118.59 140.58 49.67 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.435 -0.58 . . . . 0.17999999999999999 109.435 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -122.69 122.38 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 120.141 -0.623 . . . . 0.14999999999999999 109.975 -173.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.12 110.02 22.65 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.556 -0.535 . . . . 0.11 109.556 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.2 m -96.14 166.79 11.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.83 -0.544 . . . . 0.20999999999999999 109.658 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.7 p30 -60.21 175.07 0.45 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.619 -0.676 . . . . 1.96 110.104 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -55.22 -36.6 66.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.524 -0.735 . . . . 1.47 111.762 -165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.28 -25.5 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.487 -0.758 . . . . 0.44 110.427 -174.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.5 mt -90.42 -17.65 26.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.586 -0.697 . . . . 0.41999999999999998 111.531 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.37 -149.52 51.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.227 -1.149 . . . . 0.13 110.227 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.59 140.2 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.476 -1.014 . . . . 0.14000000000000001 110.075 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.691 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.5 p90 -132.29 159.7 38.39 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.956 -0.697 . . . . 0.23999999999999999 110.297 173.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.07 146.14 44.8 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.391 -0.596 . . . . 0.29999999999999999 109.391 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.28 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.053 -1.219 . . . . 0.14000000000000001 110.053 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.6 mt -89.75 135.29 33.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.706 -0.879 . . . . 0.13 109.988 172.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.953 HG21 HD11 ' A' ' 31' ' ' ILE . 86.5 mt -67.29 137.19 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.16 0.505 . . . . 0.14000000000000001 110.475 -176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.5 tttt -105.62 -34.53 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.761 -0.587 . . . . 2.1299999999999999 109.887 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.8 mt-30 -152.4 150.59 29.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.667 -0.646 . . . . 2.0800000000000001 109.548 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.953 HD11 HG21 ' A' ' 28' ' ' ILE . 72.5 mt -139.3 137.28 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.691 . . . . 0.19 109.944 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -146.56 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.548 -0.538 . . . . 0.19 109.548 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.66 -23.8 30.27 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.623 -0.673 . . . . 0.23999999999999999 111.387 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -25.98 18.19 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.493 -0.754 . . . . 1.46 111.162 -174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.48 156.33 33.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.37 -0.831 . . . . 0.88 111.073 -172.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.565 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.07 139.84 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.642 -0.661 . . . . 0.17000000000000001 109.469 171.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.809 HG23 HG22 ' A' ' 56' ' ' VAL . 61.5 m -125.96 131.08 52.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.58 -0.7 . . . . 0.14999999999999999 110.532 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.749 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.16 173.72 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.641 -0.662 . . . . 0.33000000000000002 110.193 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.569 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -126.87 163.3 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.728 -0.608 . . . . 0.17000000000000001 110.597 -177.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 56.72 67.05 1.05 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.489 -0.757 . . . . 2.5899999999999999 110.258 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.771 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.8 125.11 25.56 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.468 0.652 . . . . 0.56999999999999995 111.623 -173.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.44 131.84 55.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.526 -0.734 . . . . 0.40000000000000002 109.278 165.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.819 ' HB3' HD21 ' A' ' 48' ' ' LEU . 58.6 ttp180 -134.89 144.09 47.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.643 -0.661 . . . . 2.6400000000000001 110.248 -175.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.1 m120 52.66 40.17 29.71 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.402 -0.811 . . . . 0.28000000000000003 111.141 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 111.059 -0.816 . . . . 0.32000000000000001 111.059 175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.0 t -143.5 152.06 55.8 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.42 -1.047 . . . . 0.31 109.835 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.9 Cg_exo -71.84 137.04 28.89 Favored 'Trans proline' 0 N--CA 1.485 1.014 0 O-C-N 122.993 0.996 . . . . 0.34999999999999998 110.286 -175.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.9 mt -78.19 147.2 34.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.662 -0.649 . . . . 0.89000000000000001 110.276 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -58.09 -34.45 70.17 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.641 -0.662 . . . . 3.5099999999999998 110.511 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -88.08 65.13 8.06 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.69 -0.631 . . . . 2.8500000000000001 110.096 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -59.18 -39.36 82.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.635 -0.666 . . . . 1.9299999999999999 110.338 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -71.91 -26.11 62.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.679 -0.638 . . . . 2.0600000000000001 110.828 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.81 144.05 45.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.515 -0.741 . . . . 0.51000000000000001 110.467 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -88.73 150.31 23.03 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.792 -0.567 . . . . 1.0600000000000001 110.55 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 57.4 t -102.14 126.53 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.2 -0.667 . . . . 0.20999999999999999 109.2 176.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.809 HG22 HG23 ' A' ' 37' ' ' THR . 30.2 t -123.54 113.29 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.016 -0.674 . . . . 0.17000000000000001 109.582 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.691 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.56 133.85 48.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.884 -0.51 . . . . 0.14999999999999999 110.416 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -72.97 136.05 45.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.775 -0.578 . . . . 1.8700000000000001 110.443 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.99 -33.64 57.63 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.586 -0.696 . . . . 0.28000000000000003 111.211 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.6 p -64.86 -25.2 67.79 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.63 -0.669 . . . . 0.28000000000000003 110.244 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.74 -25.04 23.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.603 -0.686 . . . . 0.68000000000000005 110.006 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.01 143.86 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.616 -0.678 . . . . 0.19 109.581 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.62 -33.12 10.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.709 -0.62 . . . . 2.3599999999999999 110.319 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -160.55 153.37 21.2 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.618 -0.676 . . . . 1.22 110.771 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.851 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.3 mt -138.57 147.77 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.619 -0.676 . . . . 0.41999999999999998 109.76 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.07 129.56 30.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.762 -0.586 . . . . 1.05 110.357 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.661 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.87 113.78 14.92 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.62 -0.675 . . . . 0.42999999999999999 109.745 174.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.818 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.98 -44.91 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.614 -0.678 . . . . 0.35999999999999999 109.965 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 25.4 mt-10 -137.11 99.9 9.79 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.801 -0.562 . . . . 1.79 110.321 -176.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.65 158.19 47.51 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.325 1.171 . . . . 1.3799999999999999 110.183 176.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.97 147.53 34.01 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.66 -0.65 . . . . 2.6899999999999999 110.308 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -74.82 123.02 24.25 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.676 -0.64 . . . . 7.7999999999999998 110.376 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -101.34 -45.23 5.4 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.821 -0.549 . . . . 8.25 110.25 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -79.8 125.17 29.34 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.785 -0.572 . . . . 8.6799999999999997 110.42 -177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.41 -33.24 72.22 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.745 -0.597 . . . . 11.59 110.177 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 44.8 t0 53.31 74.04 0.33 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.394 -0.816 . . . . 12.960000000000001 110.992 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 72.46 0.51 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.726 -1.35 . . . . 14.69 109.726 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 53.8 29.25 9.38 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.39 -1.065 . . . . 16.73 111.032 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 48.8 m -60.23 -38.12 82.43 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.722 -0.611 . . . . 17.870000000000001 110.152 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -124.17 170.97 7.77 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.723 -0.611 . . . . 18.670000000000002 110.236 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.73 159.33 24.94 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.194 1.102 . . . . 19.170000000000002 110.426 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 22.7 Cg_exo -57.62 -47.72 20.22 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.127 1.067 . . . . 19.460000000000001 111.262 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 27.2 Cg_exo -58.64 146.64 90.95 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 O-C-N 122.865 0.929 . . . . 19.510000000000002 110.573 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.478 HG22 ' H ' ' A' ' 86' ' ' ASN . 8.8 p -130.2 143.74 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.775 -0.578 . . . . 20.710000000000001 110.351 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.4 t -63.53 -34.8 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.735 -0.603 . . . . 21.170000000000002 110.029 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.478 ' H ' HG22 ' A' ' 84' ' ' VAL . 18.7 t-20 -55.11 -35.57 64.78 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.582 -0.699 . . . . 22.399999999999999 110.881 -176.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -62.85 145.56 95.96 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.673 -0.642 . . . . 22.390000000000001 110.088 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.57 142.43 98.85 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.247 1.13 . . . . 22.899999999999999 110.586 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 44.2 p -122.55 100.46 41.3 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.767 -0.583 . . . . 24.07 110.13 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -65.82 -53.64 0.69 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.176 1.093 . . . . 24.879999999999999 110.336 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -135.66 142.28 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.716 -0.615 . . . . 25.859999999999999 110.31 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -87.08 136.0 33.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.704 -0.623 . . . . 26.84 110.129 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.78 110.16 27.96 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.729 -0.607 . . . . 26.129999999999999 110.153 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.5 145.29 87.32 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.071 1.037 . . . . 26.899999999999999 110.393 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 52.38 -175.38 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.409 -0.807 . . . . 26.98 111.075 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -108.23 137.47 46.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.697 -0.627 . . . . 27.989999999999998 110.191 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.3 m -63.63 157.59 23.51 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.666 -0.646 . . . . 28.440000000000001 110.118 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -57.79 -34.98 70.18 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.585 -0.697 . . . . 29.079999999999998 110.52 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.69 133.75 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.759 -0.588 . . . . 30.07 110.049 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 tp -100.31 130.27 46.4 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.667 -0.646 . . . . 30.949999999999999 110.177 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.536 0 CA-C-O 117.978 -1.457 . . . . 29.949999999999999 109.557 -179.923 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.83 146.51 52.51 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.702 -0.881 . . . . 0.0 110.141 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -87.02 136.9 32.75 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.743 -0.598 . . . . 0.0 110.218 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 4' ' ' THR . . . -67.89 145.81 45.61 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 99.56 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.144 1.076 . . . . 0.0 110.457 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 2' ' ' GLY . 67.9 p -96.94 8.94 43.34 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.624 . . . . 0.0 111.49 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -79.03 140.1 38.01 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.213 -0.93 . . . . 0.0 110.604 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -73.22 -3.87 29.46 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.643 -0.66 . . . . 0.0 111.849 176.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -68.32 -26.0 65.4 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.342 -0.849 . . . . 0.0 110.189 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.1 m95 -76.72 -13.67 60.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.688 . . . . 0.0 111.426 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.0 mm -55.6 131.63 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.883 -1.136 . . . . 0.0 110.224 -173.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.805 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.1 p -83.99 155.27 22.85 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.246 1.523 . . . . 0.0 110.507 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.73 119.76 32.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.736 -0.603 . . . . 0.0 110.225 -174.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -134.86 159.14 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.74 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HD13 ' A' ' 15' ' ' ILE . 42.4 t -120.26 139.93 51.97 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.3 122.24 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.841 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.99 22.66 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 65.3 m -95.38 166.77 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.77 168.5 1.21 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.537 -0.727 . . . . 0.0 109.783 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.34 -33.9 59.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.52 -0.737 . . . . 0.0 111.822 -165.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.54 -25.4 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.479 -0.763 . . . . 0.0 110.27 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 92.5 mt -90.77 -17.12 27.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.47 -0.768 . . . . 0.0 111.542 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.59 -151.71 50.56 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 50.7 t -131.48 140.15 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.547 -0.973 . . . . 0.0 110.07 -175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.736 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.1 p90 -131.78 159.03 39.68 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.365 173.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.75 146.94 46.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.24 169.61 42.23 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 72' ' ' LYS . 49.6 mt -89.72 135.03 33.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.889 -0.771 . . . . 0.0 109.94 172.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.773 HD12 ' SG ' ' A' ' 11' ' ' CYS . 88.2 mt -66.81 137.23 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-O 121.208 0.528 . . . . 0.0 110.436 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.9 tttt -104.89 -36.02 7.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.624 -0.673 . . . . 0.0 109.844 172.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.503 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.5 mt-30 -153.16 153.84 33.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.743 -0.598 . . . . 0.0 109.631 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.741 HD11 HG21 ' A' ' 28' ' ' ILE . 72.7 mt -138.95 139.03 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.649 -0.657 . . . . 0.0 110.001 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -145.99 158.48 43.87 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.58 -23.85 29.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.503 -0.748 . . . . 0.0 111.345 -170.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.69 -26.09 17.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.441 -0.787 . . . . 0.0 111.225 -174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -156.55 158.99 38.12 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.413 -0.804 . . . . 0.0 111.179 -172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.8 mm -113.93 140.0 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.702 -0.623 . . . . 0.0 109.491 170.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 69.4 m -123.93 131.54 53.59 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.586 -0.696 . . . . 0.0 110.446 -176.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.754 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.6 172.03 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.652 -0.655 . . . . 0.0 110.345 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -128.73 163.52 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.703 -0.623 . . . . 0.0 110.538 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.01 65.52 1.37 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.644 -0.66 . . . . 0.0 109.997 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.827 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.49 124.82 24.61 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.518 0.675 . . . . 0.0 111.5 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.72 134.35 55.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.69 . . . . 0.0 109.238 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.822 ' HB3' HD21 ' A' ' 48' ' ' LEU . 60.9 ttp85 -134.88 142.77 46.66 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.591 -0.693 . . . . 0.0 109.945 -175.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.19 38.76 28.37 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.357 -0.839 . . . . 0.0 111.041 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.84 22.11 61.79 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.1 t -142.18 151.51 58.81 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.388 -1.066 . . . . 0.0 109.674 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.8 Cg_exo -69.44 139.5 41.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.073 1.038 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD12 ' CB ' ' A' ' 41' ' ' ALA . 95.5 mt -78.01 152.73 32.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.583 -0.698 . . . . 0.0 110.193 175.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -56.36 -35.95 68.26 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.619 -0.676 . . . . 0.0 110.942 -174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.817 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 50.2 mttp -95.5 92.51 6.69 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.136 178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -62.75 -37.65 87.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.797 -0.565 . . . . 0.0 110.193 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -87.34 2.04 51.47 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.651 -0.656 . . . . 0.0 111.67 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.66 136.05 40.43 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.169 -0.957 . . . . 0.0 110.184 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -88.94 141.14 28.74 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.81 -0.556 . . . . 0.0 110.411 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 59.7 t -104.08 124.91 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 0.0 109.438 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 38.4 t -123.44 112.87 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 120.067 -0.653 . . . . 0.0 109.504 176.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.736 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.2 mt -128.65 134.02 48.42 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.482 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -74.81 143.44 43.96 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.781 -0.574 . . . . 0.0 110.63 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.03 -31.89 61.44 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.62 -0.675 . . . . 0.0 110.913 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -26.82 68.54 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.776 -0.577 . . . . 0.0 110.214 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.65 -24.54 22.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.735 -0.603 . . . . 0.0 110.193 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.27 141.12 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.589 -0.695 . . . . 0.0 109.785 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -101.05 -29.1 12.35 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.693 -0.629 . . . . 0.0 110.202 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -160.46 152.79 20.58 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.577 -0.702 . . . . 0.0 110.589 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.89 148.64 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.631 -0.668 . . . . 0.0 109.772 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.31 126.69 24.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.8 -0.563 . . . . 0.0 110.493 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.32 113.84 14.34 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.671 -0.643 . . . . 0.0 109.894 173.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.9 mt -75.99 -58.07 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.71 -0.619 . . . . 0.0 109.949 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -137.33 146.57 54.53 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.829 -0.544 . . . . 0.0 110.366 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.75 -31.36 94.88 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.124 1.065 . . . . 0.0 110.627 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -159.92 141.67 12.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.685 -0.634 . . . . 0.0 110.138 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.559 ' HB2' HD21 ' A' ' 27' ' ' LEU . 15.3 tptt -61.14 -42.34 98.36 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.694 -0.629 . . . . 0.0 110.013 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 52.11 24.32 2.67 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.526 -0.734 . . . . 0.0 111.216 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -105.91 0.86 26.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.514 -0.741 . . . . 0.0 111.595 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.44 -35.06 79.69 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.19 -0.944 . . . . 0.0 110.225 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.55 -37.28 78.01 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 110.497 -177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.57 -77.99 1.36 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.25 170.66 15.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.737 -0.86 . . . . 0.0 110.342 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.0 m -114.2 140.36 48.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.723 -0.611 . . . . 0.0 110.121 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.3 59.36 13.2 Favored Pre-proline 0 N--CA 1.503 2.225 0 O-C-N 121.435 -0.79 . . . . 0.0 110.783 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -72.93 165.59 32.37 Favored 'Trans proline' 0 N--CA 1.486 1.036 0 O-C-N 123.135 1.071 . . . . 0.0 110.381 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.6 146.76 96.49 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.21 1.111 . . . . 0.0 110.252 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.73 134.11 52.11 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.153 1.081 . . . . 0.0 110.572 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.94 -23.65 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.69 -0.631 . . . . 0.0 110.778 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.0 t -60.32 -37.88 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.495 -0.753 . . . . 0.0 110.016 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -77.57 140.03 39.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.129 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -67.65 142.22 95.83 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.614 . . . . 0.0 110.17 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -62.19 143.67 94.68 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.219 1.115 . . . . 0.0 110.321 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 p -71.03 149.67 94.8 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 110.046 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.52 -28.59 86.94 Favored 'Trans proline' 0 N--CA 1.487 1.127 0 O-C-N 123.121 1.064 . . . . 0.0 110.434 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.7 t -63.79 -40.82 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.774 -0.579 . . . . 0.0 109.717 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tttt -83.64 133.19 34.84 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.703 -0.623 . . . . 0.0 110.198 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mt -99.95 145.66 30.57 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.75 -0.594 . . . . 0.0 110.342 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.69 154.11 62.62 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.142 1.075 . . . . 0.0 110.314 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -104.8 130.06 52.96 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -60.33 -37.39 80.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.759 -0.588 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.1 m -56.91 -38.26 72.61 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.53 -0.731 . . . . 0.0 110.797 -175.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 53.9 t30 53.02 48.9 21.34 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.368 -0.833 . . . . 0.0 110.932 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 80.4 mt -110.47 134.75 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.641 . . . . 0.0 109.995 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -61.67 -35.43 77.94 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.708 -0.62 . . . . 0.0 110.232 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.529 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.571 -179.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.89 72.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.759 -0.848 . . . . 0.0 110.156 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.6 mtm -149.59 158.16 43.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.721 -0.612 . . . . 0.0 109.891 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.88 89.69 1.27 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 4' ' ' THR . 13.7 Cg_endo -61.03 140.53 90.42 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.186 1.098 . . . . 0.0 110.464 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.411 HG23 ' C ' ' A' ' 3' ' ' PRO . 56.8 p -147.29 20.32 1.21 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.678 -0.639 . . . . 0.0 110.734 177.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -79.43 150.72 31.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.483 -0.761 . . . . 0.0 110.428 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -72.14 -4.0 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.692 -0.63 . . . . 0.0 111.825 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -68.55 -25.2 64.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.225 -0.922 . . . . 0.0 110.207 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.649 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.36 -13.84 60.12 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.681 . . . . 0.0 111.436 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -55.94 133.55 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 120.863 -1.148 . . . . 0.0 110.322 -171.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.65 89.19 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.916 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.83 155.31 23.03 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 119.224 1.512 . . . . 0.0 110.462 177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.748 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.22 120.01 31.02 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.708 -0.62 . . . . 0.0 110.129 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.1 m -136.15 158.4 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.75 -0.594 . . . . 0.0 110.742 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.677 ' HB2' HD11 ' A' ' 68' ' ' ILE . 28.9 t -122.14 141.54 51.32 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.894 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -121.87 120.51 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.808 -172.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.12 109.96 22.6 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.7 m -95.3 166.81 11.71 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -59.1 170.28 0.92 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.581 -0.699 . . . . 0.0 109.988 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -54.66 -34.31 62.04 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.639 -0.663 . . . . 0.0 111.757 -165.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -74.85 -25.45 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.569 -0.707 . . . . 0.0 110.296 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.2 mt -90.87 -16.22 28.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.515 -0.741 . . . . 0.0 111.622 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.58 -151.95 50.39 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -132.18 140.67 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.507 -0.996 . . . . 0.0 110.114 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.713 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.7 p90 -131.79 159.33 38.8 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.218 172.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -136.23 145.82 46.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.701 -0.624 . . . . 0.0 109.479 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.29 169.54 42.12 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 12' ' ' ALA . 66.2 mt -89.8 135.88 33.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.851 . . . . 0.0 109.886 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.985 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.73 136.99 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.241 0.543 . . . . 0.0 110.22 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HB2' HG13 ' A' ' 39' ' ' VAL . 24.4 tptt -109.11 -28.32 9.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.707 -0.621 . . . . 0.0 110.014 174.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.1 tt0 -158.85 147.23 18.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.616 -0.677 . . . . 0.0 109.797 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.985 HD11 HG21 ' A' ' 28' ' ' ILE . 75.0 mt -137.9 137.7 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.638 -0.664 . . . . 0.0 110.008 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.6 p -146.26 158.55 43.89 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.6 -23.8 29.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.521 -0.737 . . . . 0.0 111.421 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.61 -26.03 18.04 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.482 -0.761 . . . . 0.0 111.189 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.44 156.65 34.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.441 -0.787 . . . . 0.0 111.055 -172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.642 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.5 mm -114.55 139.37 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.582 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.785 HG23 HG22 ' A' ' 56' ' ' VAL . 67.9 m -126.03 133.68 51.66 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.655 -0.653 . . . . 0.0 110.405 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -135.01 173.47 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.664 -0.647 . . . . 0.0 110.218 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -127.28 163.46 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.772 -0.58 . . . . 0.0 110.644 -177.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 81.5 mmt-85 56.76 67.05 1.04 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.566 -0.709 . . . . 0.0 110.227 -175.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.875 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.47 123.57 21.17 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.337 0.589 . . . . 0.0 111.502 -174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -115.1 132.11 56.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 109.292 166.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.833 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.4 ttp180 -134.88 143.79 47.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.514 -0.741 . . . . 0.0 110.136 -175.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 52.3 40.1 28.49 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.425 -0.797 . . . . 0.0 111.123 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.15 61.9 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.4 t -142.83 151.83 57.55 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.376 -1.073 . . . . 0.0 109.81 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -71.51 135.54 26.61 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.105 1.056 . . . . 0.0 110.486 -175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.875 HD12 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -78.31 149.15 33.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.688 -0.632 . . . . 0.0 110.368 175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -60.79 152.63 26.51 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.697 -0.627 . . . . 0.0 109.827 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 56.4 60.68 3.02 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.509 -0.744 . . . . 0.0 110.316 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -56.16 -26.5 50.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.644 -0.66 . . . . 0.0 110.834 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.62 -15.24 62.24 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.631 -0.668 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.35 141.92 47.05 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.343 -0.848 . . . . 0.0 109.932 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -88.63 149.39 23.56 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 110.809 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 61.4 t -102.04 125.49 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 37' ' ' THR . 31.4 t -123.45 113.43 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.604 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.5 mt -128.65 134.0 48.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.872 -0.518 . . . . 0.0 110.482 -173.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -73.73 138.02 44.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.766 -0.584 . . . . 0.0 110.411 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.78 -31.93 50.64 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.597 -0.689 . . . . 0.0 111.296 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.0 p -64.52 -25.82 68.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.67 -0.644 . . . . 0.0 110.317 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -87.91 -25.05 23.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 0.0 110.06 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -81.38 144.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.615 -0.678 . . . . 0.0 109.702 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.25 -33.21 10.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.714 -0.616 . . . . 0.0 110.308 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.7 t -163.92 129.97 3.08 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.936 -0.706 . . . . 0.0 111.036 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.894 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -101.02 146.37 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.714 -0.616 . . . . 0.0 110.092 173.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -131.66 124.37 29.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.584 -0.697 . . . . 0.0 110.257 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.649 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -75.98 113.81 13.9 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.686 -0.634 . . . . 0.0 109.81 176.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 14' ' ' SER . 81.6 mt -79.56 -48.6 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.659 -0.651 . . . . 0.0 110.027 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 -137.08 102.53 9.08 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.728 -0.607 . . . . 0.0 110.238 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 69' ' ' GLU . 17.0 Cg_endo -62.4 143.37 93.38 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.189 1.1 . . . . 0.0 110.184 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.94 143.5 33.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.678 -0.639 . . . . 0.0 110.345 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -97.18 144.69 26.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.742 -0.598 . . . . 0.0 110.13 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -114.06 148.27 37.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.683 -0.635 . . . . 0.0 110.239 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -76.86 177.07 7.96 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.777 -0.577 . . . . 0.0 110.275 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.448 ' CD2' ' CE1' ' A' ' 78' ' ' HIS . 27.4 tp -95.81 132.06 41.46 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.722 -0.611 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -58.47 -38.55 77.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.671 -0.643 . . . . 0.0 110.512 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.12 -172.7 38.3 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.448 ' CE1' ' CD2' ' A' ' 75' ' ' LEU . 98.7 m-70 -119.67 145.1 46.79 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.818 -0.813 . . . . 0.0 110.089 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.6 m -58.35 -40.18 81.48 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.584 -0.697 . . . . 0.0 110.389 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.55 142.82 28.37 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.762 -0.587 . . . . 0.0 110.14 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -67.95 138.18 43.46 Favored 'Trans proline' 0 N--CA 1.485 0.98 0 O-C-N 123.118 1.062 . . . . 0.0 110.128 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.2 Cg_exo -59.01 -48.72 13.29 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 O-C-N 123.143 1.076 . . . . 0.0 111.064 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 20.9 Cg_exo -61.67 141.15 89.94 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.961 0.979 . . . . 0.0 110.376 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.02 127.92 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.647 -0.658 . . . . 0.0 109.917 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.4 t -71.73 -44.58 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.752 -0.592 . . . . 0.0 110.055 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -143.0 108.58 5.08 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.724 -0.61 . . . . 0.0 110.505 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -91.97 140.32 24.73 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.0 110.12 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -61.79 145.81 96.99 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.112 1.059 . . . . 0.0 110.417 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.7 p -122.45 100.4 41.68 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.702 -0.624 . . . . 0.0 110.274 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.92 -28.62 87.56 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.149 1.078 . . . . 0.0 110.441 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -130.35 155.94 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.764 -0.585 . . . . 0.0 110.288 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -59.63 -39.11 83.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.731 -0.605 . . . . 0.0 110.313 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -113.21 110.21 51.13 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.749 -0.595 . . . . 0.0 110.061 179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.05 140.07 93.6 Favored 'Trans proline' 0 N--CA 1.489 1.208 0 O-C-N 122.916 0.956 . . . . 0.0 110.638 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -104.42 17.91 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.781 -0.574 . . . . 0.0 111.138 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -59.35 -37.89 78.98 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.351 -0.843 . . . . 0.0 110.33 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -125.58 141.69 51.9 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.695 -0.628 . . . . 0.0 110.178 179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -59.02 -34.87 72.39 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.623 -0.673 . . . . 0.0 110.343 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mm -116.03 134.86 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.701 -0.624 . . . . 0.0 110.092 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 100' ' ' LEU . 8.9 tt -99.38 130.63 45.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.714 -0.616 . . . . 0.0 110.175 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -64.17 145.25 56.28 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.764 -0.845 . . . . 0.0 110.164 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtm -149.97 154.27 37.97 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.646 -0.659 . . . . 0.0 109.935 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.87 153.84 20.48 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.42 65.72 5.5 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 O-C-N 123.194 1.102 . . . . 0.0 110.359 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -93.51 11.06 29.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 111.325 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -78.42 147.12 34.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.244 -0.91 . . . . 0.0 110.363 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.89 -3.9 31.67 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.712 -0.617 . . . . 0.0 111.885 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -67.34 -27.88 67.5 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.345 -0.847 . . . . 0.0 110.176 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.689 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.92 -13.87 59.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 111.379 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.4 mm -56.21 132.64 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 120.856 -1.152 . . . . 0.0 110.138 -173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.56 -0.62 89.22 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.904 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.784 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.0 p -83.01 155.24 24.05 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 119.228 1.514 . . . . 0.0 110.449 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.1 119.08 30.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.173 -175.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.12 157.91 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.789 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.577 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.6 t -121.58 140.92 51.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.0 mm -122.64 122.63 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.952 -172.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.9 22.59 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.2 m -95.34 166.8 11.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.773 -0.579 . . . . 0.0 109.536 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.24 169.93 1.05 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.535 -0.728 . . . . 0.0 109.86 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.62 -34.49 62.16 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.551 -0.718 . . . . 0.0 111.817 -165.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.84 -25.39 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.527 -0.733 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.4 mt -90.79 -16.95 27.46 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.458 -0.777 . . . . 0.0 111.488 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.74 -151.32 51.06 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.87 140.79 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.423 -1.045 . . . . 0.0 110.065 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.73 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.0 p90 -132.03 159.15 39.63 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.235 172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -136.36 146.4 46.48 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.734 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.4 mt -89.76 135.36 33.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.824 -0.809 . . . . 0.0 109.772 172.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.895 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.16 137.15 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.875 -0.515 . . . . 0.0 110.31 -176.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HB2' HG13 ' A' ' 39' ' ' VAL . 21.8 tptt -107.08 -31.66 8.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.83 -0.544 . . . . 0.0 109.83 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.3 mt-30 -153.03 151.88 30.75 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.724 -0.61 . . . . 0.0 109.515 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.895 HD11 HG21 ' A' ' 28' ' ' ILE . 69.2 mt -139.42 137.19 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.613 -0.679 . . . . 0.0 109.921 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.6 p -146.33 157.99 43.84 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.52 -24.35 31.39 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.533 -0.73 . . . . 0.0 111.332 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -94.85 -22.06 18.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.523 -0.735 . . . . 0.0 111.59 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.53 156.57 33.88 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.388 -0.82 . . . . 0.0 111.02 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.04 139.26 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 109.368 170.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.799 HG23 HG22 ' A' ' 56' ' ' VAL . 62.0 m -125.31 132.42 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.573 -0.705 . . . . 0.0 110.39 -176.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -135.73 171.78 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 121.663 -0.648 . . . . 0.0 110.398 -178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.4 m -128.94 163.52 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.734 -0.604 . . . . 0.0 110.547 -176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 56.75 67.1 1.04 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-O 121.503 0.668 . . . . 0.0 110.082 -173.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.802 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.43 125.31 26.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.622 0.725 . . . . 0.0 111.53 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.52 135.08 54.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.236 167.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.827 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.86 143.53 47.05 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.595 -0.691 . . . . 0.0 110.211 -176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.1 m120 52.77 39.98 29.7 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.382 -0.823 . . . . 0.0 111.097 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.86 22.12 61.85 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -143.29 151.89 56.13 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.388 -1.066 . . . . 0.0 109.752 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.4 Cg_exo -70.66 139.86 38.01 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.108 1.057 . . . . 0.0 110.302 -175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.827 HD21 ' HB3' ' A' ' 43' ' ' ARG . 95.2 mt -78.09 150.29 33.76 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.668 -0.645 . . . . 0.0 110.239 175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -57.04 -35.85 69.79 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.605 -0.684 . . . . 0.0 110.747 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.801 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 64.6 mttm -92.36 90.24 7.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 110.109 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -62.13 -38.9 90.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.834 -0.541 . . . . 0.0 110.344 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -87.24 2.12 51.06 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.719 -0.613 . . . . 0.0 111.618 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.3 136.01 40.89 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.132 -0.98 . . . . 0.0 110.212 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -88.5 141.0 28.89 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.808 -0.557 . . . . 0.0 110.376 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.621 HG12 HD12 ' A' ' 57' ' ' LEU . 58.0 t -103.87 123.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.799 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.51 112.96 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 120.031 -0.667 . . . . 0.0 109.56 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.73 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.4 mt -128.63 133.72 48.35 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.391 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -74.92 143.11 43.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.714 -0.616 . . . . 0.0 110.597 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.91 61.34 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.662 -0.649 . . . . 0.0 110.9 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -64.42 -27.34 68.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.772 -0.58 . . . . 0.0 110.13 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -89.09 -24.28 22.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.699 -0.626 . . . . 0.0 110.164 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.96 144.01 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.711 . . . . 0.0 109.824 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 tpt85 -100.69 -33.08 10.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.77 -0.581 . . . . 0.0 110.165 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.0 p -161.17 157.3 25.62 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.678 -0.639 . . . . 0.0 110.633 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.0 mt -139.81 148.74 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.722 -0.611 . . . . 0.0 109.889 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.79 127.89 27.85 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.79 -0.569 . . . . 0.0 110.453 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.689 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.37 113.84 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.612 -0.68 . . . . 0.0 109.795 174.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.7 mt -74.5 -54.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.654 -0.653 . . . . 0.0 110.001 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -137.2 139.59 28.57 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.822 -0.549 . . . . 0.0 110.308 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -58.87 153.16 52.52 Favored 'Trans proline' 0 N--CA 1.488 1.2 0 O-C-N 123.251 1.132 . . . . 0.0 110.683 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.671 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -62.95 -171.93 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.762 -0.586 . . . . 0.0 110.116 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -58.13 -35.08 70.96 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.699 -0.626 . . . . 0.0 110.562 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -97.96 137.55 36.62 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.712 -0.618 . . . . 0.0 110.206 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 135.96 39.52 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.709 -0.62 . . . . 0.0 110.152 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 75' ' ' LEU . 8.9 tt -107.25 128.55 54.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.709 -0.62 . . . . 0.0 110.271 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.73 119.14 25.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.733 -0.604 . . . . 0.0 110.032 178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.58 -171.79 34.77 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -58.56 -37.21 75.24 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.713 -0.875 . . . . 0.0 110.467 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 51.6 m -70.48 137.03 49.93 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.693 -0.629 . . . . 0.0 110.164 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.18 62.34 9.86 Favored Pre-proline 0 N--CA 1.503 2.21 0 O-C-N 121.419 -0.801 . . . . 0.0 110.818 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 21.2 Cg_exo -58.81 -48.53 14.33 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.077 1.04 . . . . 0.0 111.04 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 81' ' ' PRO . 22.8 Cg_exo -60.91 147.01 96.8 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 122.997 0.998 . . . . 0.0 110.363 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 146.56 97.56 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.212 1.111 . . . . 0.0 110.374 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.4 t -115.03 134.96 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.71 -0.619 . . . . 0.0 109.887 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.61 135.24 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.759 -0.588 . . . . 0.0 109.923 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -104.32 137.43 42.23 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.759 -0.588 . . . . 0.0 110.149 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -66.61 147.63 98.93 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.711 -0.618 . . . . 0.0 110.147 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.94 146.34 97.81 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.162 1.085 . . . . 0.0 110.397 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.595 ' O ' HG23 ' A' ' 89' ' ' THR . 6.6 t -123.54 100.22 38.47 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.783 -0.573 . . . . 0.0 110.444 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.29 -25.39 57.09 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 O-C-N 122.894 0.944 . . . . 0.0 111.135 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.691 HG23 ' HG3' ' A' ' 92' ' ' LYS . 34.0 m -64.81 -28.17 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.515 -0.741 . . . . 0.0 110.513 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.691 ' HG3' HG23 ' A' ' 91' ' ' VAL . 36.6 mtpt -96.6 138.16 34.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.569 -0.707 . . . . 0.0 110.135 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -113.18 162.01 24.11 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.71 -0.619 . . . . 0.0 110.363 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.42 153.5 65.62 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.192 1.101 . . . . 0.0 110.31 178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -108.58 137.43 46.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.792 -0.568 . . . . 0.0 110.216 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -58.66 -37.59 76.32 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.714 -0.616 . . . . 0.0 110.521 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.4 m -57.12 -34.19 68.13 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.64 -0.662 . . . . 0.0 110.757 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 54.67 44.44 28.58 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.467 -0.771 . . . . 0.0 110.745 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 97' ' ' SER . 46.6 pt -123.14 160.84 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 110.448 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.8 130.21 45.23 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.845 -0.534 . . . . 0.0 110.175 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.484 0 CA-C-O 117.987 -1.451 . . . . 0.0 109.543 -179.787 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.93 -32.36 72.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.729 -0.865 . . . . 0.0 110.093 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm -87.48 136.78 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.693 -0.629 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.36 151.76 50.12 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -55.62 148.62 53.18 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.188 1.099 . . . . 0.0 111.016 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.9 p -96.08 24.65 5.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.711 -0.618 . . . . 0.0 110.604 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -75.9 151.83 37.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.622 -0.673 . . . . 0.0 110.484 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -71.99 -4.05 26.29 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.694 -0.629 . . . . 0.0 111.877 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -67.03 -22.03 65.9 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.347 -0.845 . . . . 0.0 110.253 175.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.675 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.3 m95 -75.86 -13.97 60.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.488 -0.757 . . . . 0.0 111.302 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.07 127.12 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 120.712 -1.243 . . . . 0.0 109.783 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.81 -0.79 89.15 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.853 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.767 ' SG ' HD12 ' A' ' 28' ' ' ILE . 1.8 p -83.62 155.1 23.39 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 119.249 1.524 . . . . 0.0 110.442 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.55 120.18 32.75 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.785 -0.572 . . . . 0.0 110.467 -175.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.29 158.59 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.71 -0.619 . . . . 0.0 110.751 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.557 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.9 t -121.39 141.07 51.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.84 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.0 mm -122.24 123.25 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.041 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.3 109.9 22.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.0 m -97.29 166.83 11.37 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -58.42 169.84 0.83 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.499 -0.751 . . . . 0.0 110.194 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.78 -34.37 62.57 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.499 -0.75 . . . . 0.0 111.735 -165.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.01 -25.45 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.529 -0.732 . . . . 0.0 110.221 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.4 mt -91.11 -18.14 25.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.501 -0.75 . . . . 0.0 111.443 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.38 -152.05 49.89 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.5 t -130.57 140.13 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.96 . . . . 0.0 110.055 -176.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -131.71 159.07 39.46 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.971 -0.691 . . . . 0.0 110.345 173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.0 145.22 43.86 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.34 169.55 42.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 12' ' ' ALA . 76.1 mt -89.75 136.57 32.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.796 -0.826 . . . . 0.0 110.172 172.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 31' ' ' ILE . 87.3 mt -67.59 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.862 -0.524 . . . . 0.0 110.49 -176.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' HG13 ' A' ' 39' ' ' VAL . 47.0 tttt -106.6 -32.26 8.12 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.606 -0.684 . . . . 0.0 110.083 172.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.482 ' HA ' HD12 ' A' ' 9' ' ' ILE . 68.3 tp60 -157.8 148.55 20.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.736 -0.602 . . . . 0.0 109.843 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 28' ' ' ILE . 69.8 mt -138.94 137.24 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.662 -0.649 . . . . 0.0 110.106 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.2 p -146.5 158.54 43.91 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.64 -23.82 30.15 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 -171.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.28 -26.13 18.28 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.475 -0.766 . . . . 0.0 111.232 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.44 154.67 30.81 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.474 -0.766 . . . . 0.0 111.049 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.685 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -114.68 138.18 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.673 -0.642 . . . . 0.0 109.647 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.786 HG23 HG22 ' A' ' 56' ' ' VAL . 61.2 m -124.27 131.66 53.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.571 -0.706 . . . . 0.0 110.418 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.13 172.15 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 O-C-N 121.658 -0.651 . . . . 0.0 110.326 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.3 m -128.56 163.56 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.733 -0.604 . . . . 0.0 110.614 -176.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 59.7 66.99 0.92 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.46 0.647 . . . . 0.0 109.55 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -69.01 121.45 16.67 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.525 0.678 . . . . 0.0 111.543 -172.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -114.28 132.42 56.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.656 -0.653 . . . . 0.0 109.268 167.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 48' ' ' LEU . 80.0 mtp180 -134.88 145.65 48.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.609 -0.682 . . . . 0.0 110.106 -177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.6 39.71 28.66 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.523 -0.736 . . . . 0.0 111.033 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.95 22.05 61.96 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 47' ' ' PRO . 72.5 t -143.68 151.74 54.35 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.328 -1.101 . . . . 0.0 109.975 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.13 144.08 33.13 Favored 'Trans proline' 0 N--CA 1.484 0.97 0 O-C-N 123.099 1.052 . . . . 0.0 110.302 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.669 HD12 ' CB ' ' A' ' 41' ' ' ALA . 89.1 mt -78.13 151.73 33.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.541 -0.724 . . . . 0.0 110.163 173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -56.38 -37.46 70.12 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.649 -0.657 . . . . 0.0 110.701 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 44.2 mttt -90.13 86.59 6.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.686 -0.634 . . . . 0.0 110.024 178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -60.57 -36.71 79.15 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.784 -0.573 . . . . 0.0 110.206 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -83.11 2.08 37.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.716 -0.615 . . . . 0.0 111.682 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.37 135.96 42.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -0.987 . . . . 0.0 110.285 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -89.28 142.33 27.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.798 -0.564 . . . . 0.0 110.53 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 HD12 ' A' ' 57' ' ' LEU . 58.3 t -106.2 124.53 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.726 -0.609 . . . . 0.0 109.451 176.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.51 113.12 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.617 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.0 mt -128.64 139.41 52.27 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.885 -0.509 . . . . 0.0 110.516 -174.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -74.05 138.54 44.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.765 -0.584 . . . . 0.0 110.536 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.451 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.25 -31.99 61.97 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.687 -0.633 . . . . 0.0 110.892 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.18 -24.9 67.5 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.8 -0.563 . . . . 0.0 110.439 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -88.6 -21.92 23.77 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.508 -0.745 . . . . 0.0 110.438 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 59' ' ' CYS . 82.3 mt -80.83 139.57 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.521 -0.737 . . . . 0.0 109.7 177.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -101.51 -25.37 13.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.661 -0.649 . . . . 0.0 110.5 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.7 m -159.92 151.85 20.37 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.529 -0.732 . . . . 0.0 110.756 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.84 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.1 mt -139.83 146.06 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.63 -0.669 . . . . 0.0 109.79 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.73 130.05 27.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.838 -0.539 . . . . 0.0 110.533 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.675 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.5 113.82 15.7 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.923 174.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.4 mt -72.6 -45.75 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.568 -0.707 . . . . 0.0 109.673 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 19.3 mt-10 -137.15 94.04 12.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -61.46 -33.34 88.27 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 O-C-N 123.264 1.139 . . . . 0.0 110.432 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -169.81 -41.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.688 -0.633 . . . . 0.0 110.278 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -75.96 127.31 32.7 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.702 -0.624 . . . . 0.0 110.17 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.37 -34.62 75.63 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.739 -0.601 . . . . 0.0 110.592 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 54.04 46.8 24.74 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.372 -0.83 . . . . 0.0 110.717 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.7 tp -58.42 -36.51 73.71 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.677 -0.64 . . . . 0.0 110.529 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -58.59 -36.42 73.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.59 -0.694 . . . . 0.0 110.307 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.6 26.41 50.75 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -58.89 -41.78 87.95 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.483 -1.01 . . . . 0.0 110.207 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 45.0 m -61.08 -36.23 79.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.731 -0.606 . . . . 0.0 110.185 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.8 111.73 52.54 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.739 -0.601 . . . . 0.0 110.33 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 24.9 Cg_exo -57.88 -52.24 6.38 Favored 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.022 1.012 . . . . 0.0 111.367 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 81' ' ' PRO . 27.9 Cg_endo -70.16 153.1 67.39 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 O-C-N 122.915 0.955 . . . . 0.0 110.696 -172.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.77 155.86 35.63 Favored 'Trans proline' 0 N--CA 1.488 1.157 0 O-C-N 123.283 1.149 . . . . 0.0 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 86' ' ' ASN . 60.1 t -106.09 138.76 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.698 -0.626 . . . . 0.0 109.879 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.6 p -57.15 -34.24 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.627 -0.671 . . . . 0.0 110.753 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' H ' HG12 ' A' ' 84' ' ' VAL . 55.4 t30 54.63 48.83 19.44 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.332 -0.855 . . . . 0.0 110.705 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 1.9 tmtt? -54.62 -59.37 10.62 Favored Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.608 -0.683 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 87' ' ' LYS . 13.6 Cg_endo -62.02 146.77 96.1 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 O-C-N 123.035 1.019 . . . . 0.0 110.329 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.8 t -106.85 150.14 39.37 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.752 -0.592 . . . . 0.0 110.289 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.22 -36.51 68.34 Favored 'Trans proline' 0 N--CA 1.486 1.068 0 O-C-N 123.226 1.119 . . . . 0.0 110.502 -178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.15 150.12 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.601 -0.687 . . . . 0.0 110.464 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -65.13 -34.89 79.46 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.735 -0.603 . . . . 0.0 110.505 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 93' ' ' LEU . 25.6 mt -69.23 144.81 95.47 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.0 110.281 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.9 140.55 85.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.224 1.118 . . . . 0.0 110.383 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -59.34 -29.47 67.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.687 -0.633 . . . . 0.0 110.361 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.72 153.69 23.95 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.634 -0.666 . . . . 0.0 110.314 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 51.0 m -115.07 151.24 34.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.753 -0.592 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -93.72 148.79 21.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.774 -0.579 . . . . 0.0 110.22 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.31 -32.43 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.731 -0.606 . . . . 0.0 109.777 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.2 tp -93.68 130.51 39.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.706 -0.621 . . . . 0.0 110.181 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.62 -34.05 74.99 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.785 -0.832 . . . . 0.0 110.109 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm -146.7 149.4 33.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.732 -0.605 . . . . 0.0 109.655 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.31 74.32 0.44 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -78.12 59.57 7.04 Favored 'Trans proline' 0 N--CA 1.484 0.954 0 O-C-N 123.118 1.062 . . . . 0.0 110.595 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.5 p -96.69 12.73 30.84 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.442 -0.786 . . . . 0.0 111.09 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.73 148.69 34.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.334 -0.854 . . . . 0.0 110.291 -177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -73.74 -4.16 32.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.699 -0.626 . . . . 0.0 111.918 177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -67.58 -29.69 69.11 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.251 -0.906 . . . . 0.0 110.196 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.74 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -76.95 -13.92 59.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.632 -0.667 . . . . 0.0 111.257 -178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.6 mm -57.33 131.38 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.838 -1.164 . . . . 0.0 109.856 -175.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.66 89.2 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.896 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.0 p -81.86 155.23 25.46 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 119.199 1.499 . . . . 0.0 110.422 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.741 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.32 120.26 32.05 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.772 -0.58 . . . . 0.0 110.124 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.2 m -135.65 157.02 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.604 . . . . 0.0 110.641 -177.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.616 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.3 t -121.49 139.8 53.02 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.843 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.7 mm -122.35 122.51 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.899 -174.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.89 109.98 22.66 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 63.0 m -94.49 166.8 11.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.28 169.31 1.2 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.532 -0.73 . . . . 0.0 109.93 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.67 -33.85 61.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.555 -0.716 . . . . 0.0 111.773 -165.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.0 t -75.04 -25.34 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.5 -0.75 . . . . 0.0 110.291 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 76.1 mt -91.1 -15.58 29.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.537 -0.727 . . . . 0.0 111.575 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.71 -153.19 49.92 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.59 142.19 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -1.033 . . . . 0.0 110.075 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.732 ' CE2' HD13 ' A' ' 57' ' ' LEU . 46.4 p90 -132.62 159.0 40.8 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.28 173.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -137.28 146.03 44.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.745 -0.597 . . . . 0.0 109.391 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.46 42.04 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.3 mt -89.78 136.6 32.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.739 -0.86 . . . . 0.0 110.044 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.788 HG21 HD11 ' A' ' 31' ' ' ILE . 83.7 mt -66.96 137.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 CA-C-O 121.221 0.534 . . . . 0.0 110.6 -176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.603 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -105.13 -27.68 11.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.732 -0.605 . . . . 0.0 109.975 170.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.468 ' HA ' HD12 ' A' ' 9' ' ' ILE . 31.2 tt0 -158.71 152.09 22.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.723 -0.611 . . . . 0.0 109.927 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 28' ' ' ILE . 68.9 mt -139.31 138.66 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.611 -0.681 . . . . 0.0 109.968 -177.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.9 p -146.37 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.69 -23.93 31.46 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.504 -0.747 . . . . 0.0 111.338 -170.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.76 -25.82 18.01 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.42 -0.8 . . . . 0.0 111.232 -174.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.45 157.12 34.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.5 -0.75 . . . . 0.0 111.108 -171.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 141.06 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.66 -0.65 . . . . 0.0 109.516 172.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.774 HG23 HG22 ' A' ' 56' ' ' VAL . 68.4 m -124.09 131.67 53.57 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.619 -0.675 . . . . 0.0 110.571 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.563 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -133.11 170.14 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.736 -0.603 . . . . 0.0 110.586 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.7 m -127.05 163.39 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.744 -0.597 . . . . 0.0 110.424 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 57.79 60.65 2.69 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.473 -0.767 . . . . 0.0 109.857 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.674 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.86 128.2 35.64 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.604 0.716 . . . . 0.0 111.474 -172.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.54 134.25 54.8 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.848 ' HB3' HD21 ' A' ' 48' ' ' LEU . 40.9 ttm180 -134.85 142.55 46.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.4 m120 52.6 40.61 30.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.4 -0.813 . . . . 0.0 111.074 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.17 61.9 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.2 t -142.89 151.93 57.61 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.377 -1.072 . . . . 0.0 109.715 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 2.9 Cg_exo -72.7 137.05 26.7 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 O-C-N 123.071 1.038 . . . . 0.0 110.377 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.848 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.2 mt -78.24 144.11 36.51 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.672 -0.642 . . . . 0.0 110.227 175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -59.05 -33.22 70.52 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.732 -0.605 . . . . 0.0 110.28 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.76 52.65 2.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.742 -0.599 . . . . 0.0 110.134 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -56.45 -35.64 68.13 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.616 -0.678 . . . . 0.0 110.602 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -71.62 -21.78 61.79 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.674 -0.641 . . . . 0.0 110.619 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.65 144.2 43.93 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.488 -0.758 . . . . 0.0 110.144 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.06 144.46 26.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.728 -0.607 . . . . 0.0 110.638 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 66.4 t -102.79 124.91 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.774 HG22 HG23 ' A' ' 37' ' ' THR . 39.0 t -123.46 112.9 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.622 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.732 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.59 133.71 48.4 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.931 -0.481 . . . . 0.0 110.403 -173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -75.24 143.56 43.02 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.793 -0.567 . . . . 0.0 110.711 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.31 -31.9 62.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.647 -0.658 . . . . 0.0 110.837 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.6 p -64.66 -27.59 69.03 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.773 -0.579 . . . . 0.0 110.066 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.13 -23.92 22.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 0.0 110.188 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.9 mt -81.05 145.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.55 -0.719 . . . . 0.0 109.848 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -100.56 -32.98 10.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.705 -0.622 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.7 p -161.09 156.2 24.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.676 -0.64 . . . . 0.0 110.528 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.843 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.0 mt -140.28 149.54 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.81 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.07 130.11 28.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.827 -0.545 . . . . 0.0 110.411 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -76.36 113.77 14.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.673 -0.642 . . . . 0.0 109.697 173.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.3 mt -74.6 -54.91 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.657 -0.652 . . . . 0.0 110.08 -177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 3.6 mm-40 -137.24 138.21 24.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.819 -0.551 . . . . 0.0 110.351 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.2 148.93 91.52 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.09 1.048 . . . . 0.0 110.372 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -60.96 139.38 58.04 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.654 -0.653 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -60.36 -35.98 76.94 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.771 -0.581 . . . . 0.0 110.312 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 54.12 40.74 31.95 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.557 -0.714 . . . . 0.0 110.774 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -108.6 154.98 21.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.709 -0.619 . . . . 0.0 110.185 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.9 tp -98.32 122.46 41.52 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.733 -0.604 . . . . 0.0 110.036 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -110.68 15.07 22.19 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.762 -0.586 . . . . 0.0 111.226 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.29 136.61 30.4 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -58.42 -35.29 71.86 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.675 -0.897 . . . . 0.0 110.347 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.7 m -75.86 140.56 42.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.813 -0.555 . . . . 0.0 110.099 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 53.87 68.47 2.8 Favored Pre-proline 0 N--CA 1.504 2.24 0 O-C-N 121.42 -0.8 . . . . 0.0 110.656 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -60.06 155.45 44.87 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.159 1.084 . . . . 0.0 110.468 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -60.33 148.12 91.39 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.209 1.11 . . . . 0.0 110.425 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.32 149.3 81.93 Favored 'Trans proline' 0 N--CA 1.488 1.194 0 O-C-N 123.22 1.116 . . . . 0.0 110.609 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.26 -36.66 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.777 -0.577 . . . . 0.0 109.745 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.4 t -59.85 -38.05 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.727 -0.608 . . . . 0.0 109.917 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -96.87 126.78 42.26 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.133 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -125.79 101.77 29.4 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.729 -0.607 . . . . 0.0 110.339 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -58.15 150.64 64.39 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 O-C-N 123.126 1.066 . . . . 0.0 110.57 178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 89' ' ' THR . 6.7 t -68.21 112.54 11.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.759 -0.588 . . . . 0.0 110.418 -176.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.81 160.01 50.22 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 122.929 0.962 . . . . 0.0 110.326 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.1 133.32 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.69 -0.631 . . . . 0.0 109.696 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -65.74 126.79 29.55 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.802 -0.561 . . . . 0.0 110.681 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mp -113.17 163.2 18.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.772 -0.58 . . . . 0.0 110.067 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.65 141.66 97.44 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.047 1.025 . . . . 0.0 110.502 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -122.22 140.68 52.31 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.657 -0.652 . . . . 0.0 110.319 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -120.41 155.8 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.752 -0.592 . . . . 0.0 110.262 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 t -114.99 142.21 46.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.693 -0.629 . . . . 0.0 110.132 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -112.15 24.3 12.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.606 -0.684 . . . . 0.0 110.797 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 mm -63.17 -34.48 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.624 -0.673 . . . . 0.0 109.826 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.0 mt -93.18 141.68 28.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.714 -0.616 . . . . 0.0 110.156 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 118.003 -1.443 . . . . 0.0 109.549 -179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.96 146.02 53.99 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.763 -0.845 . . . . 0.0 110.176 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -80.12 -33.65 38.48 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.736 -0.602 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.94 81.46 0.36 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 10.1 Cg_endo -57.36 156.64 24.98 Favored 'Trans proline' 0 N--CA 1.488 1.159 0 O-C-N 123.119 1.062 . . . . 0.0 110.837 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.5 p -96.98 24.09 6.58 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.751 -0.593 . . . . 0.0 110.715 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -76.18 159.85 30.27 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.498 -0.751 . . . . 0.0 110.637 -176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.26 -3.71 25.28 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.701 -0.624 . . . . 0.0 112.108 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -65.99 -21.71 66.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.318 -0.864 . . . . 0.0 110.167 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.688 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.8 m95 -76.72 -13.87 60.0 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.457 -0.777 . . . . 0.0 111.329 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.4 mm -56.4 128.01 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.722 -1.236 . . . . 0.0 109.824 -175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.69 89.19 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.906 -175.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.7 p -82.45 155.29 24.71 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 119.183 1.492 . . . . 0.0 110.504 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.675 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.86 119.4 33.36 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.75 -0.594 . . . . 0.0 110.293 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.652 HG12 ' HG ' ' A' ' 67' ' ' LEU . 33.9 m -135.51 155.37 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.132 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.3 t -120.2 138.04 53.85 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.829 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -119.27 121.63 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 120.09 -0.644 . . . . 0.0 109.825 -174.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.98 110.55 22.87 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 68.1 m -96.2 166.81 11.56 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.11 170.34 0.91 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.572 -0.705 . . . . 0.0 109.994 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.64 -34.47 62.21 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.552 -0.718 . . . . 0.0 111.799 -165.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -74.7 -25.43 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.501 -0.749 . . . . 0.0 110.232 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.6 mt -90.93 -15.15 30.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 111.678 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.23 -156.21 48.31 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.01 141.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.384 -1.068 . . . . 0.0 110.217 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.738 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.2 p90 -132.12 156.51 46.24 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.312 174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -138.64 146.23 41.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.816 -0.552 . . . . 0.0 109.596 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.824 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -176.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.7 mt -89.82 133.84 34.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 109.868 172.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.957 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -67.89 137.2 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 CA-C-O 121.19 0.519 . . . . 0.0 110.627 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' HG11 ' A' ' 39' ' ' VAL . 87.5 tttt -111.05 -27.82 8.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.764 -0.585 . . . . 0.0 110.229 170.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -150.9 147.12 26.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.537 -0.727 . . . . 0.0 109.798 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.957 HD11 HG21 ' A' ' 28' ' ' ILE . 66.1 mt -140.32 137.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.677 -0.639 . . . . 0.0 109.955 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 94.4 p -146.2 158.71 43.89 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.53 -23.84 28.7 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.524 -0.735 . . . . 0.0 111.332 -170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.85 -26.06 17.82 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.524 -0.735 . . . . 0.0 111.25 -174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -156.47 156.82 34.4 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.37 -0.831 . . . . 0.0 111.209 -172.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.0 mm -115.6 140.5 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.658 -0.651 . . . . 0.0 109.47 171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.837 HG23 HG22 ' A' ' 56' ' ' VAL . 83.6 m -126.02 130.77 51.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.504 -0.747 . . . . 0.0 110.329 -177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.824 HD12 ' HA3' ' A' ' 26' ' ' GLY . 39.7 pt -133.76 167.79 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.643 -0.66 . . . . 0.0 110.581 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.539 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.1 m -125.58 163.44 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.792 -0.568 . . . . 0.0 110.736 -173.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 57.1 53.29 8.04 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.686 0.755 . . . . 0.0 109.756 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.787 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.13 137.54 53.48 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.018 0.913 . . . . 0.0 112.041 -169.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.71 139.36 49.74 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 168.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.673 ' HB3' HD21 ' A' ' 48' ' ' LEU . 67.0 ttt180 -134.83 141.31 46.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 109.973 -177.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 m120 53.15 41.05 32.14 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 121.424 -0.798 . . . . 0.0 111.017 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.96 22.11 62.07 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -143.83 151.82 54.02 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.326 -1.103 . . . . 0.0 109.685 173.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 46' ' ' VAL . 3.1 Cg_exo -71.3 146.31 50.58 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 O-C-N 123.103 1.054 . . . . 0.0 110.11 -175.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD12 ' HB3' ' A' ' 41' ' ' ALA . 88.0 mt -77.05 154.1 33.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.553 -0.717 . . . . 0.0 109.994 174.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -54.79 -38.15 66.95 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.615 -0.678 . . . . 0.0 111.013 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -111.21 105.72 14.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.736 -0.603 . . . . 0.0 110.419 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -62.68 -31.14 71.99 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -71.81 -17.02 62.19 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.753 -0.592 . . . . 0.0 111.134 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.56 135.88 45.68 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.368 -0.832 . . . . 0.0 109.973 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -93.93 149.24 21.41 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.795 -0.566 . . . . 0.0 111.059 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 57' ' ' LEU . 77.1 t -104.51 123.61 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 172.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 37' ' ' THR . 37.9 t -123.57 111.94 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.474 174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.738 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.3 mt -128.61 139.74 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.469 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -74.57 138.59 43.14 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.755 -0.591 . . . . 0.0 110.568 -176.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.533 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.05 -32.05 61.59 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.666 -0.647 . . . . 0.0 110.975 176.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.66 -26.09 68.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.742 -0.599 . . . . 0.0 110.389 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.28 -19.85 24.82 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.728 -0.607 . . . . 0.0 110.662 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.8 mt -80.34 145.14 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 109.832 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -99.77 -33.1 10.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.696 -0.627 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 76.6 p -159.94 156.55 27.38 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.669 -0.644 . . . . 0.0 110.522 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.829 HG23 ' CD1' ' A' ' 15' ' ' ILE . 66.1 mt -139.96 145.13 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.675 -0.641 . . . . 0.0 109.881 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.8 120.03 14.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.787 -0.57 . . . . 0.0 110.429 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.688 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.3 mp -77.8 113.88 16.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.526 -0.734 . . . . 0.0 110.032 175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.443 HG22 ' HG2' ' A' ' 69' ' ' GLU . 80.7 mt -73.85 -38.49 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.821 -0.549 . . . . 0.0 109.983 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 70.4 mm-40 -136.05 99.92 10.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.767 -0.583 . . . . 0.0 110.15 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.86 -24.61 74.35 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.32 1.168 . . . . 0.0 110.85 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.21 142.45 51.72 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.533 -0.729 . . . . 0.0 110.468 -178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -91.0 138.59 31.49 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.737 -0.602 . . . . 0.0 110.325 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -109.01 151.59 26.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.719 -0.613 . . . . 0.0 110.17 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -82.32 117.01 22.08 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.769 -0.582 . . . . 0.0 110.293 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 78' ' ' HIS . 89.5 mt -100.02 138.43 37.11 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.732 -0.605 . . . . 0.0 110.273 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -77.21 148.05 36.07 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.601 . . . . 0.0 110.378 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.27 -38.89 3.0 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 75' ' ' LEU . 79.8 m80 -59.27 -33.76 71.44 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.671 -0.899 . . . . 0.0 110.269 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.0 p -119.47 164.57 15.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.68 -0.637 . . . . 0.0 110.181 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.26 159.46 22.34 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.714 -0.616 . . . . 0.0 110.152 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.26 160.23 31.8 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.178 1.094 . . . . 0.0 110.343 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.76 -58.34 1.78 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 O-C-N 123.144 1.076 . . . . 0.0 111.884 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.8 Cg_endo -60.97 143.85 99.44 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 O-C-N 122.984 0.992 . . . . 0.0 110.385 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.55 143.32 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 110.261 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.35 -39.79 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.741 -0.599 . . . . 0.0 109.76 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -100.43 117.21 34.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.839 -0.538 . . . . 0.0 110.252 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -126.03 82.02 65.51 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.698 -0.626 . . . . 0.0 110.157 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.11 143.89 99.52 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.071 1.037 . . . . 0.0 110.512 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 p -115.26 106.58 50.85 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.647 -0.658 . . . . 0.0 110.192 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.65 145.28 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.03 1.016 . . . . 0.0 110.714 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 56.4 t -116.44 135.78 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.647 -0.658 . . . . 0.0 110.006 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt 54.47 42.51 31.32 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.549 -0.719 . . . . 0.0 110.928 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 tp -113.09 109.94 51.69 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.69 -0.631 . . . . 0.0 109.989 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -65.62 126.59 16.36 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.029 1.015 . . . . 0.0 110.597 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -69.5 -41.91 75.46 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.793 -0.567 . . . . 0.0 110.169 176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -58.02 -36.29 72.49 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.724 -0.61 . . . . 0.0 110.692 -176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.4 m -56.21 -32.55 64.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.62 -0.675 . . . . 0.0 111.039 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 42.5 p-10 -131.6 165.6 23.28 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.631 . . . . 0.0 110.567 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.5 tp -126.11 137.35 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.766 -0.584 . . . . 0.0 110.191 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -61.32 -36.95 81.55 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.66 -0.65 . . . . 0.0 110.26 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.535 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.1 -31.91 72.42 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.796 -0.826 . . . . 0.0 110.219 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.5 140.54 29.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.758 -0.589 . . . . 0.0 110.255 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 69.13 1.38 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.458 ' C ' HG23 ' A' ' 4' ' ' THR . 23.8 Cg_exo -59.59 125.03 16.73 Favored 'Trans proline' 0 N--CA 1.488 1.15 0 O-C-N 123.187 1.098 . . . . 0.0 110.615 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.458 HG23 ' C ' ' A' ' 3' ' ' PRO . 44.4 p -151.13 26.88 0.7 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.694 -0.629 . . . . 0.0 110.233 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -77.15 157.21 31.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.614 -0.679 . . . . 0.0 110.413 -177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -70.05 -6.34 32.98 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.613 -0.679 . . . . 0.0 111.749 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.26 -25.9 65.4 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.283 -0.886 . . . . 0.0 110.136 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.681 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.5 -13.79 60.07 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.503 -0.748 . . . . 0.0 111.52 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -55.94 133.59 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.822 -1.174 . . . . 0.0 110.325 -171.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.65 89.2 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.947 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.8 p -83.82 155.23 23.08 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 119.147 1.474 . . . . 0.0 110.463 178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.708 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.75 119.75 31.23 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.699 -0.625 . . . . 0.0 110.222 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.3 m -135.32 158.77 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.742 -0.599 . . . . 0.0 110.627 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.582 ' HB2' HD11 ' A' ' 68' ' ' ILE . 18.7 t -120.98 140.05 52.43 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.839 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -122.16 123.39 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 120.273 -0.571 . . . . 0.0 109.897 -173.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.45 109.98 22.5 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -94.8 166.76 11.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.16 175.05 0.45 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.519 -0.738 . . . . 0.0 110.01 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.63 -36.61 67.19 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.475 -0.765 . . . . 0.0 111.644 -165.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.34 -25.37 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.469 -0.769 . . . . 0.0 110.363 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.7 mt -90.72 -16.31 28.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.511 -0.743 . . . . 0.0 111.52 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.27 -152.26 49.51 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.85 142.07 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.458 -1.025 . . . . 0.0 110.041 -176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.1 p90 -132.76 158.88 41.28 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.369 172.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.57 144.53 42.08 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.54 42.17 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.0 mt -89.85 135.79 33.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.718 -0.872 . . . . 0.0 110.105 174.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.896 HG21 HD11 ' A' ' 31' ' ' ILE . 85.8 mt -68.23 137.16 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.235 0.54 . . . . 0.0 110.578 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' HG13 ' A' ' 39' ' ' VAL . 80.6 tttt -104.59 -30.51 9.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.685 -0.634 . . . . 0.0 109.914 171.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.546 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.3 tt0 -158.04 147.93 20.07 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.706 -0.621 . . . . 0.0 110.028 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.896 HD11 HG21 ' A' ' 28' ' ' ILE . 78.9 mt -137.94 138.15 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.623 -0.673 . . . . 0.0 109.92 -178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.4 p -146.59 158.8 43.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.68 -23.63 29.6 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.571 -0.705 . . . . 0.0 111.359 -171.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 0.0 111.217 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -156.46 155.13 31.53 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 0.0 111.027 -171.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.673 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -115.05 139.73 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.715 -0.616 . . . . 0.0 109.511 172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.789 HG23 HG22 ' A' ' 56' ' ' VAL . 63.7 m -125.49 131.83 52.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.506 -0.746 . . . . 0.0 110.606 -176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.96 170.48 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.746 -0.596 . . . . 0.0 110.208 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -128.29 163.22 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.62 -0.675 . . . . 0.0 110.944 -177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.9 mtt85 51.85 50.57 18.35 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.431 -0.793 . . . . 0.0 110.861 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.796 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.95 139.8 56.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.939 0.876 . . . . 0.0 111.614 -172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -114.42 140.49 48.65 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 168.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.561 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.5 ttt180 -134.71 142.6 46.83 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.621 -0.674 . . . . 0.0 110.183 -175.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.3 m120 53.14 41.24 32.15 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.381 -0.824 . . . . 0.0 111.008 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.411 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.82 22.07 61.72 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 47' ' ' PRO . 75.0 t -145.62 151.44 46.56 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.422 -1.046 . . . . 0.0 109.657 172.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.425 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.9 Cg_exo -69.39 150.21 70.15 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.104 1.055 . . . . 0.0 110.31 -175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -75.75 152.36 37.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.548 -0.72 . . . . 0.0 109.917 174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -56.37 -36.09 68.44 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.64 -0.662 . . . . 0.0 110.908 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.602 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 81.9 tttt -105.94 108.08 19.41 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.736 -0.602 . . . . 0.0 110.22 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.46 -36.13 83.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.679 -0.638 . . . . 0.0 110.339 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -80.22 1.99 26.18 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.755 -0.591 . . . . 0.0 111.713 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.602 ' HB2' ' HD3' ' A' ' 50' ' ' LYS . . . -74.85 135.93 41.56 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 0.0 110.19 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -90.54 138.53 31.48 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.416 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG21 ' CB ' ' A' ' 41' ' ' ALA . 75.6 t -105.83 121.35 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.642 -0.661 . . . . 0.0 109.478 176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.789 HG22 HG23 ' A' ' 37' ' ' THR . 40.2 t -123.53 114.32 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.236 -0.585 . . . . 0.0 109.428 177.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.6 mt -128.59 134.21 48.54 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.214 0.531 . . . . 0.0 110.537 -172.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -73.79 136.45 43.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.779 -0.576 . . . . 0.0 110.52 -176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.4 p -53.71 -32.33 51.55 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.578 -0.701 . . . . 0.0 111.307 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.3 p -64.5 -24.94 67.78 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.657 -0.652 . . . . 0.0 110.301 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -87.71 -24.22 23.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.2 mt -81.17 137.95 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.548 -0.72 . . . . 0.0 109.617 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -102.89 -21.73 13.95 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.691 -0.63 . . . . 0.0 110.804 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 t -160.78 148.92 16.09 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.414 -0.804 . . . . 0.0 110.671 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.839 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.7 mt -139.55 146.79 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.599 -0.688 . . . . 0.0 109.799 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -138.1 127.07 24.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.749 -0.594 . . . . 0.0 110.524 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.681 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.5 OUTLIER -76.95 113.74 14.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.667 -0.645 . . . . 0.0 109.72 173.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.5 mt -79.21 -48.24 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.733 -0.604 . . . . 0.0 110.022 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 mm-40 -137.12 100.09 9.72 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.788 -0.57 . . . . 0.0 110.227 -176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.58 124.64 12.66 Favored 'Trans proline' 0 N--CA 1.484 0.929 0 O-C-N 123.294 1.155 . . . . 0.0 110.165 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.33 155.37 7.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.627 -0.671 . . . . 0.0 110.307 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -130.46 126.51 37.1 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.681 -0.637 . . . . 0.0 109.965 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -59.66 -39.99 86.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.668 -0.645 . . . . 0.0 110.49 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.29 -166.25 0.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.552 -0.717 . . . . 0.0 110.341 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.8 tp -58.09 -36.08 72.34 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.636 -0.665 . . . . 0.0 110.456 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 54.46 45.94 26.0 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.427 -0.796 . . . . 0.0 110.885 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.01 146.49 46.48 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -118.52 134.59 54.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.737 -0.86 . . . . 0.0 110.374 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 67.9 p -83.53 -17.63 41.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.756 -0.59 . . . . 0.0 111.086 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -51.55 -48.79 85.76 Favored Pre-proline 0 N--CA 1.506 2.336 0 O-C-N 121.155 -0.965 . . . . 0.0 111.496 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 24.9 Cg_exo -59.03 140.49 95.55 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 122.95 0.974 . . . . 0.0 110.52 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.0 Cg_exo -58.7 -49.24 12.2 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.17 1.09 . . . . 0.0 111.077 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 24.2 Cg_exo -59.49 140.64 95.05 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 122.915 0.955 . . . . 0.0 110.643 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -122.14 134.85 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.765 -0.584 . . . . 0.0 109.912 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.7 p -134.31 141.62 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.723 -0.611 . . . . 0.0 110.458 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -109.43 139.74 44.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.818 -0.551 . . . . 0.0 110.222 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -65.53 154.35 88.34 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.713 -0.617 . . . . 0.0 110.192 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.24 148.52 89.61 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.21 1.111 . . . . 0.0 110.531 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 95' ' ' HIS . 7.5 p -113.93 100.47 52.44 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.701 -0.624 . . . . 0.0 110.103 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.09 142.74 98.01 Favored 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.158 1.083 . . . . 0.0 110.45 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -74.04 -23.28 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.662 -0.649 . . . . 0.0 110.794 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -58.0 -35.2 70.9 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.793 . . . . 0.0 110.519 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 28.6 mt -109.55 110.09 59.8 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.721 -0.612 . . . . 0.0 110.076 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.27 134.43 48.69 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.059 1.031 . . . . 0.0 110.396 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.422 ' CE1' ' HB ' ' A' ' 89' ' ' THR . 78.5 m80 -97.48 -23.0 16.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.817 -0.552 . . . . 0.0 110.697 178.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -135.59 164.47 27.76 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.517 -0.739 . . . . 0.0 110.266 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 92.5 p -117.72 154.7 31.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.634 -0.666 . . . . 0.0 110.243 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -58.12 -33.63 69.34 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.42 -33.87 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.733 -0.604 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.0 tp -97.86 130.49 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.673 -0.642 . . . . 0.0 110.198 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.48 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.84 144.83 56.75 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.703 -0.88 . . . . 0.0 110.135 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.1 mtp -150.04 145.4 26.38 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.765 -0.584 . . . . 0.0 110.028 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -144.5 159.11 27.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -82.96 55.48 5.23 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 O-C-N 123.166 1.088 . . . . 0.0 111.008 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -99.64 10.71 40.87 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 111.18 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 51.1 p30 -79.44 171.26 15.4 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.277 -0.889 . . . . 0.0 110.9 -174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.424 ' HA ' HG12 ' A' ' 9' ' ' ILE . 95.4 mt-30 -75.52 -3.94 36.98 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.718 -0.614 . . . . 0.0 111.974 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.99 -31.92 73.11 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.247 -0.908 . . . . 0.0 110.281 -174.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.678 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.81 -13.78 59.78 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.563 -0.711 . . . . 0.0 111.411 -179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.9 mm -56.57 133.32 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 120.829 -1.169 . . . . 0.0 110.192 -171.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.64 -0.62 89.2 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.946 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.787 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.6 p -83.63 155.16 23.35 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 119.205 1.503 . . . . 0.0 110.474 178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.743 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 120.0 31.48 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.705 -0.622 . . . . 0.0 110.231 -176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.43 158.51 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.684 -0.635 . . . . 0.0 110.641 -179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.739 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.1 t -121.03 141.08 51.09 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.845 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.4 mm -122.47 122.76 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.012 -173.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.4 110.04 22.69 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.43 166.76 11.9 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -59.13 167.99 1.53 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.481 -0.762 . . . . 0.0 109.828 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.55 -33.05 53.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.568 -0.707 . . . . 0.0 112.057 -165.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.8 t -75.34 -25.4 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.703 . . . . 0.0 110.364 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.4 mt -91.33 -15.29 29.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.391 -0.818 . . . . 0.0 111.651 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.41 -151.62 50.26 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.0 t -131.42 141.93 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.513 -0.993 . . . . 0.0 110.035 -175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.71 ' CE2' HD13 ' A' ' 57' ' ' LEU . 42.0 p90 -133.05 159.85 38.88 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.272 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -137.64 146.52 44.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.31 169.55 42.14 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.4 mt -89.74 135.78 33.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.682 -0.893 . . . . 0.0 109.908 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 31' ' ' ILE . 85.4 mt -66.44 137.06 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.863 -0.523 . . . . 0.0 110.286 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.641 ' HB2' HG13 ' A' ' 39' ' ' VAL . 56.0 tptt -109.08 -28.61 8.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.737 -0.602 . . . . 0.0 109.988 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -159.03 148.7 18.96 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.718 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 28' ' ' ILE . 71.6 mt -138.41 137.23 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.618 -0.676 . . . . 0.0 110.073 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.2 p -146.41 158.4 43.89 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.76 -23.73 31.28 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.549 -0.719 . . . . 0.0 111.369 -170.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.42 -26.11 18.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.451 -0.78 . . . . 0.0 111.148 -173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.49 157.09 34.84 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.402 -0.811 . . . . 0.0 111.075 -172.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.64 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.1 mm -114.72 138.84 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 171.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.802 HG23 HG22 ' A' ' 56' ' ' VAL . 60.5 m -125.61 132.98 52.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.582 -0.699 . . . . 0.0 110.371 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.9 pt -133.89 171.56 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.654 -0.654 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -128.3 163.47 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.708 -0.62 . . . . 0.0 110.586 -176.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 57.51 66.98 1.03 Allowed 'General case' 0 N--CA 1.505 2.303 0 CA-C-O 121.509 0.671 . . . . 0.0 109.838 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.748 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.91 125.45 26.34 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.503 0.668 . . . . 0.0 111.454 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.64 135.79 53.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.626 -0.671 . . . . 0.0 109.257 167.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.668 ' HG3' HD11 ' A' ' 48' ' ' LEU . 84.8 mtt180 -134.87 145.48 48.31 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.561 -0.712 . . . . 0.0 110.154 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.9 m120 52.22 40.24 28.54 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.414 -0.803 . . . . 0.0 111.108 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.14 62.01 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 76.5 t -142.16 151.44 58.68 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.439 -1.036 . . . . 0.0 109.985 174.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.0 Cg_exo -74.1 141.78 30.0 Favored 'Trans proline' 0 N--CA 1.484 0.961 0 O-C-N 123.092 1.049 . . . . 0.0 110.372 -175.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 41' ' ' ALA . 93.0 mt -78.19 151.59 33.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.578 -0.701 . . . . 0.0 110.049 172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -56.27 -37.5 69.9 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.635 -0.666 . . . . 0.0 110.826 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -100.19 87.32 3.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.622 -0.674 . . . . 0.0 110.466 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.05 -31.93 73.18 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 0.0 110.062 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -71.59 -22.96 61.65 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.652 -0.655 . . . . 0.0 110.966 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.47 136.46 45.96 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.465 -0.772 . . . . 0.0 110.156 -177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.5 150.89 22.26 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.815 -0.553 . . . . 0.0 110.689 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG12 HD12 ' A' ' 57' ' ' LEU . 61.3 t -103.1 125.76 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 174.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 37' ' ' THR . 35.5 t -123.49 112.47 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.984 -0.686 . . . . 0.0 109.651 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.71 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.66 137.15 51.49 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.079 0.466 . . . . 0.0 110.395 -174.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.6 mttm -74.58 141.22 44.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 0.0 110.506 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.86 -31.96 60.16 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.561 -0.712 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.99 -25.88 68.05 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.673 -0.642 . . . . 0.0 110.347 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -23.12 22.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.647 -0.658 . . . . 0.0 110.33 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -80.91 143.25 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.573 -0.705 . . . . 0.0 109.847 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 45.5 tpt85 -100.7 -32.93 10.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.763 -0.586 . . . . 0.0 110.248 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.7 t -160.64 152.34 19.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.59 -0.694 . . . . 0.0 110.561 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.845 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.2 mt -138.54 147.38 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.721 -0.612 . . . . 0.0 109.892 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -137.88 129.24 27.81 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.767 -0.583 . . . . 0.0 110.529 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -77.17 113.82 15.32 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.682 173.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.739 HD11 ' HB2' ' A' ' 14' ' ' SER . 83.4 mt -78.39 -44.71 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.605 -0.685 . . . . 0.0 109.788 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 59.0 mm-40 -137.06 94.69 12.4 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.809 -0.557 . . . . 0.0 109.717 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.29 -29.31 85.91 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 O-C-N 123.279 1.147 . . . . 0.0 110.672 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.582 ' HB1' ' OD1' ' A' ' 74' ' ' ASP . . . 51.81 97.08 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.38 -0.825 . . . . 0.0 111.065 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -92.7 147.07 23.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.766 -0.584 . . . . 0.0 110.446 -178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 54.82 44.19 28.82 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.501 -0.749 . . . . 0.0 110.812 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.582 ' OD1' ' HB1' ' A' ' 71' ' ' ALA . 82.1 m-20 -60.32 -37.22 79.9 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.713 -0.617 . . . . 0.0 110.289 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.9 tp -101.52 130.69 47.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.734 -0.604 . . . . 0.0 110.349 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.67 44.85 29.13 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.393 -0.817 . . . . 0.0 110.963 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.19 -73.86 1.21 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.96 -41.22 91.41 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.744 -0.857 . . . . 0.0 110.368 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.1 m -59.91 -40.4 88.69 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.741 -0.599 . . . . 0.0 110.414 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.84 79.43 74.52 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.741 -0.599 . . . . 0.0 110.443 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 140.25 45.47 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.131 1.069 . . . . 0.0 110.132 178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 19.5 Cg_exo -59.05 -48.7 13.27 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 O-C-N 123.038 1.02 . . . . 0.0 111.015 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 21.5 Cg_exo -61.26 140.23 87.52 Favored 'Trans proline' 0 N--CA 1.488 1.184 0 O-C-N 123.01 1.005 . . . . 0.0 110.361 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 85' ' ' VAL . 75.4 t -63.86 -43.3 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.637 -0.664 . . . . 0.0 109.621 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 HG12 ' A' ' 84' ' ' VAL . 34.4 m -132.88 155.82 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.761 -0.587 . . . . 0.0 110.287 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -91.8 12.97 19.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.697 -0.627 . . . . 0.0 111.301 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -56.8 -59.75 11.48 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.286 -0.884 . . . . 0.0 110.859 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.98 146.95 96.06 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 O-C-N 123.049 1.026 . . . . 0.0 110.409 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.2 m -95.46 118.54 66.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.696 -0.627 . . . . 0.0 110.078 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.82 -25.21 78.64 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 122.973 0.986 . . . . 0.0 110.837 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.45 135.36 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.652 -0.655 . . . . 0.0 109.994 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -59.29 -37.41 77.61 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.71 -0.619 . . . . 0.0 110.383 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.63 110.15 62.64 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.669 -0.644 . . . . 0.0 110.125 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -60.93 140.67 91.48 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 O-C-N 123.02 1.01 . . . . 0.0 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -88.22 -18.44 28.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.759 -0.588 . . . . 0.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -102.51 137.52 40.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.374 -0.829 . . . . 0.0 110.388 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -117.93 151.3 37.69 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.753 -0.592 . . . . 0.0 110.148 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -66.63 152.49 45.24 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.693 -0.63 . . . . 0.0 110.164 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 81.3 mt -114.86 137.1 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.751 -0.593 . . . . 0.0 109.909 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 87.7 mt -90.2 141.93 28.22 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.763 -0.585 . . . . 0.0 110.177 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.53 0 CA-C-O 117.912 -1.493 . . . . 0.0 109.466 -179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.398 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -143.4 153.78 43.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.731 -0.864 . . . . 0.0 110.161 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm -81.01 -33.68 33.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.779 -0.576 . . . . 0.0 110.159 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.88 81.15 0.83 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' C ' HG23 ' A' ' 4' ' ' THR . 18.5 Cg_exo -61.27 135.4 57.82 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 O-C-N 123.311 1.164 . . . . 0.0 110.272 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.659 ' HA ' HG21 ' A' ' 31' ' ' ILE . 31.5 p -149.83 28.24 0.77 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.743 -0.598 . . . . 0.0 110.372 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -77.1 151.48 35.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.612 -0.68 . . . . 0.0 110.26 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -67.95 -9.18 43.18 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.736 -0.602 . . . . 0.0 111.613 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.48 -25.39 65.85 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.402 -0.812 . . . . 0.0 110.095 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.647 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.3 m95 -76.61 -13.76 60.04 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 111.4 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.9 mm -55.87 133.07 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 O-C-N 120.802 -1.186 . . . . 0.0 110.349 -171.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.77 -0.75 89.16 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.079 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.774 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.7 p -84.03 155.23 22.83 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.208 1.504 . . . . 0.0 110.61 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.718 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.21 119.87 30.08 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.76 -0.588 . . . . 0.0 110.289 -175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -137.09 160.42 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.791 -177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 68' ' ' ILE . 11.0 t -127.74 142.13 51.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.897 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.5 mm -119.96 120.92 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.817 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.72 110.82 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.6 m -96.52 166.76 11.53 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -58.94 170.43 0.84 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.549 -0.719 . . . . 0.0 110.008 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.62 -34.49 62.14 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.597 -0.689 . . . . 0.0 111.736 -165.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.71 -25.39 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.5 -0.75 . . . . 0.0 110.358 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.8 mt -91.02 -14.9 30.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.519 -0.738 . . . . 0.0 111.61 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.11 -155.96 48.35 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.0 140.56 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.526 -0.984 . . . . 0.0 110.12 -175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.706 ' CE2' HD13 ' A' ' 57' ' ' LEU . 52.8 p90 -131.52 155.14 47.96 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.511 174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -136.96 146.28 45.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.754 -0.591 . . . . 0.0 109.554 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.43 169.6 42.16 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.718 HD23 ' HA ' ' A' ' 12' ' ' ALA . 68.8 mt -89.63 134.25 34.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.653 -0.91 . . . . 0.0 109.777 170.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.976 HG21 HD11 ' A' ' 31' ' ' ILE . 84.2 mt -66.75 137.13 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.388 0.613 . . . . 0.0 110.492 -173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HB2' HG13 ' A' ' 39' ' ' VAL . 83.6 tttt -107.88 -28.99 9.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.797 -0.565 . . . . 0.0 109.888 172.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HA ' HD12 ' A' ' 9' ' ' ILE . 63.0 tt0 -158.28 147.05 19.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.668 -0.645 . . . . 0.0 110.029 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.976 HD11 HG21 ' A' ' 28' ' ' ILE . 75.7 mt -138.15 137.07 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 109.948 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.6 p -146.21 158.57 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 174.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.55 -24.0 29.8 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.614 -0.679 . . . . 0.0 111.357 -171.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.68 -25.47 18.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.473 -0.767 . . . . 0.0 111.195 -174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -156.4 155.03 31.45 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.387 -0.821 . . . . 0.0 111.114 -172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.625 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.5 mm -115.26 138.89 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.656 -0.652 . . . . 0.0 109.493 172.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 91.4 m -126.02 131.35 52.21 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.592 -0.693 . . . . 0.0 110.446 -177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.788 HG22 ' HA ' ' A' ' 28' ' ' ILE . 35.4 pt -134.81 172.45 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.745 -0.597 . . . . 0.0 110.282 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 40' ' ' ARG . 35.3 m -125.38 163.7 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.548 -0.72 . . . . 0.0 110.954 -172.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 39' ' ' VAL . 5.9 mtp85 56.2 67.18 1.04 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.485 0.659 . . . . 0.0 110.145 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.654 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -66.03 122.78 18.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.691 0.758 . . . . 0.0 111.241 -172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -113.89 127.37 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 167.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.552 ' HE ' HD11 ' A' ' 48' ' ' LEU . 57.0 mtm180 -134.83 146.02 48.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.396 -177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.3 m120 52.96 40.26 30.75 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.598 -0.689 . . . . 0.0 110.86 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.91 22.25 62.11 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 173.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG13 ' HD2' ' A' ' 47' ' ' PRO . 70.2 t -142.25 149.81 53.04 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.346 -1.09 . . . . 0.0 110.389 173.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD2' HG13 ' A' ' 46' ' ' VAL . 4.2 Cg_exo -74.45 140.12 26.69 Favored 'Trans proline' 0 N--CA 1.483 0.9 0 O-C-N 123.243 1.128 . . . . 0.0 110.158 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' ALA . 81.1 mt -78.21 150.21 33.53 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 110.22 172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -56.34 -37.47 70.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -96.5 88.02 4.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.649 . . . . 0.0 110.391 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -62.81 -30.75 71.71 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.735 -0.603 . . . . 0.0 110.253 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -71.66 -22.94 61.6 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.707 -0.621 . . . . 0.0 111.0 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.14 135.99 46.36 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.443 -0.786 . . . . 0.0 110.079 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -91.24 152.54 20.47 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.869 -0.519 . . . . 0.0 110.564 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.654 HG23 ' HB2' ' A' ' 41' ' ' ALA . 64.2 t -101.66 123.16 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 173.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.3 111.67 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.717 175.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.706 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.4 mt -128.7 141.12 51.43 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.519 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -74.49 141.17 44.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.802 -0.561 . . . . 0.0 110.639 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -54.97 -31.99 61.23 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.683 -0.636 . . . . 0.0 110.947 176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.52 -25.99 68.23 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.76 -0.588 . . . . 0.0 110.291 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 21' ' ' LEU . 80.2 m-20 -88.58 -23.38 23.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.714 -0.616 . . . . 0.0 110.237 177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.0 mt -81.14 145.4 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.543 -0.723 . . . . 0.0 109.881 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -100.66 -33.19 10.39 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.714 -0.616 . . . . 0.0 110.201 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -163.24 130.71 3.55 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.008 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.897 HG23 ' CD1' ' A' ' 15' ' ' ILE . 74.5 mt -100.93 146.41 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.717 -0.614 . . . . 0.0 110.168 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -132.69 124.4 28.13 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.643 -0.661 . . . . 0.0 110.411 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.74 113.8 14.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.579 -0.701 . . . . 0.0 109.875 175.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 14' ' ' SER . 77.8 mt -75.8 -46.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.606 -0.684 . . . . 0.0 109.902 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.689 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 15.1 mt-10 -137.09 95.65 11.8 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.934 -0.479 . . . . 0.0 109.959 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.45 -55.76 0.11 Allowed 'Trans proline' 0 C--N 1.321 -0.878 0 O-C-N 123.324 1.171 . . . . 0.0 110.453 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.87 145.68 54.38 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.681 -0.637 . . . . 0.0 110.297 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.3 mttm -94.28 145.7 24.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.753 -0.592 . . . . 0.0 110.21 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -99.38 122.87 43.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.752 -0.593 . . . . 0.0 110.201 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 47.0 p-10 -104.87 149.79 25.39 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.744 -0.597 . . . . 0.0 110.322 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -65.05 -34.73 79.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.779 -0.576 . . . . 0.0 110.129 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -150.76 162.17 41.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.757 -0.59 . . . . 0.0 110.256 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 159.93 -29.6 0.37 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -127.92 167.73 16.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.636 -0.92 . . . . 0.0 110.163 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 44.2 m -58.5 -39.19 79.36 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.663 -0.648 . . . . 0.0 110.361 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -133.17 153.54 80.81 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.718 -0.614 . . . . 0.0 110.142 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.58 144.39 84.48 Favored 'Trans proline' 0 N--CA 1.484 0.963 0 O-C-N 123.239 1.126 . . . . 0.0 110.347 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -66.3 155.14 71.36 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.182 1.096 . . . . 0.0 110.188 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -60.28 138.46 81.29 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.181 1.095 . . . . 0.0 110.439 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -125.05 138.06 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.748 -0.595 . . . . 0.0 110.002 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.42 134.68 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.638 . . . . 0.0 109.833 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -103.01 127.52 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.684 -0.635 . . . . 0.0 110.407 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -122.86 79.14 49.77 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.768 -0.583 . . . . 0.0 110.053 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -58.61 148.75 80.29 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.11 1.058 . . . . 0.0 110.758 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.0 p -114.34 100.52 53.0 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.717 -0.614 . . . . 0.0 110.192 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.47 -24.38 77.81 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.167 1.088 . . . . 0.0 110.809 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 70.2 t -59.99 -40.69 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.525 -0.734 . . . . 0.0 109.986 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -87.94 -68.63 0.75 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.705 -0.622 . . . . 0.0 110.425 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.22 110.15 51.16 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.557 -0.715 . . . . 0.0 110.056 -178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 144.85 99.39 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 O-C-N 123.012 1.006 . . . . 0.0 110.409 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -118.03 136.31 53.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.719 -0.613 . . . . 0.0 110.435 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -108.11 143.2 37.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.755 -0.59 . . . . 0.0 109.667 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -57.01 -39.72 75.28 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.512 -0.742 . . . . 0.0 111.13 -172.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -59.51 -39.99 85.62 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.653 -0.654 . . . . 0.0 110.62 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -126.8 134.52 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.621 -0.674 . . . . 0.0 110.4 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.1 mt -63.55 -35.35 80.19 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.701 -0.624 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.477 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.573 -179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.47 144.36 31.5 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.719 -0.871 . . . . 0.0 110.151 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -87.86 137.98 31.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.813 -0.554 . . . . 0.0 110.359 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -126.58 75.06 0.41 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 4' ' ' THR . 36.6 Cg_endo -70.81 65.61 2.41 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.177 1.093 . . . . 0.0 110.427 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 3' ' ' PRO . 76.7 p -148.48 130.49 15.33 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.586 -0.696 . . . . 0.0 110.127 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.6 p30 -166.48 169.03 14.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.779 -0.576 . . . . 0.0 110.409 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' HA ' HG12 ' A' ' 9' ' ' ILE . 96.5 mt-30 -67.3 -16.58 64.35 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.69 -0.631 . . . . 0.0 111.354 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -68.16 -30.07 69.1 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.531 -0.731 . . . . 0.0 109.987 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.673 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.8 m95 -77.57 -13.7 59.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.713 -0.617 . . . . 0.0 111.518 -178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.1 mm -55.79 133.26 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 O-C-N 120.921 -1.112 . . . . 0.0 110.294 -171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.59 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.862 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.3 p -83.03 155.29 24.0 Favored 'General case' 0 N--CA 1.504 2.232 0 CA-C-N 119.234 1.517 . . . . 0.0 110.402 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.744 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.8 118.71 30.42 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.703 -0.623 . . . . 0.0 110.116 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.4 m -134.76 157.89 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.612 -177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.726 ' HB2' HD11 ' A' ' 68' ' ' ILE . 19.8 t -121.67 141.27 51.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.889 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.2 mm -122.48 119.45 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.771 -172.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -97.19 109.92 22.57 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.0 m -95.46 166.73 11.72 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -60.08 175.12 0.43 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -55.46 -36.19 66.32 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.489 -0.757 . . . . 0.0 111.651 -165.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.1 t -75.79 -25.38 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.717 . . . . 0.0 110.478 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.6 mt -90.78 -14.95 31.0 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.507 -0.746 . . . . 0.0 111.619 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.13 -152.44 49.07 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.254 -1.139 . . . . 0.0 110.254 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.45 142.24 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.464 -1.021 . . . . 0.0 110.166 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.727 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.2 p90 -133.99 158.92 42.29 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.302 172.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -136.86 144.4 43.57 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.12 169.51 42.13 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 136.2 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.811 -0.817 . . . . 0.0 109.989 173.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 31' ' ' ILE . 83.8 mt -67.54 137.18 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.187 0.518 . . . . 0.0 110.592 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.596 ' HB2' HG13 ' A' ' 39' ' ' VAL . 39.2 tttm -103.75 -34.76 8.46 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.812 -0.555 . . . . 0.0 109.681 171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.545 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.2 mt-30 -152.81 151.79 30.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.693 -0.629 . . . . 0.0 109.582 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.853 HD11 HG21 ' A' ' 28' ' ' ILE . 75.1 mt -138.79 138.93 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.59 -0.694 . . . . 0.0 109.842 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.8 p -146.6 158.51 43.91 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.76 29.38 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.582 -0.699 . . . . 0.0 111.436 -171.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.6 -25.95 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.442 -0.786 . . . . 0.0 111.226 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -156.44 157.08 34.9 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.413 -0.805 . . . . 0.0 111.048 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.62 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.16 140.35 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.623 . . . . 0.0 109.659 171.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.727 HG23 HG22 ' A' ' 56' ' ' VAL . 79.6 m -123.71 130.03 52.01 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.559 -0.713 . . . . 0.0 110.496 -176.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.641 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -132.17 169.69 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.67 -0.644 . . . . 0.0 110.321 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -128.11 163.16 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.63 -0.669 . . . . 0.0 110.758 -177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 51.69 48.85 22.05 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.385 -0.822 . . . . 0.0 110.892 -176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -68.47 141.45 55.61 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.869 0.842 . . . . 0.0 111.721 -172.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.5 m-85 -116.09 139.28 50.46 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 168.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.6 ttt180 -134.77 142.88 46.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.563 -0.711 . . . . 0.0 110.228 -175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.95 41.62 32.06 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.36 -0.838 . . . . 0.0 111.067 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.94 21.96 61.85 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.0 t -144.53 151.76 51.4 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.401 -1.058 . . . . 0.0 109.746 172.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 3.0 Cg_exo -71.89 149.37 53.49 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.059 1.031 . . . . 0.0 110.17 -175.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 41' ' ' ALA . 90.1 mt -76.79 149.55 36.24 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.603 -0.686 . . . . 0.0 109.837 174.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.9 ttp180 -56.12 -36.95 68.79 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.521 -0.737 . . . . 0.0 110.788 -175.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.678 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 32.4 mttp -95.36 101.48 13.21 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.636 -0.665 . . . . 0.0 110.154 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.53 -35.61 79.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.743 -0.598 . . . . 0.0 110.141 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -87.61 2.16 51.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.705 -0.622 . . . . 0.0 111.685 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.678 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.31 135.94 42.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.162 -0.961 . . . . 0.0 110.217 -177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.61 138.78 31.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.831 -0.543 . . . . 0.0 110.677 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.632 HG21 ' CB ' ' A' ' 41' ' ' ALA . 67.9 t -105.2 122.39 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 37' ' ' THR . 36.5 t -123.37 113.28 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.635 177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.727 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.7 mt -128.58 134.36 48.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.927 -0.483 . . . . 0.0 110.453 -173.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -74.81 143.52 43.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.72 -0.613 . . . . 0.0 110.664 -175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.89 -31.97 60.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.59 -0.694 . . . . 0.0 110.915 176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.0 p -64.8 -27.2 68.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.697 -0.627 . . . . 0.0 110.153 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.65 -26.3 21.94 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.697 -0.627 . . . . 0.0 110.003 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.83 145.87 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.684 -0.635 . . . . 0.0 109.789 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -99.97 -33.12 10.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.663 -0.648 . . . . 0.0 110.208 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.0 t -163.83 129.89 3.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.539 -0.726 . . . . 0.0 111.07 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.889 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.8 mt -100.95 147.83 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.649 -0.657 . . . . 0.0 110.198 173.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -133.87 126.73 31.09 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.66 -0.65 . . . . 0.0 110.302 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -75.78 113.68 13.53 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.7 -0.625 . . . . 0.0 109.916 176.313 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.726 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.4 mt -76.94 -51.96 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.73 -0.606 . . . . 0.0 110.049 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 5.4 mt-10 -137.17 131.92 17.86 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.816 -0.553 . . . . 0.0 110.203 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -59.0 151.59 64.75 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 O-C-N 122.996 0.998 . . . . 0.0 110.657 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -60.02 150.43 29.23 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.73 -0.607 . . . . 0.0 110.266 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -78.79 151.9 31.71 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.683 -0.636 . . . . 0.0 110.283 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -57.71 -35.26 70.41 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.696 -0.627 . . . . 0.0 110.597 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -61.71 139.88 58.26 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.713 -0.617 . . . . 0.0 110.165 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -99.32 141.76 31.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.754 -0.591 . . . . 0.0 110.254 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 53.84 46.68 25.23 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.428 -0.795 . . . . 0.0 110.961 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.45 64.94 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -55.98 -37.76 69.49 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.595 -0.944 . . . . 0.0 110.888 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -133.16 156.54 47.29 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 110.468 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.9 73.28 76.09 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.663 -0.648 . . . . 0.0 110.221 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.68 151.5 84.81 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.079 1.042 . . . . 0.0 110.193 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.49 111.28 1.44 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.177 1.093 . . . . 0.0 110.096 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.51 143.47 99.68 Favored 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 122.902 0.948 . . . . 0.0 110.682 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.1 m -71.68 -24.26 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.753 -0.592 . . . . 0.0 110.613 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.14 145.45 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -59.4 137.75 57.89 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.738 -0.601 . . . . 0.0 110.317 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 82.72 64.45 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.728 -0.608 . . . . 0.0 110.212 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -60.28 145.36 98.75 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 123.059 1.031 . . . . 0.0 110.411 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -68.34 142.27 94.45 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.773 -0.58 . . . . 0.0 110.096 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.08 -26.92 83.61 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.633 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.97 135.14 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.585 -0.697 . . . . 0.0 110.009 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -97.52 153.92 17.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.769 -0.582 . . . . 0.0 110.19 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.3 161.82 24.32 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.737 -0.602 . . . . 0.0 110.17 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -59.5 138.26 82.81 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.125 1.066 . . . . 0.0 110.61 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.0 t60 54.85 170.2 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.594 -0.692 . . . . 0.0 110.971 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -113.32 135.36 53.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.686 -0.634 . . . . 0.0 110.136 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.0 m -123.19 145.15 48.87 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.707 -0.62 . . . . 0.0 110.237 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -126.7 120.55 29.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.749 -0.595 . . . . 0.0 110.509 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.5 pt -125.44 159.35 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.716 -0.615 . . . . 0.0 110.38 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.4 tp -102.24 130.49 48.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.73 -0.607 . . . . 0.0 110.191 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 CA-C-O 117.924 -1.487 . . . . 0.0 109.535 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -63.4 144.75 56.7 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.749 -0.853 . . . . 0.0 110.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm -80.67 -34.94 34.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.716 -0.615 . . . . 0.0 110.038 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 4' ' ' THR . . . -126.37 78.63 0.38 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -61.1 85.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.139 1.073 . . . . 0.0 110.336 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 2' ' ' GLY . 71.2 p -94.81 9.72 38.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.67 -0.644 . . . . 0.0 111.346 178.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -78.07 145.11 36.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -73.39 -3.99 30.72 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.713 -0.617 . . . . 0.0 111.883 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -67.23 -27.61 67.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.323 -0.86 . . . . 0.0 110.163 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.631 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.645 -0.66 . . . . 0.0 111.499 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.6 mm -56.05 132.74 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 O-C-N 120.794 -1.191 . . . . 0.0 110.188 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.74 89.19 Favored Glycine 0 N--CA 1.493 2.499 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.007 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.9 p -83.8 155.27 23.08 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-N 119.171 1.486 . . . . 0.0 110.452 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.726 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.57 119.54 30.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.779 -0.576 . . . . 0.0 110.072 -175.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.34 161.09 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.727 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.76 ' HB2' HD11 ' A' ' 68' ' ' ILE . 12.4 t -129.05 140.52 51.57 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.893 ' CD1' HG23 ' A' ' 65' ' ' ILE . 22.8 mm -118.16 120.97 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.731 -173.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 110.26 22.87 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 69.1 m -96.35 166.81 11.54 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -58.96 170.01 0.92 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.506 -0.746 . . . . 0.0 109.971 -177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.74 -34.2 62.17 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.611 -0.68 . . . . 0.0 111.775 -164.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.2 t -74.72 -25.42 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.496 -0.752 . . . . 0.0 110.201 -176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.416 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 93.3 mt -90.76 -15.71 29.7 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.56 -0.713 . . . . 0.0 111.61 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.77 -154.59 48.92 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -133.36 139.92 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.514 -0.992 . . . . 0.0 110.213 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.769 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.3 p90 -131.09 156.39 45.3 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.273 174.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -137.28 148.04 46.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.733 -0.604 . . . . 0.0 109.761 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.901 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.28 169.59 42.19 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.726 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.4 mt -89.7 134.95 33.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.699 -0.883 . . . . 0.0 109.791 171.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 81.7 mt -66.86 137.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.352 0.596 . . . . 0.0 110.79 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.495 ' HB2' HG13 ' A' ' 39' ' ' VAL . 32.6 ttpt -106.76 -29.73 9.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.803 -0.56 . . . . 0.0 109.82 171.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.494 ' HA ' HD12 ' A' ' 9' ' ' ILE . 62.7 tt0 -158.57 149.19 20.15 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.673 -0.642 . . . . 0.0 109.985 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 73.0 mt -138.59 136.11 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 109.944 -178.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.9 p -146.71 158.25 43.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.819 -0.55 . . . . 0.0 109.543 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.82 -23.6 31.25 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.601 -0.687 . . . . 0.0 111.371 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.01 -26.07 18.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.545 -0.722 . . . . 0.0 111.083 -174.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -156.49 155.76 32.55 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.431 -0.793 . . . . 0.0 111.064 -172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.641 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.3 mm -114.83 139.44 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.653 -0.654 . . . . 0.0 109.498 171.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.879 HG23 HG22 ' A' ' 56' ' ' VAL . 90.2 m -126.14 130.23 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.575 -0.703 . . . . 0.0 110.361 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.901 HD12 ' HA3' ' A' ' 26' ' ' GLY . 29.4 pt -134.63 171.05 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.639 -0.663 . . . . 0.0 110.343 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.12 163.49 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.635 -0.666 . . . . 0.0 110.773 -174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 58.01 67.07 1.0 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.786 -174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.743 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.41 125.49 26.3 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.683 0.754 . . . . 0.0 111.245 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -114.01 135.98 53.41 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.868 ' HB3' HD21 ' A' ' 48' ' ' LEU . 36.0 ttp180 -134.81 141.66 46.47 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.681 -0.637 . . . . 0.0 110.161 -175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.66 41.01 31.23 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.525 -0.734 . . . . 0.0 111.131 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.11 62.12 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' ' HD2' ' A' ' 47' ' ' PRO . 75.5 t -142.15 151.72 59.48 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.357 -1.084 . . . . 0.0 109.708 174.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD2' ' CG1' ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.39 136.93 27.29 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 O-C-N 123.006 1.003 . . . . 0.0 110.418 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 43' ' ' ARG . 94.4 mt -78.21 146.65 34.83 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.612 -0.68 . . . . 0.0 110.131 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -58.55 -33.85 70.36 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.721 -0.612 . . . . 0.0 110.533 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -91.87 69.56 5.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.647 -0.658 . . . . 0.0 110.259 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -60.74 -35.13 75.6 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.61 -0.681 . . . . 0.0 110.128 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -71.8 -23.7 61.61 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.704 -0.622 . . . . 0.0 110.677 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 139.6 43.65 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.518 -0.739 . . . . 0.0 110.255 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.78 149.35 23.47 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.914 -0.491 . . . . 0.0 110.549 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.682 HG12 HD12 ' A' ' 57' ' ' LEU . 69.2 t -100.61 123.37 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.3 111.55 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.511 175.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.769 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.3 mt -128.66 137.64 51.74 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.457 -173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -74.77 143.19 44.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.789 -0.569 . . . . 0.0 110.674 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -31.89 60.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.639 -0.663 . . . . 0.0 110.991 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -63.84 -26.93 68.84 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.672 -0.643 . . . . 0.0 110.214 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.92 -24.91 22.35 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.641 -0.662 . . . . 0.0 110.192 177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 15' ' ' ILE . 83.2 mt -81.48 146.56 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.63 -0.669 . . . . 0.0 109.854 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.9 -33.2 10.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.67 -0.644 . . . . 0.0 110.194 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.0 t -163.67 130.97 3.4 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.562 -0.711 . . . . 0.0 111.004 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.893 HG23 ' CD1' ' A' ' 15' ' ' ILE . 71.2 mt -100.96 146.16 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.699 -0.625 . . . . 0.0 110.184 174.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -132.95 128.39 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 0.0 110.513 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.631 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.11 113.88 15.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.659 -0.651 . . . . 0.0 109.955 175.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.9 mt -78.56 -47.86 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.656 -0.653 . . . . 0.0 110.059 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 33.8 mt-10 -137.09 107.66 8.82 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.777 -0.577 . . . . 0.0 110.2 -176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -58.45 151.32 62.27 Favored 'Trans proline' 0 N--CA 1.489 1.223 0 O-C-N 123.166 1.088 . . . . 0.0 110.723 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.37 -28.84 68.52 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.805 -0.559 . . . . 0.0 110.242 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -130.38 155.44 46.39 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.679 -0.638 . . . . 0.0 110.385 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -98.15 121.89 40.63 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.744 -0.598 . . . . 0.0 110.223 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -83.81 -166.79 1.5 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.626 . . . . 0.0 110.465 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.3 149.53 26.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 110.108 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -78.38 119.2 21.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.65 -0.656 . . . . 0.0 110.205 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -84.09 -170.33 46.54 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -57.91 -39.55 78.22 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.624 -0.927 . . . . 0.0 110.495 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -80.26 159.78 25.76 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.805 -0.559 . . . . 0.0 110.154 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -130.1 162.59 53.04 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.705 -0.622 . . . . 0.0 110.368 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -66.99 154.77 73.57 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 O-C-N 123.224 1.118 . . . . 0.0 110.365 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -60.69 149.54 87.03 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 O-C-N 123.188 1.099 . . . . 0.0 110.357 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.73 141.96 96.42 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.183 1.096 . . . . 0.0 110.451 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.9 m -116.04 24.46 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.721 -0.612 . . . . 0.0 110.661 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -128.83 142.27 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.612 -0.68 . . . . 0.0 110.295 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -117.46 161.67 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.755 -0.591 . . . . 0.0 110.248 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt 53.86 67.66 3.4 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 121.451 -0.78 . . . . 0.0 110.797 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -59.58 145.05 99.16 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.05 1.026 . . . . 0.0 110.601 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.5 m -73.24 143.88 83.79 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.739 -0.6 . . . . 0.0 110.205 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -60.85 147.54 95.02 Favored 'Trans proline' 0 N--CA 1.486 1.085 0 O-C-N 123.077 1.041 . . . . 0.0 110.442 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 92' ' ' LYS . 13.6 p -133.08 144.65 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.685 -0.635 . . . . 0.0 110.403 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 91' ' ' VAL . 90.8 mttt 54.75 44.29 28.74 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.464 -0.773 . . . . 0.0 110.738 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.408 HD23 ' CD ' ' A' ' 94' ' ' PRO . 1.4 tt -74.24 142.42 78.66 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.727 -0.608 . . . . 0.0 110.232 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 93' ' ' LEU . 16.6 Cg_endo -62.11 151.92 78.87 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.065 1.034 . . . . 0.0 110.259 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -109.19 130.57 55.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.762 -0.586 . . . . 0.0 110.222 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -74.67 -22.88 58.64 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.748 -0.595 . . . . 0.0 110.843 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m -60.29 153.07 23.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.5 t30 53.86 43.59 30.72 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.399 -0.813 . . . . 0.0 110.926 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.79 -28.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.661 -0.649 . . . . 0.0 110.447 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' C ' HD23 ' A' ' 100' ' ' LEU . 9.2 tt -60.1 -37.01 78.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.749 -0.595 . . . . 0.0 110.313 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.478 0 CA-C-O 118.007 -1.44 . . . . 0.0 109.573 -179.922 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -32.17 72.54 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.758 -0.848 . . . . 0.0 110.159 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm -149.76 158.44 44.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.684 -0.635 . . . . 0.0 109.825 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 4' ' ' THR . . . 73.5 103.93 0.08 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.1 83.18 0.11 Allowed 'Trans proline' 0 N--CA 1.487 1.11 0 O-C-N 123.056 1.029 . . . . 0.0 110.48 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 2' ' ' GLY . 68.3 p -95.45 12.8 28.1 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.73 -0.606 . . . . 0.0 111.051 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -78.64 145.15 34.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.286 -0.884 . . . . 0.0 110.621 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -73.19 -3.96 29.94 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.667 -0.646 . . . . 0.0 111.938 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -67.51 -27.38 66.94 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.31 -0.869 . . . . 0.0 110.162 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.0 OUTLIER -77.13 -13.83 59.89 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.593 -0.692 . . . . 0.0 111.452 -177.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.6 mm -55.95 132.72 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 120.87 -1.144 . . . . 0.0 110.261 -172.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.78 -0.77 89.16 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.959 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.775 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.5 p -83.56 155.11 23.45 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-N 119.31 1.555 . . . . 0.0 110.461 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.76 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.83 121.08 32.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.765 -0.584 . . . . 0.0 110.296 -176.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.9 m -135.84 157.95 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.731 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.798 ' HB2' HD11 ' A' ' 68' ' ' ILE . 36.7 t -118.14 140.88 49.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.854 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.71 121.52 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.813 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.52 109.83 22.52 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.9 m -95.94 166.77 11.62 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -59.16 168.77 1.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.529 -0.732 . . . . 0.0 109.837 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.46 -33.57 59.87 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.492 -0.755 . . . . 0.0 111.801 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.67 -25.44 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.552 -0.718 . . . . 0.0 110.24 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.7 mt -91.01 -16.94 27.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 111.471 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.83 -151.37 51.2 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.37 141.8 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.551 -0.97 . . . . 0.0 110.094 -175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.701 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.2 p90 -134.08 158.82 42.61 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.354 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -136.5 143.5 43.8 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.49 42.1 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 -173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.86 135.97 33.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.75 -0.853 . . . . 0.0 109.935 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.921 HG21 HD11 ' A' ' 31' ' ' ILE . 85.7 mt -67.06 137.1 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.235 0.54 . . . . 0.0 110.199 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.607 ' HB2' HG13 ' A' ' 39' ' ' VAL . 34.4 tptt -108.69 -31.02 7.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.723 -0.611 . . . . 0.0 109.802 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.78 150.26 29.19 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.704 -0.622 . . . . 0.0 109.461 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.921 HD11 HG21 ' A' ' 28' ' ' ILE . 79.5 mt -138.98 137.78 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.598 -0.689 . . . . 0.0 109.852 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 89.1 p -146.44 158.53 43.9 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.49 -23.84 28.21 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.499 -0.751 . . . . 0.0 111.42 -171.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.56 -26.02 18.09 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 0.0 111.142 -174.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.54 157.49 35.47 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.42 -0.8 . . . . 0.0 111.118 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.671 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.0 mm -113.97 139.01 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.62 -0.675 . . . . 0.0 109.491 171.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.783 HG23 HG22 ' A' ' 56' ' ' VAL . 67.8 m -124.11 132.25 53.63 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.582 -0.699 . . . . 0.0 110.565 -176.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.1 pt -131.81 169.35 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.689 -0.632 . . . . 0.0 110.167 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.7 m -127.95 163.08 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.691 -0.63 . . . . 0.0 110.691 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? 52.91 45.79 28.08 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.501 -0.749 . . . . 0.0 110.635 -175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.741 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.78 141.47 53.37 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.858 0.837 . . . . 0.0 111.748 -171.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 47' ' ' PRO . 4.2 m-85 -116.31 139.93 49.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -134.78 144.06 47.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.614 -0.678 . . . . 0.0 110.158 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 52.94 41.21 32.0 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.423 -0.798 . . . . 0.0 110.962 179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.92 21.94 61.78 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 45' ' ' GLY . 71.6 t -144.88 151.99 50.74 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.41 -1.053 . . . . 0.0 109.749 173.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 42' ' ' PHE . 2.6 Cg_exo -72.78 152.02 52.22 Favored 'Trans proline' 0 N--CA 1.484 0.92 0 O-C-N 123.065 1.034 . . . . 0.0 110.264 -175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.741 HD12 ' HB3' ' A' ' 41' ' ' ALA . 62.3 mt -75.02 154.64 37.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.607 -0.683 . . . . 0.0 109.752 173.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 -54.95 -38.81 68.19 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.508 -0.745 . . . . 0.0 110.99 -174.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.727 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 79.0 tttt -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.628 -0.67 . . . . 0.0 110.137 178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.17 -35.49 80.48 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 110.102 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -84.85 2.24 43.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.782 -0.574 . . . . 0.0 111.714 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -73.3 135.95 44.47 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.152 -0.967 . . . . 0.0 110.097 -176.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.83 138.57 31.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.657 -0.652 . . . . 0.0 110.744 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 41' ' ' ALA . 88.5 t -106.07 122.57 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.673 -0.642 . . . . 0.0 109.333 175.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 37' ' ' THR . 39.7 t -123.45 113.58 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.537 177.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.701 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.8 mt -128.58 133.77 48.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.874 -0.516 . . . . 0.0 110.414 -173.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -75.01 142.77 43.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.01 -32.03 61.49 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.618 -0.676 . . . . 0.0 110.882 176.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.9 p -64.11 -27.56 69.17 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.75 -0.594 . . . . 0.0 110.02 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.93 -24.53 22.43 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.723 -0.611 . . . . 0.0 110.199 177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.5 mt -81.14 144.47 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.585 -0.697 . . . . 0.0 109.731 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -100.94 -33.05 10.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.72 -0.612 . . . . 0.0 110.242 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.8 p -160.61 155.97 24.92 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.57 -0.706 . . . . 0.0 110.746 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.854 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -140.21 148.01 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 0.0 109.768 -178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -138.81 131.19 28.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.422 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.0 113.76 15.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 173.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.798 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.5 mt -77.72 -43.53 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.64 -0.663 . . . . 0.0 109.779 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 10.4 mt-10 -137.01 92.12 14.4 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.855 -0.528 . . . . 0.0 109.838 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -60.91 146.02 98.22 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.245 1.129 . . . . 0.0 110.591 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.17 -28.99 70.43 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.795 -0.566 . . . . 0.0 110.012 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttp 55.44 46.67 22.76 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.461 -0.775 . . . . 0.0 110.827 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 54.18 60.23 3.72 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.422 -0.799 . . . . 0.0 111.037 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -55.91 -36.6 67.89 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.492 -0.755 . . . . 0.0 110.652 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.2 tp -98.23 124.08 42.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.709 -0.619 . . . . 0.0 110.084 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -90.85 117.69 29.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.755 -0.59 . . . . 0.0 110.347 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.29 169.01 38.54 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -137.18 162.83 32.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.716 -0.873 . . . . 0.0 110.206 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.0 m -120.28 135.25 55.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.664 -0.647 . . . . 0.0 110.066 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.828 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -77.03 -57.86 1.09 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.723 -0.611 . . . . 0.0 110.384 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.828 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 37.6 Cg_endo -72.04 141.12 35.84 Favored 'Trans proline' 0 N--CA 1.484 0.959 0 O-C-N 123.09 1.047 . . . . 0.0 110.4 -178.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 81' ' ' PRO . 16.6 Cg_exo -64.0 145.82 90.35 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.105 1.055 . . . . 0.0 110.092 177.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.79 85.04 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.079 1.041 . . . . 0.0 110.546 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.76 -39.71 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.679 -0.638 . . . . 0.0 109.92 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.13 -40.2 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.713 -0.617 . . . . 0.0 110.017 -177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -105.48 137.51 43.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.656 -0.652 . . . . 0.0 110.409 -177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.07 161.48 36.39 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.707 -0.62 . . . . 0.0 110.13 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.78 138.04 80.45 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.165 1.087 . . . . 0.0 110.551 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -77.07 143.97 71.06 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.788 -0.57 . . . . 0.0 110.224 178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.51 -33.25 88.04 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.163 1.086 . . . . 0.0 110.391 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 p -135.16 141.61 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.721 -0.612 . . . . 0.0 110.187 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -83.35 129.77 35.01 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.769 -0.582 . . . . 0.0 110.154 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.71 153.74 70.53 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.743 -0.598 . . . . 0.0 110.279 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.97 148.91 91.32 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.199 1.105 . . . . 0.0 110.387 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -113.72 139.52 49.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.701 -0.625 . . . . 0.0 110.237 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -134.73 162.94 30.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.76 -0.587 . . . . 0.0 110.317 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.6 m 51.98 92.52 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.369 -0.832 . . . . 0.0 111.076 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -58.51 -37.1 74.89 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.662 -0.649 . . . . 0.0 110.45 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.9 tt -123.33 138.85 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.74 -0.6 . . . . 0.0 110.198 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.5 tp -98.74 130.63 45.21 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.617 . . . . 0.0 110.219 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.602 -179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.9 -33.49 74.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.723 -0.869 . . . . 0.0 110.195 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -150.07 152.26 34.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.683 -0.635 . . . . 0.0 109.944 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.06 63.67 4.85 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 14.9 Cg_endo -61.58 153.28 67.88 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.239 1.126 . . . . 0.0 110.433 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 p -90.75 107.3 19.09 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.567 -0.708 . . . . 0.0 110.162 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -166.51 174.13 9.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.736 -0.602 . . . . 0.0 110.561 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -73.92 -3.95 32.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.656 -0.653 . . . . 0.0 111.968 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -68.01 -28.64 67.59 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.253 -0.904 . . . . 0.0 110.151 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.695 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 4.1 m95 -76.88 -13.72 59.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.598 -0.689 . . . . 0.0 111.346 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.4 mm -56.5 130.31 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.708 -1.245 . . . . 0.0 110.022 -173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.62 89.19 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.956 -177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 28' ' ' ILE . 7.1 p -81.95 155.32 25.29 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 119.189 1.494 . . . . 0.0 110.609 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -94.23 118.3 31.38 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.833 -0.542 . . . . 0.0 110.185 -174.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -135.4 155.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.207 -175.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.435 ' O ' HD13 ' A' ' 15' ' ' ILE . 28.1 t -118.23 139.18 51.68 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.859 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.9 mm -121.12 123.81 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.056 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.59 109.93 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 82.7 m -98.36 166.86 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.922 -0.486 . . . . 0.0 109.821 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -56.91 168.43 0.64 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.525 -0.735 . . . . 0.0 110.283 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.86 -34.02 62.45 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.532 -0.73 . . . . 0.0 111.737 -165.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.74 -25.46 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.466 -0.771 . . . . 0.0 110.184 -175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 85.0 mt -90.4 -19.42 23.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.688 . . . . 0.0 111.352 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.3 -147.41 50.83 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.04 140.28 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.511 -0.994 . . . . 0.0 110.034 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.718 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.2 p90 -132.37 159.25 39.78 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.273 173.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -137.47 143.75 41.92 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.44 42.03 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' ALA . 71.4 mt -89.97 134.67 34.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.738 -0.86 . . . . 0.0 110.054 174.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.883 HG21 HD11 ' A' ' 31' ' ' ILE . 84.1 mt -68.15 137.14 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.912 -0.493 . . . . 0.0 110.208 -178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HD2' HG11 ' A' ' 39' ' ' VAL . 45.2 tttp -109.16 -27.59 9.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.703 -0.623 . . . . 0.0 110.176 170.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -151.21 148.51 28.33 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.538 -0.726 . . . . 0.0 109.778 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.883 HD11 HG21 ' A' ' 28' ' ' ILE . 71.0 mt -139.95 141.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 121.426 0.631 . . . . 0.0 109.92 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.0 p -145.8 158.79 43.83 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 173.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.24 -23.95 25.26 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.589 -0.695 . . . . 0.0 111.373 -171.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -93.65 -26.12 17.2 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.471 -0.768 . . . . 0.0 111.392 -174.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 159.01 38.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.292 -0.88 . . . . 0.0 111.188 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.765 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -118.01 142.18 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.702 -0.624 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.87 HG23 HG22 ' A' ' 56' ' ' VAL . 57.5 m -125.97 131.88 52.17 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.503 -0.748 . . . . 0.0 110.496 -177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.661 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.6 170.57 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.663 -0.648 . . . . 0.0 110.351 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.538 HG11 ' HD2' ' A' ' 29' ' ' LYS . 35.9 m -130.38 163.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.68 -0.637 . . . . 0.0 110.815 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 54.86 48.02 20.99 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.48 -0.762 . . . . 0.0 110.252 -175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.77 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.01 139.08 54.97 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.828 0.823 . . . . 0.0 111.773 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.0 m-85 -115.77 141.72 47.71 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 168.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.736 ' CB ' HD21 ' A' ' 48' ' ' LEU . 59.9 ttp180 -134.83 143.64 47.15 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.631 -0.668 . . . . 0.0 110.012 -177.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.0 m120 53.07 40.59 31.46 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.344 -0.847 . . . . 0.0 111.008 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.8 22.06 61.66 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 47' ' ' PRO . 79.2 t -145.56 151.25 46.32 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.351 -1.088 . . . . 0.0 109.681 173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.7 Cg_exo -67.59 148.61 78.66 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.106 1.056 . . . . 0.0 110.234 -175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.2 mt -75.94 154.52 35.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.57 -0.706 . . . . 0.0 110.066 176.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -54.98 -38.04 67.32 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.49 -0.756 . . . . 0.0 110.93 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 55.1 mttm -99.7 104.25 15.97 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.702 -0.624 . . . . 0.0 110.136 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.23 -35.7 79.72 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.789 -0.569 . . . . 0.0 110.067 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -86.81 2.14 49.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.8 -0.563 . . . . 0.0 111.706 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.644 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.19 135.97 42.8 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.222 -0.924 . . . . 0.0 110.139 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -89.77 140.21 29.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.78 -0.575 . . . . 0.0 110.526 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG21 ' CB ' ' A' ' 41' ' ' ALA . 80.8 t -106.93 120.88 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.66 -0.65 . . . . 0.0 109.521 176.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.87 HG22 HG23 ' A' ' 37' ' ' THR . 45.5 t -123.57 114.94 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.718 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.8 mt -128.59 137.22 51.59 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.494 -173.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -74.34 147.72 41.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.44 -31.69 55.99 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.418 -0.801 . . . . 0.0 110.761 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.9 p -64.62 -36.02 82.91 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.715 -0.616 . . . . 0.0 110.993 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' HB2' HD11 ' A' ' 21' ' ' LEU . 4.5 p30 -90.98 -11.53 38.65 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.395 -0.815 . . . . 0.0 111.23 -177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.5 mt -83.66 136.99 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.349 -0.844 . . . . 0.0 109.658 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -99.17 -30.68 12.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.581 -0.699 . . . . 0.0 110.742 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.4 m -159.64 153.93 23.73 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.938 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.859 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.9 mt -139.49 144.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.742 -0.598 . . . . 0.0 109.842 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -138.61 119.91 14.76 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.765 -0.584 . . . . 0.0 110.406 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.695 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.6 mp -77.36 113.73 15.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.489 -0.757 . . . . 0.0 110.019 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 82.9 mt -73.62 -37.99 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.75 -0.594 . . . . 0.0 109.681 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.705 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 69.5 mt-10 -135.83 91.93 17.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.807 -0.558 . . . . 0.0 109.753 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -63.95 -29.59 66.91 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 O-C-N 123.295 1.155 . . . . 0.0 110.488 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 139.21 53.03 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.74 -0.6 . . . . 0.0 110.283 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -60.44 -34.16 73.58 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.05 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -140.85 164.8 29.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.805 -0.559 . . . . 0.0 110.284 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -64.18 144.13 57.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.743 -0.598 . . . . 0.0 110.16 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -90.96 141.39 28.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.79 -0.569 . . . . 0.0 110.147 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -58.96 -37.09 75.97 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.709 -0.619 . . . . 0.0 110.407 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.26 179.09 50.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -129.71 148.72 51.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.781 -0.835 . . . . 0.0 110.249 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 50.5 m -121.33 138.2 54.36 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.724 -0.61 . . . . 0.0 110.159 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -127.54 76.92 76.55 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.75 -0.594 . . . . 0.0 110.314 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.52 144.12 97.65 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.095 1.05 . . . . 0.0 110.201 178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -67.12 111.03 2.12 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.214 1.113 . . . . 0.0 110.321 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.82 139.86 76.85 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.04 1.021 . . . . 0.0 110.353 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.31 133.37 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.728 -0.608 . . . . 0.0 109.96 178.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.35 131.46 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.733 -0.604 . . . . 0.0 109.903 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -152.31 171.92 17.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.666 -0.646 . . . . 0.0 110.472 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.8 mttt 53.85 177.15 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.252 0 O-C-N 121.492 -0.755 . . . . 0.0 110.933 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.48 152.84 58.63 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 O-C-N 123.015 1.008 . . . . 0.0 110.553 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 16.2 p -68.31 143.06 95.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.702 -0.624 . . . . 0.0 110.151 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.19 -25.07 80.26 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 O-C-N 123.099 1.052 . . . . 0.0 110.772 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.64 134.27 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.561 -0.712 . . . . 0.0 110.043 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -101.54 153.69 19.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.699 -0.626 . . . . 0.0 110.24 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.8 pp -66.61 155.65 88.4 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.771 -0.581 . . . . 0.0 110.197 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -60.22 134.44 55.77 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.17 1.089 . . . . 0.0 110.521 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -59.46 -38.79 81.68 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.609 -0.682 . . . . 0.0 110.448 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -101.22 131.25 47.31 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.69 -0.632 . . . . 0.0 110.5 -177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.3 m -121.73 148.73 44.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.79 -0.569 . . . . 0.0 110.003 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -97.93 108.65 21.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.675 -0.64 . . . . 0.0 110.215 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.0 pt -68.5 -22.33 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.718 -0.614 . . . . 0.0 110.756 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.37 143.34 29.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.51 -0.744 . . . . 0.0 110.152 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.526 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.526 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.13 -33.45 74.5 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.743 -0.857 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt -80.74 -34.33 34.47 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.769 -0.582 . . . . 0.0 110.021 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.62 112.16 4.11 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.16 135.09 66.12 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 122.906 0.95 . . . . 0.0 110.815 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -98.1 109.15 21.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.652 -0.655 . . . . 0.0 110.312 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -167.01 166.02 15.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.681 -0.637 . . . . 0.0 110.703 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -72.47 -6.26 42.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.665 -0.647 . . . . 0.0 111.7 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -68.1 -28.2 67.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.309 -0.87 . . . . 0.0 110.1 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.2 m95 -76.9 -13.84 59.94 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.723 -0.611 . . . . 0.0 111.351 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.3 mm -56.53 129.46 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.73 -1.231 . . . . 0.0 109.995 -172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.66 89.19 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.895 -176.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.0 p -82.51 155.22 24.67 Favored 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 119.234 1.517 . . . . 0.0 110.451 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.665 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.15 120.45 32.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.71 -0.619 . . . . 0.0 110.387 -175.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.18 157.15 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.575 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' HD11 ' A' ' 68' ' ' ILE . 21.3 t -120.0 141.28 49.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.829 -0.544 . . . . 0.0 109.585 174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.852 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.3 mm -123.97 123.44 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.946 -173.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.79 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 67.2 m -97.38 166.77 11.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.891 -0.506 . . . . 0.0 109.664 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 p30 -59.89 175.08 0.41 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.592 -0.693 . . . . 0.0 110.14 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.43 -36.46 66.51 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.594 -0.691 . . . . 0.0 111.692 -165.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.7 t -75.04 -25.46 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.497 -0.752 . . . . 0.0 110.419 -174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 89.3 mt -90.62 -17.84 26.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.573 -0.705 . . . . 0.0 111.575 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.81 -148.67 50.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.52 141.77 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.511 -0.994 . . . . 0.0 110.007 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.696 ' CE2' HD13 ' A' ' 57' ' ' LEU . 44.4 p90 -134.34 158.94 42.52 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.349 172.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -137.58 144.59 42.1 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.17 169.47 42.07 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -173.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.665 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.2 mt -89.9 135.98 33.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.846 -0.796 . . . . 0.0 109.928 174.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.878 HG21 HD11 ' A' ' 31' ' ' ILE . 85.3 mt -67.09 137.17 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.222 0.534 . . . . 0.0 110.441 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HB2' HG13 ' A' ' 39' ' ' VAL . 27.5 tptt -109.06 -29.93 8.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.748 -0.595 . . . . 0.0 109.929 171.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -151.82 151.24 31.07 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.687 -0.633 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.878 HD11 HG21 ' A' ' 28' ' ' ILE . 65.5 mt -140.38 139.09 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.56 -0.712 . . . . 0.0 109.999 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.5 p -146.71 158.2 43.86 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.95 32.81 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.548 -0.72 . . . . 0.0 111.328 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.44 -26.04 18.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.493 -0.754 . . . . 0.0 111.174 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -156.4 158.35 37.19 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.439 -0.788 . . . . 0.0 111.064 -171.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.4 mm -113.88 140.36 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.791 -0.568 . . . . 0.0 109.518 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.865 HG23 HG22 ' A' ' 56' ' ' VAL . 55.7 m -123.03 131.25 53.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.566 -0.709 . . . . 0.0 110.471 -177.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.2 pt -131.62 169.26 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.702 -0.624 . . . . 0.0 110.23 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.02 163.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.709 -0.619 . . . . 0.0 110.633 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.4 mtt-85 51.12 50.22 19.51 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.414 -0.804 . . . . 0.0 110.921 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -67.94 141.44 56.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.97 0.89 . . . . 0.0 111.688 -171.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -113.75 137.81 51.11 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.75 141.92 46.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.634 -0.666 . . . . 0.0 110.177 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.3 m120 52.67 41.06 31.28 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.516 -0.74 . . . . 0.0 111.112 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.03 61.85 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 69.6 t -143.48 151.79 55.2 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.429 -1.042 . . . . 0.0 109.68 174.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.3 Cg_exo -73.97 148.94 41.12 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 O-C-N 123.083 1.044 . . . . 0.0 110.145 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.5 mt -76.87 148.02 36.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.559 -0.713 . . . . 0.0 109.871 173.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -57.55 -36.24 71.38 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.654 -0.654 . . . . 0.0 110.697 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 49.9 tptt -98.04 105.46 17.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.634 -0.667 . . . . 0.0 110.221 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -63.98 -34.95 79.15 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.738 -0.601 . . . . 0.0 110.124 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.4 2.2 45.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.795 -0.566 . . . . 0.0 111.613 -177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.571 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.01 135.9 43.13 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.141 -0.974 . . . . 0.0 110.031 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -91.49 138.08 31.85 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.79 -0.569 . . . . 0.0 110.75 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG21 ' CB ' ' A' ' 41' ' ' ALA . 66.1 t -106.84 121.33 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 37' ' ' THR . 45.1 t -123.42 113.67 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.456 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.696 HD13 ' CE2' ' A' ' 24' ' ' PHE . 7.4 mt -128.63 134.63 48.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.846 -0.534 . . . . 0.0 110.443 -173.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -74.86 139.29 43.08 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.768 -0.582 . . . . 0.0 110.688 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HA ' HD12 ' A' ' 62' ' ' ILE . 26.3 p -55.44 -32.05 62.43 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.63 -0.669 . . . . 0.0 110.886 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.2 p -64.39 -27.31 68.92 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.674 -0.641 . . . . 0.0 110.091 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -89.19 -22.69 22.66 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.738 -0.601 . . . . 0.0 110.214 176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 59' ' ' CYS . 84.4 mt -80.69 144.73 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.606 -0.683 . . . . 0.0 109.732 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -100.38 -28.91 12.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.719 -0.613 . . . . 0.0 110.444 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -161.11 151.11 17.35 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.561 -0.712 . . . . 0.0 110.771 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.852 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.6 mt -139.07 147.82 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.583 -0.698 . . . . 0.0 109.868 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -139.23 129.0 24.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.777 -0.577 . . . . 0.0 110.453 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.7 OUTLIER -76.47 113.72 14.38 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.56 -0.712 . . . . 0.0 109.724 173.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.603 HD11 ' HB2' ' A' ' 14' ' ' SER . 79.0 mt -74.7 -50.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.677 -0.639 . . . . 0.0 109.886 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 20.4 mt-10 -137.18 99.44 9.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.896 -0.502 . . . . 0.0 109.993 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -65.61 132.16 30.05 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 O-C-N 123.309 1.163 . . . . 0.0 110.266 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.78 72.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.729 -0.607 . . . . 0.0 110.145 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.1 tttp -142.51 124.89 15.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.782 -0.574 . . . . 0.0 110.186 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -130.26 93.29 3.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.639 -0.663 . . . . 0.0 110.229 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -62.31 -39.73 93.96 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.707 -0.62 . . . . 0.0 110.29 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.8 tp -108.23 129.38 55.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.721 -0.612 . . . . 0.0 110.276 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -61.37 -35.93 78.85 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.75 -0.594 . . . . 0.0 110.541 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.48 179.76 46.2 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -60.17 -41.29 92.56 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.74 -0.859 . . . . 0.0 110.278 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 78.7 p -122.8 162.35 22.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.772 -0.58 . . . . 0.0 110.293 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -73.99 159.09 84.9 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.733 -0.604 . . . . 0.0 110.22 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.29 156.43 59.84 Favored 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.199 1.105 . . . . 0.0 110.452 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.405 ' CB ' ' CD ' ' A' ' 83' ' ' PRO . 1.4 Cg_endo -49.94 -58.52 1.66 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 O-C-N 123.129 1.068 . . . . 0.0 111.908 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 82' ' ' PRO . 12.2 Cg_endo -60.41 148.82 89.21 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 122.975 0.987 . . . . 0.0 110.495 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.39 145.16 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.706 -0.621 . . . . 0.0 110.318 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.97 137.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.679 -0.638 . . . . 0.0 109.898 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -81.12 131.7 35.32 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.687 -0.633 . . . . 0.0 110.318 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.0 tttm 53.26 57.71 14.06 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.429 -0.794 . . . . 0.0 110.84 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.3 146.03 85.02 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 O-C-N 123.039 1.021 . . . . 0.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.9 t -68.3 150.36 97.74 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.706 -0.621 . . . . 0.0 110.073 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.04 -35.14 93.93 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.065 1.034 . . . . 0.0 110.492 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.4 t -128.04 131.09 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.677 -0.639 . . . . 0.0 109.834 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.542 ' HG2' HD12 ' A' ' 93' ' ' LEU . 29.7 tttt -96.78 -64.84 1.01 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.729 -0.607 . . . . 0.0 110.262 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -100.12 163.15 18.87 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.677 -0.639 . . . . 0.0 110.183 -178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -58.86 148.49 83.76 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.126 1.066 . . . . 0.0 110.631 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -113.67 171.14 7.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -114.74 149.07 37.45 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.722 -0.611 . . . . 0.0 110.235 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.9 m -59.05 -35.13 72.82 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.75 -0.594 . . . . 0.0 110.418 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 54.66 44.98 27.77 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.441 -0.787 . . . . 0.0 110.711 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.5 tt -59.44 -28.1 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.751 -0.593 . . . . 0.0 110.542 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.2 -34.68 76.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.775 -0.578 . . . . 0.0 110.171 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.535 179.973 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.91 -32.3 72.68 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.71 -0.876 . . . . 0.0 110.12 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.3 mtm -149.83 154.08 37.81 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.703 -0.623 . . . . 0.0 109.825 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -127.39 77.52 0.39 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.85 133.33 44.16 Favored 'Trans proline' 0 N--CA 1.486 1.053 0 O-C-N 123.118 1.062 . . . . 0.0 110.145 177.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.434 ' HA ' HG22 ' A' ' 31' ' ' ILE . 55.8 p -146.84 16.96 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.673 -0.642 . . . . 0.0 111.077 178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.46 141.67 35.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.371 -0.83 . . . . 0.0 110.262 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -66.73 -13.85 61.84 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.63 -0.669 . . . . 0.0 111.193 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.71 -26.59 67.09 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.582 -0.699 . . . . 0.0 110.13 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.708 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 0.7 OUTLIER -76.41 -13.88 60.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.604 -0.685 . . . . 0.0 111.275 -178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 30' ' ' GLN . 48.4 mm -57.19 131.93 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.708 -1.245 . . . . 0.0 109.976 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.73 -0.76 89.17 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.053 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.773 ' SG ' HD12 ' A' ' 28' ' ' ILE . 9.0 p -82.66 155.27 24.46 Favored 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 119.165 1.482 . . . . 0.0 110.399 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.31 120.29 31.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.799 -0.563 . . . . 0.0 110.218 -175.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -135.92 160.41 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.685 -0.635 . . . . 0.0 110.658 -178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.779 ' HB2' HD11 ' A' ' 68' ' ' ILE . 25.9 t -125.22 141.48 52.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.841 -0.537 . . . . 0.0 109.562 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.85 ' CD1' HG23 ' A' ' 65' ' ' ILE . 27.3 mm -122.44 122.89 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.994 -173.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.33 109.87 22.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 63.4 m -97.33 166.84 11.35 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -57.15 167.33 0.9 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.472 -0.767 . . . . 0.0 110.228 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -54.77 -33.93 61.96 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.588 -0.695 . . . . 0.0 111.673 -165.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.36 -25.39 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.486 -0.759 . . . . 0.0 110.118 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.5 mt -90.56 -17.09 27.6 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 111.398 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 -153.01 49.87 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 51.8 t -131.64 138.42 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.524 -0.986 . . . . 0.0 109.894 -176.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.741 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.6 p90 -130.43 158.44 39.88 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.351 174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.07 146.7 47.34 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.25 169.5 42.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.5 mt -89.78 135.87 33.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.843 . . . . 0.0 110.071 172.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.871 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -67.38 137.2 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-O 121.302 0.572 . . . . 0.0 110.488 -176.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.579 ' HB2' HG13 ' A' ' 39' ' ' VAL . 33.9 tttt -106.72 -27.61 10.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.682 -0.636 . . . . 0.0 110.11 171.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 9' ' ' ILE . 51.0 tt0 -158.55 150.46 21.34 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.725 -0.609 . . . . 0.0 109.832 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -138.99 137.92 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.607 -0.683 . . . . 0.0 110.013 -177.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.1 p -146.57 158.01 43.83 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.78 -23.77 31.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.567 -0.708 . . . . 0.0 111.323 -170.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -92.15 -26.02 18.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.449 -0.782 . . . . 0.0 111.148 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -156.45 158.42 37.24 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.349 -0.844 . . . . 0.0 111.132 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 31' ' ' ILE . 49.7 mm -113.95 139.49 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.651 -0.656 . . . . 0.0 109.438 172.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.746 HG23 HG22 ' A' ' 56' ' ' VAL . 56.6 m -122.16 130.55 53.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.567 -0.708 . . . . 0.0 110.471 -177.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -133.55 171.69 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.732 -0.605 . . . . 0.0 110.424 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.8 m -126.9 163.48 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.752 -0.593 . . . . 0.0 110.624 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 52.57 67.15 1.03 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.451 -0.781 . . . . 0.0 110.889 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.794 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.3 126.49 29.75 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.363 0.602 . . . . 0.0 111.453 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.66 132.55 56.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.625 -0.672 . . . . 0.0 109.258 166.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.821 ' HB3' HD21 ' A' ' 48' ' ' LEU . 68.0 ttt180 -134.86 143.64 47.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.673 -0.642 . . . . 0.0 110.07 -175.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.6 m120 52.43 39.45 27.67 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.429 -0.794 . . . . 0.0 111.117 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.92 22.13 62.01 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 73.7 t -142.56 151.84 58.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.339 -1.095 . . . . 0.0 109.779 174.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 6.9 Cg_exo -70.99 135.69 28.08 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 O-C-N 123.058 1.031 . . . . 0.0 110.472 -175.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 43' ' ' ARG . 96.5 mt -78.26 149.1 33.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.646 -0.659 . . . . 0.0 110.462 176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -62.79 154.03 31.08 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.759 -0.588 . . . . 0.0 109.439 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 56.28 59.25 3.76 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.443 -0.785 . . . . 0.0 110.248 -176.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -56.55 -27.64 58.13 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.665 -0.647 . . . . 0.0 110.657 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -71.7 -12.76 61.48 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.695 -0.628 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.86 141.19 46.12 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.162 -0.961 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.96 144.68 26.41 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.77 -0.582 . . . . 0.0 110.657 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.639 HG12 HD12 ' A' ' 57' ' ' LEU . 67.8 t -102.56 125.22 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.746 HG22 HG23 ' A' ' 37' ' ' THR . 36.6 t -123.48 112.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.482 176.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.741 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.9 mt -128.61 134.57 48.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.913 -0.492 . . . . 0.0 110.296 -173.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -74.82 141.88 44.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.827 -0.546 . . . . 0.0 110.674 -175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.0 -31.94 61.41 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.62 -0.675 . . . . 0.0 110.889 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.3 p -63.94 -26.71 68.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.777 -0.577 . . . . 0.0 110.182 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -88.47 -26.57 22.01 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.772 -0.58 . . . . 0.0 109.919 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.427 HG21 HG23 ' A' ' 15' ' ' ILE . 83.6 mt -82.22 139.43 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.66 -0.65 . . . . 0.0 109.743 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -104.14 -16.48 15.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.691 -0.631 . . . . 0.0 111.165 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.2 t -160.48 147.82 15.96 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.304 -0.872 . . . . 0.0 110.887 176.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.85 HG23 ' CD1' ' A' ' 15' ' ' ILE . 67.2 mt -139.69 145.43 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.721 -0.612 . . . . 0.0 109.672 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -138.28 132.31 31.48 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.867 -0.52 . . . . 0.0 110.621 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.53 113.83 15.75 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.628 -0.67 . . . . 0.0 109.689 172.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.779 HD11 ' HB2' ' A' ' 14' ' ' SER . 82.2 mt -76.98 -46.63 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 36.3 mt-10 -137.09 98.38 10.41 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.819 -0.551 . . . . 0.0 110.09 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -64.15 138.45 61.7 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 O-C-N 123.286 1.15 . . . . 0.0 110.464 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.28 -14.0 60.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.637 -0.664 . . . . 0.0 111.319 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.82 -34.71 69.95 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.178 -0.951 . . . . 0.0 110.879 -175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.34 -51.27 70.64 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.58 -35.07 70.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 110.656 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.13 -36.98 83.43 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.642 -0.661 . . . . 0.0 110.466 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.94 -174.01 3.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.624 . . . . 0.0 110.48 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.42 30.14 19.95 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -111.58 128.94 56.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.667 -0.902 . . . . 0.0 110.181 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 76.6 p -128.64 159.08 36.71 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.737 -0.602 . . . . 0.0 110.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -79.28 -48.85 1.5 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.706 -0.621 . . . . 0.0 110.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 23.8 Cg_exo -59.7 167.86 6.23 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 122.981 0.99 . . . . 0.0 110.459 178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -62.08 160.25 30.98 Favored 'Trans proline' 0 N--CA 1.486 1.051 0 O-C-N 123.25 1.132 . . . . 0.0 110.3 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.78 154.64 48.23 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.111 1.058 . . . . 0.0 110.585 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.0 t -59.67 -39.64 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.669 -0.645 . . . . 0.0 109.916 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m -127.0 144.81 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.745 -0.597 . . . . 0.0 110.267 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -155.38 -176.33 5.89 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.767 -0.583 . . . . 0.0 110.445 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -66.12 163.84 34.55 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.739 -0.601 . . . . 0.0 110.001 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.92 145.1 92.62 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.047 1.025 . . . . 0.0 110.759 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.4 p -122.97 100.53 39.97 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.749 -0.595 . . . . 0.0 110.158 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.5 -25.95 76.19 Favored 'Trans proline' 0 N--CA 1.489 1.237 0 O-C-N 123.17 1.089 . . . . 0.0 110.807 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.44 141.68 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.724 -0.61 . . . . 0.0 110.371 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -101.54 141.97 33.61 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.736 -0.602 . . . . 0.0 110.139 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.57 142.1 70.13 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.735 -0.603 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 146.86 95.22 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.149 1.079 . . . . 0.0 110.287 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -122.07 131.16 53.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.684 -0.635 . . . . 0.0 110.177 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -61.14 -42.96 99.5 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.777 -0.577 . . . . 0.0 110.238 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 96.1 p -131.23 157.79 42.3 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.754 -0.591 . . . . 0.0 110.242 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -58.21 -34.26 70.21 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.73 -0.606 . . . . 0.0 110.53 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.6 mt -115.56 131.22 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.667 -0.646 . . . . 0.0 109.825 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.5 mm? -61.4 -38.84 88.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.677 -0.639 . . . . 0.0 110.241 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.182 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.17 -33.46 74.55 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.861 -0.788 . . . . 0.0 110.219 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mtp -81.25 -39.64 24.99 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.772 -0.58 . . . . 0.0 110.126 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.15 150.82 20.91 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 26.7 Cg_endo -67.5 85.4 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.168 1.088 . . . . 0.0 110.331 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.8 p -94.77 8.01 43.96 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.617 -0.677 . . . . 0.0 111.428 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -78.3 141.14 38.71 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.247 -0.908 . . . . 0.0 110.414 -177.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -72.43 -4.49 30.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.707 -0.621 . . . . 0.0 111.881 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -68.26 -25.43 65.16 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.848 . . . . 0.0 110.122 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.644 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 2.0 m95 -76.13 -13.82 60.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.638 -0.664 . . . . 0.0 111.388 -178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mm -55.79 131.03 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.878 -1.139 . . . . 0.0 110.102 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.67 -0.72 89.19 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.947 -176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.753 ' SG ' HD12 ' A' ' 28' ' ' ILE . 5.1 p -83.68 155.17 23.28 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.208 1.504 . . . . 0.0 110.324 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -90.68 120.06 31.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.636 . . . . 0.0 110.335 -175.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.74 160.3 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.674 -178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.851 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.2 t -125.01 139.33 53.91 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.825 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.3 mm -119.48 121.27 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.74 -175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.74 111.38 23.71 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.415 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.5 m -95.22 166.79 11.73 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.77 168.29 1.28 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.5 -0.75 . . . . 0.0 109.943 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.68 -33.98 61.65 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.544 -0.723 . . . . 0.0 111.795 -164.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -74.51 -25.43 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.508 -0.745 . . . . 0.0 110.225 -176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.41 -14.66 32.48 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.526 -0.734 . . . . 0.0 111.591 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.08 -157.03 47.04 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -133.14 141.55 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.496 -1.002 . . . . 0.0 110.04 -175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.787 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.9 p90 -131.13 155.85 46.29 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.184 174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -137.49 147.94 45.64 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.79 -0.569 . . . . 0.0 109.534 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.863 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.29 169.54 42.13 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -176.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.5 mt -89.72 134.73 34.01 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.696 -0.884 . . . . 0.0 109.714 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.91 HG21 HD11 ' A' ' 31' ' ' ILE . 84.6 mt -65.36 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.449 0.642 . . . . 0.0 110.596 -174.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.605 ' HB2' HG13 ' A' ' 39' ' ' VAL . 19.1 tptp -109.95 -27.24 9.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.889 -0.507 . . . . 0.0 109.89 173.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -159.05 149.05 19.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.559 -0.713 . . . . 0.0 109.923 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 28' ' ' ILE . 70.6 mt -138.59 137.33 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.628 -0.67 . . . . 0.0 109.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.8 p -146.34 158.14 43.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.81 -0.556 . . . . 0.0 109.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.8 -23.71 31.68 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.554 -0.717 . . . . 0.0 111.322 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.42 -26.13 18.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.456 -0.778 . . . . 0.0 111.144 -173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -156.49 158.48 37.3 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.459 -0.775 . . . . 0.0 111.072 -172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.7 mm -115.22 139.31 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.64 -0.662 . . . . 0.0 109.518 172.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.867 HG23 HG22 ' A' ' 56' ' ' VAL . 91.7 m -126.02 131.4 52.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.528 -0.732 . . . . 0.0 110.466 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.863 HD12 ' HA3' ' A' ' 26' ' ' GLY . 32.8 pt -134.11 169.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.698 -0.626 . . . . 0.0 110.216 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -123.95 163.51 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.601 -0.687 . . . . 0.0 110.692 -175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 59.22 66.84 0.98 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.614 -0.679 . . . . 0.0 109.569 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.26 124.8 24.46 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.613 0.72 . . . . 0.0 111.508 -172.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -114.04 132.06 56.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.486 -0.759 . . . . 0.0 109.162 167.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.807 ' HB3' HD21 ' A' ' 48' ' ' LEU . 42.2 ttm180 -134.92 143.16 46.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.626 -0.671 . . . . 0.0 110.194 -175.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.5 m120 53.08 40.19 30.8 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.375 -0.828 . . . . 0.0 111.08 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 22.13 61.86 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 47' ' ' PRO . 69.7 t -143.2 151.81 56.23 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.335 -1.097 . . . . 0.0 109.731 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' HG13 ' A' ' 46' ' ' VAL . 2.8 Cg_exo -72.13 138.67 31.15 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.087 1.046 . . . . 0.0 110.236 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 43' ' ' ARG . 93.8 mt -78.08 147.35 34.75 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.0 110.067 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -56.39 -37.8 70.62 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.612 -0.68 . . . . 0.0 110.819 -174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.1 mttm -96.0 80.02 3.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.713 -0.617 . . . . 0.0 110.252 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.38 -32.4 72.32 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.775 -0.578 . . . . 0.0 110.139 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -71.61 -21.51 61.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.737 -0.602 . . . . 0.0 110.887 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.78 137.53 43.96 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.427 -0.795 . . . . 0.0 110.192 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -89.1 149.56 23.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.807 -0.558 . . . . 0.0 110.645 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 57' ' ' LEU . 78.3 t -100.99 122.68 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 37' ' ' THR . 38.2 t -123.27 111.84 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.479 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.787 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.6 137.87 51.91 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.474 -172.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -74.69 142.19 44.47 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.18 0.514 . . . . 0.0 110.558 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.87 -31.95 60.25 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.665 -0.647 . . . . 0.0 111.009 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -64.3 -26.83 68.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.699 -0.626 . . . . 0.0 110.359 -177.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -89.2 -22.21 22.89 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.591 -0.693 . . . . 0.0 110.555 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.3 mt -80.91 143.75 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.516 -0.74 . . . . 0.0 109.978 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.37 -32.98 10.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.668 -0.645 . . . . 0.0 110.177 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.2 t -160.11 152.5 20.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 0.0 110.473 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.825 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.7 mt -138.71 146.1 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.665 -0.647 . . . . 0.0 109.807 -178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -138.19 133.81 33.74 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.572 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.644 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.0 OUTLIER -77.86 113.82 16.12 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.591 -0.693 . . . . 0.0 109.596 171.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.851 HD11 ' HB2' ' A' ' 14' ' ' SER . 86.0 mt -76.65 -46.13 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.587 -0.696 . . . . 0.0 109.91 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.701 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 37.7 mt-10 -137.17 102.37 9.04 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.815 -0.553 . . . . 0.0 110.051 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -61.32 -34.41 87.57 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.292 1.153 . . . . 0.0 110.352 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 58.12 -84.37 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.579 -0.701 . . . . 0.0 111.111 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.92 -34.61 68.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.309 -0.869 . . . . 0.0 110.919 -174.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.12 119.65 27.57 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.607 -0.683 . . . . 0.0 110.384 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -162.61 170.3 18.75 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.291 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 tp -101.05 120.23 39.9 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.715 -0.616 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -66.61 -45.62 78.57 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.734 -0.604 . . . . 0.0 110.489 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.19 -175.56 28.94 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -120.95 118.69 30.52 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.769 -0.842 . . . . 0.0 110.132 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.2 t -145.75 155.0 42.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.652 -0.655 . . . . 0.0 110.091 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.678 ' HB1' ' HD2' ' A' ' 81' ' ' PRO . . . 51.95 -174.5 0.01 OUTLIER Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.338 -0.852 . . . . 0.0 110.756 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 80' ' ' ALA . 24.3 Cg_exo -59.72 137.8 79.22 Favored 'Trans proline' 0 N--CA 1.487 1.141 0 O-C-N 123.035 1.018 . . . . 0.0 110.314 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 152.41 76.53 Favored 'Trans proline' 0 N--CA 1.485 1.019 0 O-C-N 123.096 1.051 . . . . 0.0 110.379 -177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.9 143.95 99.46 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 O-C-N 123.151 1.08 . . . . 0.0 110.351 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.32 159.48 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.744 -0.598 . . . . 0.0 110.329 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.31 162.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.772 -0.58 . . . . 0.0 110.161 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -79.15 117.26 20.02 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.741 -0.599 . . . . 0.0 110.188 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -126.49 170.11 10.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.705 -0.622 . . . . 0.0 110.292 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -58.51 147.9 83.87 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.082 1.043 . . . . 0.0 110.633 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 m -68.31 141.55 93.75 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.775 -0.578 . . . . 0.0 110.213 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.32 -28.51 86.96 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.101 1.053 . . . . 0.0 110.509 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.1 p -132.09 145.82 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.768 -0.582 . . . . 0.0 110.161 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 54.5 mttt -81.61 138.15 35.39 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.729 -0.607 . . . . 0.0 110.059 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.88 160.86 26.74 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.736 -0.603 . . . . 0.0 110.271 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -61.42 154.04 61.79 Favored 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.138 1.073 . . . . 0.0 110.455 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -116.66 177.28 4.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.76 -0.587 . . . . 0.0 110.041 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -59.13 -30.54 68.21 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.694 -0.628 . . . . 0.0 110.361 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -62.71 -27.3 69.16 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.825 -0.547 . . . . 0.0 110.288 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -80.65 137.3 36.33 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.671 -0.643 . . . . 0.0 110.202 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 94.7 mt -61.14 -36.48 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.769 -0.582 . . . . 0.0 109.794 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.4 mt -94.83 141.52 28.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.718 -0.614 . . . . 0.0 110.167 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.54 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.498 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.08 73.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.669 -0.9 . . . . 0.0 110.165 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp -87.84 134.34 33.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.698 -0.626 . . . . 0.0 110.226 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.62 161.53 24.27 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -69.95 68.01 1.82 Allowed 'Trans proline' 0 N--CA 1.485 1.017 0 O-C-N 123.2 1.105 . . . . 0.0 110.345 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -94.3 14.0 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.642 -0.661 . . . . 0.0 111.202 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -78.76 145.68 34.27 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.344 -0.848 . . . . 0.0 110.611 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -73.15 -3.91 29.51 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.689 -0.632 . . . . 0.0 111.983 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -67.49 -25.35 65.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 0.0 110.355 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.68 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -77.42 -13.8 59.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.556 -0.715 . . . . 0.0 111.605 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.0 mm -55.69 133.87 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 120.899 -1.126 . . . . 0.0 110.283 -172.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.6 -0.68 89.21 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.958 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 71' ' ' ALA . 8.6 p -84.18 155.16 22.68 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 119.247 1.523 . . . . 0.0 110.597 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.715 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -91.97 120.4 32.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.765 -0.584 . . . . 0.0 110.205 -175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -135.14 156.63 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 120.219 -0.593 . . . . 0.0 110.686 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.486 ' O ' HD13 ' A' ' 15' ' ' ILE . 40.7 t -117.2 140.02 50.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.833 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.8 mm -123.54 120.87 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.846 -173.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.39 109.93 22.6 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.7 m -96.16 166.77 11.58 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.546 . . . . 0.0 109.552 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -59.3 170.76 0.89 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.517 -0.74 . . . . 0.0 109.985 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -54.71 -34.21 62.1 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.587 -0.696 . . . . 0.0 111.816 -165.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.6 t -74.83 -25.49 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.512 -0.743 . . . . 0.0 110.337 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 71.9 mt -90.83 -17.58 26.31 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.602 -0.686 . . . . 0.0 111.496 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.85 -152.39 50.72 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.6 t -131.17 140.02 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.482 -1.011 . . . . 0.0 110.118 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.723 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.3 p90 -132.48 159.07 40.42 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.34 173.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -136.91 144.32 43.41 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.21 169.45 42.03 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.81 135.64 33.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.759 -0.848 . . . . 0.0 109.871 173.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 31' ' ' ILE . 85.2 mt -66.63 137.08 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 CA-C-O 121.156 0.503 . . . . 0.0 110.052 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB2' HG13 ' A' ' 39' ' ' VAL . 26.0 tptp -107.8 -31.19 8.14 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.752 -0.593 . . . . 0.0 109.793 173.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' HA ' HD12 ' A' ' 9' ' ' ILE . 88.9 mt-30 -152.96 150.71 29.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.74 -0.6 . . . . 0.0 109.543 178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 28' ' ' ILE . 79.1 mt -139.1 138.54 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.619 -0.676 . . . . 0.0 109.887 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.5 p -146.41 158.75 43.93 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.4 -23.9 27.19 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.622 -0.673 . . . . 0.0 111.399 -171.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.91 -26.05 17.78 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.539 -0.725 . . . . 0.0 111.25 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -156.4 155.34 31.97 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.408 -0.808 . . . . 0.0 111.163 -171.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.9 139.65 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.664 -0.647 . . . . 0.0 109.61 171.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.805 HG23 HG22 ' A' ' 56' ' ' VAL . 67.5 m -125.97 133.47 51.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.527 -0.733 . . . . 0.0 110.513 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.3 169.67 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.685 -0.634 . . . . 0.0 110.452 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.6 m -130.45 163.45 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.781 -0.574 . . . . 0.0 110.383 -176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 56.96 54.62 6.85 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.568 -0.707 . . . . 0.0 109.92 -174.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.24 135.41 50.49 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.949 0.881 . . . . 0.0 111.985 -170.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 4.2 m-85 -117.23 141.37 48.38 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 167.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.787 ' HB3' HD21 ' A' ' 48' ' ' LEU . 66.1 ttt180 -134.75 144.42 47.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.546 -0.721 . . . . 0.0 110.054 -177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.0 m120 52.91 40.5 31.02 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.391 -0.818 . . . . 0.0 111.004 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.05 61.8 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 47' ' ' PRO . 73.3 t -144.78 151.51 49.87 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.405 -1.056 . . . . 0.0 109.745 173.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD2' HG13 ' A' ' 46' ' ' VAL . 7.7 Cg_exo -69.59 145.72 58.99 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 O-C-N 123.043 1.023 . . . . 0.0 110.288 -175.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD21 ' HB3' ' A' ' 43' ' ' ARG . 90.7 mt -78.03 151.84 33.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.621 -0.674 . . . . 0.0 110.067 175.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -56.97 -34.88 68.52 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.62 -0.675 . . . . 0.0 110.512 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 56.2 mtmt -96.74 88.94 4.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.781 -0.574 . . . . 0.0 109.919 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -60.87 -36.29 78.8 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.795 -0.566 . . . . 0.0 110.219 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -85.44 2.15 45.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.705 -0.622 . . . . 0.0 111.612 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.63 135.98 41.97 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.203 -0.935 . . . . 0.0 110.15 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -89.09 140.89 28.99 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.723 -0.611 . . . . 0.0 110.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG12 HD12 ' A' ' 57' ' ' LEU . 92.8 t -106.51 124.82 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.673 -0.642 . . . . 0.0 109.552 176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.805 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.52 113.36 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.511 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.723 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.57 135.2 49.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.941 -0.475 . . . . 0.0 110.467 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.99 141.48 43.97 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.761 -0.587 . . . . 0.0 110.581 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.91 -32.06 60.75 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.647 -0.658 . . . . 0.0 110.939 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.7 p -65.01 -26.17 68.17 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.695 -0.628 . . . . 0.0 110.248 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -88.84 -23.63 22.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.653 -0.654 . . . . 0.0 110.262 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.0 mt -81.02 144.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -100.92 -32.99 10.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.693 -0.629 . . . . 0.0 110.3 -178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.7 t -160.11 150.71 18.75 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.635 -0.665 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.833 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.8 mt -139.13 148.38 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -177.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -137.35 128.64 28.0 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.729 -0.607 . . . . 0.0 110.407 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -76.43 113.93 14.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.727 -0.608 . . . . 0.0 109.946 175.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 69' ' ' GLU . 80.9 mt -74.97 -56.13 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.745 -0.597 . . . . 0.0 110.152 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.774 ' HG3' HG22 ' A' ' 68' ' ' ILE . 23.9 mt-10 -137.21 144.21 44.89 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.662 -0.649 . . . . 0.0 110.656 -175.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.46 150.11 82.81 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.278 1.146 . . . . 0.0 110.543 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.882 ' HB2' ' HB3' ' A' ' 11' ' ' CYS . . . -72.39 142.05 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.717 -0.615 . . . . 0.0 110.443 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -93.18 143.05 26.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.731 -0.606 . . . . 0.0 109.942 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -56.21 139.46 47.69 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.57 -0.706 . . . . 0.0 110.756 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.683 -0.636 . . . . 0.0 110.409 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.7 tp -102.4 131.26 49.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.74 -0.6 . . . . 0.0 109.897 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.17 13.75 10.71 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.618 -0.676 . . . . 0.0 111.686 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 76.74 30.16 56.51 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -59.19 -40.72 86.59 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.654 -0.91 . . . . 0.0 110.39 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 82.5 p -86.13 165.36 16.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.72 -0.613 . . . . 0.0 110.225 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.05 160.35 16.73 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.752 -0.592 . . . . 0.0 110.16 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -58.7 110.06 0.61 Allowed 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.17 1.09 . . . . 0.0 110.596 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.66 167.15 26.44 Favored 'Trans proline' 0 N--CA 1.486 1.064 0 O-C-N 123.099 1.052 . . . . 0.0 110.34 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -58.51 152.96 51.34 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 O-C-N 123.129 1.068 . . . . 0.0 110.548 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -125.32 157.41 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.758 -0.589 . . . . 0.0 110.441 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -131.54 147.12 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.814 -0.553 . . . . 0.0 110.197 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -61.3 170.13 1.87 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.68 -0.637 . . . . 0.0 110.059 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -59.23 142.71 85.92 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.641 -0.662 . . . . 0.0 110.201 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -59.42 136.67 73.28 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.161 1.085 . . . . 0.0 110.61 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -76.73 140.38 67.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.744 -0.597 . . . . 0.0 110.206 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.41 -35.59 71.49 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.111 1.058 . . . . 0.0 110.177 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.49 153.52 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.808 -0.558 . . . . 0.0 110.145 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -118.11 135.28 54.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.692 -0.63 . . . . 0.0 110.382 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.8 mt -110.63 163.08 18.11 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.791 -0.568 . . . . 0.0 109.984 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.5 134.77 60.37 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.121 1.064 . . . . 0.0 110.601 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -135.53 -44.32 0.68 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.759 -0.588 . . . . 0.0 110.281 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -133.96 152.35 51.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.678 -0.639 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -75.96 -25.37 55.81 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.684 -0.635 . . . . 0.0 110.966 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -61.96 142.74 57.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.508 -0.745 . . . . 0.0 110.14 -177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 101' ' ' GLY . 82.0 mt -118.23 136.16 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.771 -0.581 . . . . 0.0 109.901 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.7 mt -60.86 -34.74 75.06 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.755 -0.591 . . . . 0.0 110.169 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.435 ' H ' HG22 ' A' ' 99' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.476 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -61.83 -31.61 71.87 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.727 -0.867 . . . . 0.0 110.125 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm -145.95 153.07 40.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.697 -0.627 . . . . 0.0 109.733 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.19 62.01 6.51 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 28.6 Cg_endo -68.13 78.27 0.6 Allowed 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.109 1.058 . . . . 0.0 110.315 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' ALA . 72.2 p -94.89 15.34 18.86 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.725 -0.61 . . . . 0.0 111.246 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -78.21 147.21 34.55 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 110.507 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -73.12 -3.97 29.77 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.757 -0.589 . . . . 0.0 112.096 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -68.58 -24.4 64.6 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.376 -0.827 . . . . 0.0 110.41 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.657 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.2 m95 -78.3 -13.78 59.7 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.546 -0.721 . . . . 0.0 111.434 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.2 mm -55.86 133.41 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.883 -1.136 . . . . 0.0 110.319 -171.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.68 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.924 -178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.778 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.9 p -84.05 155.22 22.81 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-N 119.26 1.53 . . . . 0.0 110.491 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.36 120.85 31.84 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.758 -0.589 . . . . 0.0 110.22 -176.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.0 m -136.07 158.45 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.709 -0.619 . . . . 0.0 110.677 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.803 ' HB2' HD11 ' A' ' 68' ' ' ILE . 30.8 t -118.91 141.31 48.77 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.856 ' CD1' HG23 ' A' ' 65' ' ' ILE . 25.1 mm -123.58 121.56 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 120.079 -0.648 . . . . 0.0 109.824 -172.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 109.95 22.63 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 62.4 m -95.32 166.89 11.67 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -59.51 168.86 1.43 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.495 -0.753 . . . . 0.0 109.886 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.52 -34.16 61.23 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.524 -0.735 . . . . 0.0 111.748 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.3 t -74.68 -25.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.521 -0.737 . . . . 0.0 110.29 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 95.1 mt -91.05 -15.25 29.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.576 -0.702 . . . . 0.0 111.562 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.54 -151.55 50.56 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -132.86 142.32 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.502 -0.999 . . . . 0.0 110.046 -174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.699 ' CE2' HD13 ' A' ' 57' ' ' LEU . 48.8 p90 -133.99 158.61 43.07 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.279 171.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -136.36 143.91 44.31 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.13 169.53 42.16 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.715 HD23 ' HA ' ' A' ' 12' ' ' ALA . 74.9 mt -89.8 135.53 33.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.873 -0.78 . . . . 0.0 109.845 174.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 31' ' ' ILE . 85.0 mt -67.0 137.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 121.294 0.568 . . . . 0.0 110.14 -176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.619 ' HB2' HG13 ' A' ' 39' ' ' VAL . 18.2 tptp -108.71 -30.95 7.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.733 -0.604 . . . . 0.0 109.779 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.408 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.1 mt-30 -152.83 149.28 28.13 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.695 -0.628 . . . . 0.0 109.58 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 28' ' ' ILE . 75.5 mt -138.88 135.89 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.621 -0.674 . . . . 0.0 109.793 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.2 p -146.57 158.06 43.83 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HA ' HG21 ' A' ' 4' ' ' THR . . . -55.44 -24.22 29.47 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.548 -0.72 . . . . 0.0 111.424 -170.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -94.51 -22.54 18.18 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.373 -0.829 . . . . 0.0 111.588 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -156.56 155.42 31.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.344 -0.848 . . . . 0.0 111.126 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -113.97 139.32 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.63 -0.669 . . . . 0.0 109.49 171.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.761 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -126.02 132.0 52.08 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.51 -0.744 . . . . 0.0 110.632 -176.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.701 HG22 ' HA ' ' A' ' 28' ' ' ILE . 6.0 pt -132.8 169.86 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.672 -0.642 . . . . 0.0 110.31 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.619 HG13 ' HB2' ' A' ' 29' ' ' LYS . 34.9 m -129.39 163.18 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.66 -0.65 . . . . 0.0 110.577 -177.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 54.72 46.46 24.6 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.385 -0.822 . . . . 0.0 110.341 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.809 ' HB3' HD12 ' A' ' 48' ' ' LEU . . . -69.93 140.3 53.03 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.861 0.839 . . . . 0.0 111.944 -170.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 3.9 m-85 -115.63 141.19 48.4 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 168.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.734 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.4 ttt180 -134.83 143.3 46.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.636 -0.665 . . . . 0.0 110.11 -176.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.6 m120 53.08 40.78 31.78 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.342 -0.848 . . . . 0.0 111.033 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 46' ' ' VAL . . . 61.93 22.1 61.99 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 176.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' A' ' 47' ' ' PRO . 77.7 t -145.68 151.41 46.26 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.316 -1.108 . . . . 0.0 109.594 173.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' HG13 ' A' ' 46' ' ' VAL . 11.5 Cg_exo -67.77 148.89 78.1 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.082 1.043 . . . . 0.0 110.152 -176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.809 HD12 ' HB3' ' A' ' 41' ' ' ALA . 91.7 mt -75.56 155.33 36.11 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.529 -0.732 . . . . 0.0 110.058 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -56.11 -35.61 67.26 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.605 -0.684 . . . . 0.0 110.787 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' CB ' ' HB2' ' A' ' 53' ' ' ALA . 92.2 mttt -104.75 105.24 15.24 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.651 -0.656 . . . . 0.0 110.058 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -62.54 -36.66 83.31 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.654 -0.654 . . . . 0.0 110.071 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -85.38 2.03 46.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.763 -0.586 . . . . 0.0 111.542 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 50' ' ' LYS . . . -74.58 136.01 42.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.143 -0.973 . . . . 0.0 110.025 -177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -88.16 137.84 31.97 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.732 -0.605 . . . . 0.0 110.461 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.618 HG21 ' CB ' ' A' ' 41' ' ' ALA . 87.1 t -104.34 121.54 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.761 HG22 HG23 ' A' ' 37' ' ' THR . 38.9 t -123.53 113.95 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.409 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.699 HD13 ' CE2' ' A' ' 24' ' ' PHE . 6.9 mt -128.63 133.18 48.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.943 -0.473 . . . . 0.0 110.322 -173.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -74.63 143.87 44.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.804 -0.56 . . . . 0.0 110.613 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.57 -31.92 57.59 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.714 . . . . 0.0 110.915 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.69 -27.4 68.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.763 -0.586 . . . . 0.0 110.105 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -89.12 -25.86 21.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.658 -0.652 . . . . 0.0 110.123 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.2 mt -81.58 143.45 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 109.804 176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.2 tpt180 -100.82 -33.13 10.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.702 -0.624 . . . . 0.0 110.183 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.9 p -160.86 156.74 25.51 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.621 -0.675 . . . . 0.0 110.704 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 15' ' ' ILE . 68.9 mt -139.71 147.72 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.631 -0.668 . . . . 0.0 109.88 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -138.05 130.62 29.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.757 -0.59 . . . . 0.0 110.492 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.657 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 1.1 mt -76.93 113.78 15.0 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.62 -0.675 . . . . 0.0 109.83 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.803 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.6 mt -78.19 -44.9 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.593 -0.692 . . . . 0.0 109.848 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 49.1 mt-10 -137.13 95.13 12.03 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.862 -0.524 . . . . 0.0 110.039 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -61.04 150.47 84.04 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 O-C-N 123.307 1.162 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.95 144.33 25.76 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.727 -0.608 . . . . 0.0 110.087 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -87.2 133.1 33.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.635 -0.665 . . . . 0.0 110.276 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -61.77 -36.73 81.89 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.728 -0.607 . . . . 0.0 110.168 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -59.93 -38.01 81.13 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.695 -0.628 . . . . 0.0 110.344 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -103.51 133.57 48.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.707 -0.621 . . . . 0.0 109.901 -179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 75' ' ' LEU . 33.1 t0 -81.25 118.0 22.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.747 -0.596 . . . . 0.0 110.068 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.21 -31.34 69.14 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -97.49 77.99 2.64 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.667 -0.902 . . . . 0.0 110.437 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 76' ' ' ASP . 69.7 p -127.25 156.12 42.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.67 -0.643 . . . . 0.0 110.01 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -98.08 -53.5 0.2 Allowed Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.697 -0.627 . . . . 0.0 111.191 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 18.6 Cg_exo -58.09 -49.64 12.13 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 122.877 0.935 . . . . 0.0 111.253 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HD3' ' CD ' ' A' ' 81' ' ' PRO . 19.7 Cg_exo -62.54 146.0 95.43 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 122.964 0.981 . . . . 0.0 110.428 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -61.68 153.46 67.14 Favored 'Trans proline' 0 N--CA 1.486 1.057 0 O-C-N 123.139 1.073 . . . . 0.0 110.21 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.4 m -59.92 130.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.629 -0.669 . . . . 0.0 110.42 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.5 t -65.01 -36.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.761 -0.587 . . . . 0.0 110.055 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.587 HD22 HD11 ' A' ' 27' ' ' LEU . 55.0 t-20 -71.28 122.87 21.02 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.736 -0.603 . . . . 0.0 110.387 -176.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -134.04 166.33 30.04 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.793 -0.567 . . . . 0.0 110.122 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.96 144.15 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.156 1.082 . . . . 0.0 110.309 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.1 p -119.38 100.34 49.82 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.713 -0.617 . . . . 0.0 110.47 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.34 151.2 86.07 Favored 'Trans proline' 0 N--CA 1.487 1.09 0 O-C-N 123.317 1.167 . . . . 0.0 110.162 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 65.3 t -60.43 -40.76 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.662 -0.649 . . . . 0.0 109.832 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -82.84 136.78 34.52 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.676 -0.64 . . . . 0.0 110.12 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 tp -66.7 140.62 96.45 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.722 -0.611 . . . . 0.0 110.027 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.83 145.45 98.22 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.093 1.049 . . . . 0.0 110.589 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -122.03 146.01 47.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.718 -0.614 . . . . 0.0 110.092 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -61.5 -27.38 68.55 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.712 -0.617 . . . . 0.0 110.288 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.0 t -117.95 141.12 48.79 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.677 -0.639 . . . . 0.0 110.148 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -105.55 119.97 40.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.654 -0.654 . . . . 0.0 110.265 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.36 -35.37 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.703 -0.623 . . . . 0.0 109.743 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.1 141.6 28.36 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.766 -0.584 . . . . 0.0 110.264 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.609 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -104.09 146.65 28.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.746 -0.856 . . . . 0.0 110.276 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp -87.32 147.7 25.38 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.638 -0.664 . . . . 0.0 110.264 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 4' ' ' THR . . . -109.4 164.29 12.45 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 14.1 Cg_endo -61.27 98.12 0.14 Allowed 'Trans proline' 0 N--CA 1.487 1.108 0 O-C-N 123.249 1.131 . . . . 0.0 110.403 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 2' ' ' GLY . 73.4 p -97.43 15.7 22.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.672 -0.643 . . . . 0.0 111.141 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -78.15 142.25 38.15 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.389 -0.819 . . . . 0.0 110.49 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -73.1 -4.0 29.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.659 -0.651 . . . . 0.0 111.892 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.281 -0.887 . . . . 0.0 110.18 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.573 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.9 m95 -76.2 -13.64 60.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.598 -0.689 . . . . 0.0 111.36 -178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 30' ' ' GLN . 47.7 mm -55.89 129.68 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 120.743 -1.223 . . . . 0.0 110.064 -174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.63 89.18 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.905 -176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 4.2 p -83.16 155.27 23.85 Favored 'General case' 0 N--CA 1.505 2.303 0 CA-C-N 119.232 1.516 . . . . 0.0 110.389 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . . . -90.79 119.72 31.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.754 -0.591 . . . . 0.0 110.173 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG12 ' HG ' ' A' ' 67' ' ' LEU . 34.0 m -136.05 156.6 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.681 -0.637 . . . . 0.0 110.655 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' HD13 ' A' ' 15' ' ' ILE . 12.5 t -122.03 141.85 50.94 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.904 ' CD1' HG23 ' A' ' 65' ' ' ILE . 26.1 mm -122.11 120.3 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.045 -173.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.36 109.97 22.4 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 64.8 m -94.24 166.77 11.94 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -58.65 169.28 0.98 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.528 -0.732 . . . . 0.0 110.018 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -54.69 -34.26 62.06 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.675 -0.64 . . . . 0.0 111.785 -164.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.96 -25.45 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.558 -0.714 . . . . 0.0 110.304 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 96.2 mt -90.72 -14.28 32.44 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.498 -0.751 . . . . 0.0 111.734 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.43 -153.76 48.68 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.19 140.86 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.469 -1.018 . . . . 0.0 110.134 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.748 ' CE2' HD13 ' A' ' 57' ' ' LEU . 49.0 p90 -131.23 159.42 37.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.322 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -137.27 145.84 44.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.33 169.48 42.04 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -175.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 12' ' ' ALA . 72.6 mt -89.66 135.84 33.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.667 -0.902 . . . . 0.0 110.099 171.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.943 HG21 HD11 ' A' ' 31' ' ' ILE . 86.9 mt -67.7 137.26 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.199 0.523 . . . . 0.0 110.425 -176.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HB2' HG13 ' A' ' 39' ' ' VAL . 42.1 tttp -106.37 -31.11 8.73 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.717 -0.615 . . . . 0.0 109.933 172.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.522 ' HA ' HD12 ' A' ' 9' ' ' ILE . 44.9 tt0 -157.83 148.46 20.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.698 -0.626 . . . . 0.0 109.92 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.943 HD11 HG21 ' A' ' 28' ' ' ILE . 73.6 mt -138.4 137.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.698 -0.627 . . . . 0.0 109.961 -177.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.6 p -146.44 158.64 43.92 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.61 -23.8 29.53 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.586 -0.696 . . . . 0.0 111.312 -171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.57 -25.98 18.09 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.382 -0.824 . . . . 0.0 111.166 -174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 156.21 33.39 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.4 -0.813 . . . . 0.0 111.185 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.6 mm -113.92 139.07 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.661 -0.65 . . . . 0.0 109.442 171.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.791 HG23 HG22 ' A' ' 56' ' ' VAL . 51.3 m -124.66 131.36 53.47 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.522 -0.736 . . . . 0.0 110.398 -177.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.756 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.66 171.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.677 -0.639 . . . . 0.0 110.329 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.6 m -127.59 163.53 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.744 -0.597 . . . . 0.0 110.723 -176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 57.05 67.01 1.04 Allowed 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.492 0.663 . . . . 0.0 110.046 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.77 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -68.7 122.24 18.14 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.507 0.67 . . . . 0.0 111.429 -173.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -114.11 131.07 56.54 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 167.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.732 ' CD ' HD11 ' A' ' 48' ' ' LEU . 75.7 mtp180 -134.85 145.36 48.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.557 -0.714 . . . . 0.0 110.187 -175.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 52.45 40.09 28.95 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.451 -0.781 . . . . 0.0 111.073 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.83 22.08 61.73 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG13 ' HD2' ' A' ' 47' ' ' PRO . 71.9 t -143.93 151.92 53.95 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.407 -1.055 . . . . 0.0 109.94 174.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.421 ' HD2' HG13 ' A' ' 46' ' ' VAL . 5.8 Cg_exo -74.09 144.22 33.51 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 O-C-N 123.141 1.074 . . . . 0.0 110.23 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.77 HD12 ' CB ' ' A' ' 41' ' ' ALA . 96.9 mt -78.12 150.62 33.64 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.559 -0.713 . . . . 0.0 110.174 173.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -57.26 -34.97 69.17 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.701 -0.625 . . . . 0.0 110.688 -176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 52.0 mttt -91.31 91.88 8.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.662 -0.649 . . . . 0.0 110.142 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -62.4 -35.83 80.45 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.702 -0.624 . . . . 0.0 110.27 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -86.31 2.1 48.58 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.736 -0.603 . . . . 0.0 111.798 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -75.28 135.94 40.91 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.228 -0.92 . . . . 0.0 110.236 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -90.41 143.47 26.72 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.749 -0.595 . . . . 0.0 110.497 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG12 HD12 ' A' ' 57' ' ' LEU . 58.8 t -105.07 124.56 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.679 -0.638 . . . . 0.0 109.389 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.791 HG22 HG23 ' A' ' 37' ' ' THR . 38.1 t -123.44 112.95 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.612 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.748 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.1 mt -128.7 136.88 51.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.894 -0.504 . . . . 0.0 110.441 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.3 mttt -74.52 141.8 44.83 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.737 -0.602 . . . . 0.0 110.606 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -55.15 -32.04 61.79 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.697 -0.627 . . . . 0.0 110.879 176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.1 p -64.75 -25.43 67.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.725 -0.61 . . . . 0.0 110.334 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -88.75 -23.4 22.93 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.599 -0.688 . . . . 0.0 110.295 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.15 143.11 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.502 -0.749 . . . . 0.0 109.843 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.45 -33.17 10.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.732 -0.605 . . . . 0.0 110.224 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -163.22 129.93 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.588 -0.695 . . . . 0.0 111.026 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.904 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.4 mt -100.92 146.47 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.662 -0.649 . . . . 0.0 110.343 174.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.04 122.15 20.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.614 -0.679 . . . . 0.0 110.439 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.713 ' HG ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -75.26 113.94 13.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.519 -0.738 . . . . 0.0 110.417 178.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 14' ' ' SER . 80.0 mt -70.68 -44.05 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 7.9 mt-10 -137.06 91.9 14.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.804 -0.56 . . . . 0.0 110.101 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -74.96 -12.55 21.6 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.478 1.251 . . . . 0.0 111.507 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.75 -162.57 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.402 -0.811 . . . . 0.0 110.621 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.9 mttm 55.15 50.29 15.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.532 -0.73 . . . . 0.0 110.706 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -105.18 149.33 26.02 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.755 -0.591 . . . . 0.0 110.022 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -103.32 165.41 11.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.64 . . . . 0.0 110.306 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.3 tp -101.3 127.47 47.89 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.71 -0.619 . . . . 0.0 110.217 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 78' ' ' HIS . 36.0 t0 -143.39 143.01 31.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 110.188 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.58 132.54 14.46 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.408 ' CE1' ' HB3' ' A' ' 76' ' ' ASP . 75.0 m80 -125.93 142.1 51.67 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.623 -0.928 . . . . 0.0 110.261 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 46.9 m -59.83 -38.25 81.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.647 -0.658 . . . . 0.0 110.203 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 81' ' ' PRO . . . -80.82 173.76 7.21 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.74 -0.6 . . . . 0.0 110.219 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' A' ' 80' ' ' ALA . 24.2 Cg_exo -59.63 162.41 15.41 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 O-C-N 123.268 1.141 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -59.69 151.59 69.1 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.1 1.052 . . . . 0.0 110.491 -178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.94 146.41 93.9 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 O-C-N 123.206 1.108 . . . . 0.0 110.655 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.9 t 53.34 97.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 121.414 -0.804 . . . . 0.0 110.643 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -113.58 21.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.666 -0.646 . . . . 0.0 110.886 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -58.75 -36.3 74.14 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.439 -0.788 . . . . 0.0 110.354 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.1 145.77 46.91 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.705 -0.622 . . . . 0.0 110.168 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.89 143.75 99.55 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.155 1.082 . . . . 0.0 110.504 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 70.5 p -105.67 114.53 62.89 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.753 -0.592 . . . . 0.0 110.026 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -57.53 -22.09 49.44 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 O-C-N 122.978 0.988 . . . . 0.0 111.242 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.9 t -59.51 -45.54 93.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.492 -0.755 . . . . 0.0 110.105 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.0 mtmt -61.65 -34.7 76.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.653 -0.654 . . . . 0.0 110.162 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' HD13 ' A' ' 93' ' ' LEU . 2.4 mm? -82.34 120.08 76.21 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.796 -0.565 . . . . 0.0 110.229 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -61.52 152.71 71.54 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 122.91 0.952 . . . . 0.0 110.283 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -107.56 130.09 54.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.788 -0.57 . . . . 0.0 110.126 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -60.4 -34.66 74.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.768 -0.583 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t 51.67 94.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.393 -0.817 . . . . 0.0 111.107 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -57.7 -37.62 73.78 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.644 -0.66 . . . . 0.0 110.539 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 79.2 mt -116.78 133.61 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.695 -0.628 . . . . 0.0 109.774 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.63 130.37 46.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.736 -0.602 . . . . 0.0 110.243 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.557 0 CA-C-O 118.018 -1.435 . . . . 0.0 109.529 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -103.62 145.61 29.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.757 -0.849 . . . . 0.0 110.254 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm -155.16 148.66 25.17 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.742 -0.599 . . . . 0.0 110.097 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.58 162.52 15.3 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 31' ' ' ILE . 38.3 Cg_endo -71.92 63.58 3.24 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.176 1.093 . . . . 0.0 110.426 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -92.89 -14.12 28.05 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.617 -0.677 . . . . 0.0 111.384 -178.568 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.6 p30 -78.33 163.38 25.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.323 -0.861 . . . . 0.0 110.999 -175.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -75.49 -3.76 35.87 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.702 -0.624 . . . . 0.0 112.031 178.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -65.97 -30.26 70.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.259 -0.9 . . . . 0.0 110.12 -175.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.634 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 1.4 m95 -78.42 -13.75 59.7 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.699 -0.626 . . . . 0.0 111.626 -178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.1 mm -55.4 133.31 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 O-C-N 120.794 -1.191 . . . . 0.0 110.271 -172.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.78 89.19 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.005 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 28' ' ' ILE . 8.4 p -84.32 155.22 22.48 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 119.306 1.553 . . . . 0.0 110.431 176.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -89.9 120.72 31.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.76 -0.587 . . . . 0.0 110.21 -176.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 67' ' ' LEU . 34.2 m -136.73 161.32 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.754 -177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.829 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.3 t -126.54 140.17 52.65 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 177.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.83 ' CD1' HG23 ' A' ' 65' ' ' ILE . 23.6 mm -119.32 122.72 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.838 -174.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 111.87 24.17 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 68.6 m -95.89 166.85 11.59 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -59.16 167.63 1.67 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.56 -0.712 . . . . 0.0 109.89 -177.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -52.09 -34.67 44.92 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.661 -0.65 . . . . 0.0 112.197 -165.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.1 t -74.86 -25.43 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.482 -0.761 . . . . 0.0 110.332 -176.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 74.2 mt -90.81 -15.13 30.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.488 -0.757 . . . . 0.0 111.645 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.13 -155.16 49.34 Favored Glycine 0 N--CA 1.498 2.773 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.8 141.55 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.499 -1.0 . . . . 0.0 110.044 -175.329 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.781 ' CE2' HD13 ' A' ' 57' ' ' LEU . 51.1 p90 -131.39 156.62 45.24 Favored 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.259 174.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -137.51 148.27 45.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.774 -0.579 . . . . 0.0 109.697 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.918 ' HA3' HD12 ' A' ' 38' ' ' ILE . . . -176.36 169.55 42.12 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -176.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.725 HD23 ' HA ' ' A' ' 12' ' ' ALA . 75.5 mt -89.65 135.12 33.8 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.761 -0.847 . . . . 0.0 109.832 171.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 31' ' ' ILE . 79.6 mt -66.09 137.07 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-O 121.448 0.642 . . . . 0.0 110.624 -174.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HB2' HG13 ' A' ' 39' ' ' VAL . 35.0 tttp -107.76 -34.09 7.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.831 -0.543 . . . . 0.0 109.767 172.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -152.85 150.47 29.36 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 28' ' ' ILE . 71.1 mt -139.51 138.37 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.637 -0.665 . . . . 0.0 110.036 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.7 p -146.79 158.34 43.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.74 -23.86 31.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.555 -0.715 . . . . 0.0 111.376 -171.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -92.45 -26.0 18.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.416 -0.802 . . . . 0.0 111.187 -174.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -156.4 158.46 37.37 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.41 -0.806 . . . . 0.0 111.019 -171.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.612 ' CD1' HG23 ' A' ' 31' ' ' ILE . 51.4 mm -118.64 140.0 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.765 -0.584 . . . . 0.0 109.645 173.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.989 HG23 HG22 ' A' ' 56' ' ' VAL . 70.7 m -126.03 130.56 51.39 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.542 -0.724 . . . . 0.0 110.358 -177.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.918 HD12 ' HA3' ' A' ' 26' ' ' GLY . 19.4 pt -135.14 172.91 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.664 -0.648 . . . . 0.0 110.356 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.1 m -127.47 163.68 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.517 -0.739 . . . . 0.0 110.614 -173.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 59.72 67.04 0.92 Allowed 'General case' 0 N--CA 1.506 2.336 0 CA-C-O 121.545 0.688 . . . . 0.0 109.592 -172.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -67.84 120.55 14.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.623 0.725 . . . . 0.0 111.456 -172.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -115.72 133.27 56.2 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 168.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.802 ' HG3' HD11 ' A' ' 48' ' ' LEU . 45.7 mtm180 -134.94 146.1 48.8 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.625 -0.672 . . . . 0.0 110.252 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m120 53.01 39.74 29.98 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.478 -0.764 . . . . 0.0 110.94 179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.82 22.23 61.89 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 174.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG13 ' HD2' ' A' ' 47' ' ' PRO . 76.3 t -141.65 151.2 59.64 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.412 -1.052 . . . . 0.0 110.051 174.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' HG13 ' A' ' 46' ' ' VAL . 6.3 Cg_exo -74.16 142.16 30.34 Favored 'Trans proline' 0 N--CA 1.485 1.003 0 O-C-N 123.24 1.126 . . . . 0.0 110.374 -176.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HG3' ' A' ' 43' ' ' ARG . 73.8 mt -78.13 151.88 33.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.645 -0.66 . . . . 0.0 110.211 172.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -56.78 -35.62 68.91 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.669 -0.644 . . . . 0.0 110.785 -175.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 46.5 mttt -95.12 96.89 9.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.188 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.68 -35.1 78.57 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.813 -0.554 . . . . 0.0 110.17 179.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -84.73 2.11 43.48 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.733 -0.605 . . . . 0.0 111.724 -177.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 50' ' ' LYS . . . -74.98 135.96 41.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.21 -0.931 . . . . 0.0 110.148 -179.164 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -91.4 144.44 25.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.758 -0.589 . . . . 0.0 110.632 179.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG12 HD12 ' A' ' 57' ' ' LEU . 66.6 t -103.54 120.21 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.651 -0.655 . . . . 0.0 109.333 173.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.989 HG22 HG23 ' A' ' 37' ' ' THR . 42.9 t -123.35 112.6 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.781 HD13 ' CE2' ' A' ' 24' ' ' PHE . 4.7 mt -128.63 139.96 52.0 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.191 0.519 . . . . 0.0 110.617 -172.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -73.37 137.2 44.55 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.886 -0.509 . . . . 0.0 110.381 -175.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.51 -31.99 57.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.692 -0.63 . . . . 0.0 111.095 178.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -64.74 -25.94 68.15 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.79 -0.569 . . . . 0.0 110.354 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.66 -23.18 23.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.639 -0.663 . . . . 0.0 110.345 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 84.8 mt -81.02 144.29 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.652 -0.655 . . . . 0.0 109.814 177.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -100.75 -33.07 10.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.712 -0.617 . . . . 0.0 110.149 -179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.5 t -160.58 153.66 21.55 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.653 -0.654 . . . . 0.0 110.535 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.83 HG23 ' CD1' ' A' ' 15' ' ' ILE . 69.9 mt -138.3 145.93 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.677 -0.639 . . . . 0.0 109.743 -177.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -136.26 132.26 35.55 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.787 -0.571 . . . . 0.0 110.646 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.634 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.88 113.75 16.08 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.674 -0.641 . . . . 0.0 109.709 172.153 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 14' ' ' SER . 84.9 mt -77.75 -48.44 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.609 -0.682 . . . . 0.0 109.994 -179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.692 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 12.8 mt-10 -137.12 99.26 10.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.798 -0.564 . . . . 0.0 110.324 -176.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 69' ' ' GLU . 16.8 Cg_endo -62.56 -25.78 75.72 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 O-C-N 123.267 1.141 . . . . 0.0 110.426 175.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -130.88 165.27 23.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.594 -0.691 . . . . 0.0 110.143 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -57.56 -37.14 72.63 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.691 -0.631 . . . . 0.0 110.638 -178.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -102.47 130.18 49.2 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.683 -0.636 . . . . 0.0 110.165 178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -60.84 -40.29 92.31 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.722 -0.611 . . . . 0.0 110.291 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 79' ' ' THR . 16.9 tp -112.16 135.66 52.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.726 -0.609 . . . . 0.0 110.146 -179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -57.04 -33.88 67.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.529 -0.732 . . . . 0.0 110.728 -178.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -62.3 177.74 5.54 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -178.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -58.75 -41.39 86.4 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.678 -0.895 . . . . 0.0 110.648 -177.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 75' ' ' LEU . 10.1 t -132.62 158.11 43.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.702 -0.624 . . . . 0.0 110.659 -177.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -125.15 83.9 60.07 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -59.97 147.06 94.32 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.162 1.085 . . . . 0.0 110.426 -178.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 21.9 Cg_exo -58.4 -48.68 14.54 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.186 1.098 . . . . 0.0 111.146 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 82' ' ' PRO . 28.2 Cg_exo -58.06 147.29 83.67 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 O-C-N 122.908 0.952 . . . . 0.0 110.754 -178.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.03 137.43 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.735 -0.603 . . . . 0.0 110.297 -179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.2 m -68.31 -27.11 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.735 -0.603 . . . . 0.0 110.468 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -94.03 117.76 30.55 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.648 -0.657 . . . . 0.0 110.212 -179.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -128.56 167.02 20.62 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.751 -0.593 . . . . 0.0 110.209 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.61 146.79 96.46 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.148 1.078 . . . . 0.0 110.401 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.6 t -68.23 142.47 94.85 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 0.0 110.255 -179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 144.86 95.23 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.164 1.086 . . . . 0.0 110.41 -179.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t 52.99 97.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 121.393 -0.817 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -132.14 128.16 37.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 0.0 110.233 178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' HB2' ' CG ' ' A' ' 96' ' ' PHE . 8.7 mt -76.9 146.51 75.94 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.782 -0.574 . . . . 0.0 110.169 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -61.38 139.94 85.26 Favored 'Trans proline' 0 N--CA 1.486 1.038 0 O-C-N 123.113 1.06 . . . . 0.0 110.335 179.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 59.2 m80 53.13 29.73 8.66 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.369 -0.832 . . . . 0.0 110.938 -179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.426 ' CG ' ' HB2' ' A' ' 93' ' ' LEU . 67.3 t80 -103.15 132.7 49.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.729 -0.607 . . . . 0.0 110.252 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.51 ' H ' HD12 ' A' ' 100' ' ' LEU . 49.6 m -119.61 145.31 46.54 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.764 -0.585 . . . . 0.0 110.231 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -59.5 -32.73 70.55 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.767 -0.583 . . . . 0.0 110.349 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -58.77 -28.78 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.715 -0.616 . . . . 0.0 110.645 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 97' ' ' SER . 98.1 mt -61.89 -34.61 76.35 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.686 -0.634 . . . . 0.0 110.126 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 CA-C-O 117.969 -1.462 . . . . 0.0 109.501 179.987 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -100.58 26.05 7.14 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.715 -0.874 . . . . 0.0 110.434 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp -149.7 154.9 39.29 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.644 -0.66 . . . . 0.0 109.973 -179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.89 68.62 1.59 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' O ' ' CD1' ' A' ' 8' ' ' TRP . 9.5 Cg_endo -58.56 155.4 36.79 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 O-C-N 123.14 1.073 . . . . 0.0 110.799 -178.228 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.8 p -97.41 25.37 5.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.693 -0.629 . . . . 0.0 110.415 178.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.36 159.45 30.5 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.627 -0.671 . . . . 0.0 110.709 -175.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -71.82 -3.85 24.57 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.718 -0.614 . . . . 0.0 111.965 178.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -65.94 -22.26 66.47 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.226 -0.921 . . . . 0.0 110.242 175.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.685 ' CZ3' HD22 ' A' ' 67' ' ' LEU . 3.0 m95 -76.92 -13.93 59.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.468 -0.77 . . . . 0.0 111.536 -178.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 30' ' ' GLN . 46.7 mm -55.67 129.26 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 O-C-N 120.845 -1.159 . . . . 0.0 110.105 -173.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.66 -0.7 89.19 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.902 -175.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' A' ' 28' ' ' ILE . 2.5 p -83.96 155.19 22.93 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 119.241 1.52 . . . . 0.0 110.441 177.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.742 ' HA ' HD23 ' A' ' 27' ' ' LEU . . . -92.05 121.36 33.54 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.718 -0.613 . . . . 0.0 110.384 -174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 67' ' ' LEU . 33.6 m -136.56 158.72 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.709 -0.619 . . . . 0.0 110.838 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.589 ' HB2' HD11 ' A' ' 68' ' ' ILE . 29.5 t -121.38 140.32 52.28 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 174.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.834 ' CD1' HG23 ' A' ' 65' ' ' ILE . 24.9 mm -121.27 121.85 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.872 -173.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.17 109.96 22.63 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' CB ' ' HB2' ' A' ' 21' ' ' LEU . 66.4 m -94.99 166.8 11.76 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -58.93 170.21 0.88 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.463 -0.773 . . . . 0.0 109.987 -177.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -54.69 -34.37 62.23 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.575 -0.703 . . . . 0.0 111.781 -165.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -74.85 -25.44 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.539 -0.726 . . . . 0.0 110.284 -176.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 17' ' ' CYS . 95.0 mt -91.04 -16.35 28.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.536 -0.727 . . . . 0.0 111.569 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.61 -153.26 49.58 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.24 138.39 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.488 -1.007 . . . . 0.0 109.921 -175.653 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.711 ' CE2' HD13 ' A' ' 57' ' ' LEU . 47.1 p90 -129.08 159.37 36.19 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.352 173.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -135.86 146.6 47.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.82 -0.55 . . . . 0.0 109.522 177.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.4 169.52 42.07 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -176.547 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.742 HD23 ' HA ' ' A' ' 12' ' ' ALA . 73.3 mt -89.89 136.75 32.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.702 -0.881 . . . . 0.0 110.027 171.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.868 HG21 HD11 ' A' ' 31' ' ' ILE . 85.9 mt -67.2 137.23 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.892 -0.505 . . . . 0.0 110.478 -177.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' HG13 ' A' ' 39' ' ' VAL . 29.1 tttp -107.32 -35.78 6.7 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.694 -0.629 . . . . 0.0 109.914 172.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.428 ' HA ' HD12 ' A' ' 9' ' ' ILE . 89.9 mt-30 -152.24 152.44 32.2 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 -179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.868 HD11 HG21 ' A' ' 28' ' ' ILE . 69.6 mt -139.83 139.22 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.644 -0.66 . . . . 0.0 109.957 -178.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -146.35 158.27 43.87 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.67 -23.81 30.48 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.571 -0.706 . . . . 0.0 111.435 -171.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -92.66 -26.03 18.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.446 -0.784 . . . . 0.0 111.207 -174.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 158.05 36.58 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.442 -0.786 . . . . 0.0 111.139 -172.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CD1' HG23 ' A' ' 31' ' ' ILE . 50.9 mm -114.01 139.95 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.588 -0.695 . . . . 0.0 109.493 172.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.78 HG23 HG22 ' A' ' 56' ' ' VAL . 61.7 m -124.27 131.44 53.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.687 . . . . 0.0 110.412 -177.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.778 HG22 ' HA ' ' A' ' 28' ' ' ILE . 5.8 pt -134.58 174.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.605 -0.684 . . . . 0.0 110.495 -177.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 29' ' ' LYS . 35.0 m -128.42 163.72 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.866 -0.521 . . . . 0.0 110.303 -177.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 59.33 66.59 1.01 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.398 0.618 . . . . 0.0 109.695 -173.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.866 ' HB1' HD12 ' A' ' 48' ' ' LEU . . . -68.87 115.21 7.93 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.269 0.557 . . . . 0.0 111.313 -175.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 47' ' ' PRO . 11.3 m-85 -116.53 136.72 52.74 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.559 -0.713 . . . . 0.0 109.717 169.482 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.684 ' CB ' HD21 ' A' ' 48' ' ' LEU . 68.1 ttt180 -134.81 143.28 46.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 109.735 -177.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 m120 52.15 39.3 26.47 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.279 -0.888 . . . . 0.0 111.138 -178.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.9 22.06 61.87 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.487 HG13 ' HD2' ' A' ' 47' ' ' PRO . 58.8 t -145.07 151.18 47.94 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.45 -1.029 . . . . 0.0 109.63 174.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 46' ' ' VAL . 19.0 Cg_exo -63.56 141.24 79.31 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 O-C-N 123.114 1.06 . . . . 0.0 110.125 -175.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.866 HD12 ' HB1' ' A' ' 41' ' ' ALA . 37.4 mt -74.13 -50.69 18.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.563 -0.711 . . . . 0.0 110.634 -178.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -171.93 -65.9 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.507 -0.745 . . . . 0.0 110.328 178.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 34.2 mttm -114.12 132.78 55.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.655 -0.653 . . . . 0.0 110.25 -178.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.1 -34.78 76.96 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.745 -0.597 . . . . 0.0 110.208 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -83.97 2.11 40.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.62 . . . . 0.0 111.7 -176.569 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . . . -74.81 135.86 41.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.185 -0.947 . . . . 0.0 110.121 -179.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -92.4 139.86 30.17 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.788 -0.57 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 57' ' ' LEU . 61.1 t -106.61 123.96 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 174.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.78 HG22 HG23 ' A' ' 37' ' ' THR . 36.4 t -123.46 112.97 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.555 176.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.711 HD13 ' CE2' ' A' ' 24' ' ' PHE . 5.9 mt -128.65 135.94 49.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.954 -0.466 . . . . 0.0 110.356 -173.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.74 141.97 44.39 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.789 -0.569 . . . . 0.0 110.64 -176.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 26.3 p -54.94 -31.99 60.95 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.625 -0.672 . . . . 0.0 110.849 176.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.5 p -64.77 -27.03 68.61 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.764 -0.585 . . . . 0.0 110.152 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -88.95 -24.46 22.43 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.681 -0.637 . . . . 0.0 110.192 177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.4 mt -81.13 143.53 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.657 -0.652 . . . . 0.0 109.785 177.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -100.95 -33.04 10.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.659 -0.651 . . . . 0.0 110.257 -178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.9 t -160.59 153.37 21.14 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.665 -0.647 . . . . 0.0 110.581 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.834 HG23 ' CD1' ' A' ' 15' ' ' ILE . 70.6 mt -138.42 146.38 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.629 -0.669 . . . . 0.0 109.885 -178.058 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -136.3 129.06 30.86 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.0 110.337 179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD22 ' CZ3' ' A' ' 8' ' ' TRP . 0.9 OUTLIER -77.02 113.83 15.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.625 -0.672 . . . . 0.0 109.796 174.434 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 14' ' ' SER . 78.7 mt -73.84 -48.27 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.633 -0.667 . . . . 0.0 109.845 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' ALA . 30.7 mt-10 -137.16 99.9 9.75 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.862 -0.524 . . . . 0.0 110.132 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -62.6 141.43 86.0 Favored 'Trans proline' 0 N--CA 1.484 0.917 0 O-C-N 123.224 1.118 . . . . 0.0 110.083 177.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.97 85.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.715 -0.616 . . . . 0.0 110.168 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -61.5 -45.16 95.38 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.65 -0.656 . . . . 0.0 110.534 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -142.99 153.13 42.68 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.669 -0.644 . . . . 0.0 110.582 -178.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -93.37 120.2 33.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.838 -0.539 . . . . 0.0 110.053 175.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' ILE . 97.1 mt -59.95 -37.32 79.21 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.622 -0.673 . . . . 0.0 110.325 -179.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -160.7 165.99 29.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.731 -0.605 . . . . 0.0 110.386 179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.85 124.55 7.89 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -128.49 136.89 51.42 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.692 -0.887 . . . . 0.0 110.239 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.6 m -80.97 134.62 35.73 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.623 -0.673 . . . . 0.0 110.14 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 81' ' ' PRO . . . -174.46 -52.63 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.109 0 O-C-N 121.624 -0.673 . . . . 0.0 110.884 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 80' ' ' ALA . 21.7 Cg_exo -62.47 162.9 22.51 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 122.791 0.89 . . . . 0.0 110.292 -177.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -62.14 163.53 19.64 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.221 1.116 . . . . 0.0 110.27 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.45 147.69 90.26 Favored 'Trans proline' 0 N--CA 1.488 1.16 0 O-C-N 123.135 1.071 . . . . 0.0 110.653 -178.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.84 160.32 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.771 -0.58 . . . . 0.0 110.388 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 64.2 t -60.65 -38.63 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.734 -0.604 . . . . 0.0 109.98 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.1 t30 54.46 48.19 21.1 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.326 -0.859 . . . . 0.0 110.767 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.2 mttt 57.06 161.99 0.08 OUTLIER Pre-proline 0 N--CA 1.504 2.238 0 O-C-N 121.788 -0.57 . . . . 0.0 110.898 -177.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.12 149.35 89.58 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 O-C-N 122.938 0.967 . . . . 0.0 110.418 178.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.3 p -123.6 155.36 66.17 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.757 -0.589 . . . . 0.0 110.276 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -60.5 146.78 96.24 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.246 1.129 . . . . 0.0 110.555 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.23 -38.87 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.757 -0.589 . . . . 0.0 109.797 179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -85.3 148.19 26.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.752 -0.593 . . . . 0.0 110.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 93' ' ' LEU . 4.5 mm? -66.67 148.26 98.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.727 -0.608 . . . . 0.0 110.092 -179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.71 144.21 99.51 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 O-C-N 123.187 1.098 . . . . 0.0 110.495 -179.303 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.402 ' CE1' ' O ' ' A' ' 93' ' ' LEU . 75.5 m80 -121.49 144.0 48.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.76 -0.588 . . . . 0.0 110.214 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -98.6 132.92 43.63 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.731 -0.605 . . . . 0.0 110.033 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.6 t -113.05 145.48 40.8 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.739 -0.601 . . . . 0.0 110.35 -177.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.3 m120 55.0 171.05 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.62 -0.675 . . . . 0.0 110.866 -178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.7 tp -125.05 137.49 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.722 -0.612 . . . . 0.0 110.123 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.3 tp -58.92 -40.09 83.5 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.625 -0.672 . . . . 0.0 110.532 -177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.467 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.523 178.9 . . . . . . . . 0 0 . 1 stop_ save_